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As António Damásio says in Descartes’ Error “neither anguish nor the elation that love 
or art can bring about are devalued by understanding some of the myriad biological 
processes that make them what they are. Precisely the opposite should be true: our 
sense of wonder should increase before the intricate mechanisms that make such 
magic possible”. Every thought, feeling and action initiates in the brain. For this, the 
brain needs to compute a large amount and wide variety of information. Neurons, the 
functional units of the brain, are specialized in sending and receiving information, 
which is essential for brain function. It is thus unsurprising that the brain develops in 
well-defined and highly regulated steps that ensure neurons form and organize 
correctly1-5. Fast communication between neurons occurs mostly at synapses, 
specialized structures where two neurons connect. However, neurons can also 
receive information from the milieu, for example at the primary cilium, a structure 
sticking out from the cell soma as a little antenna (reviewed in 6). These two types of 
information allow neurons to communicate rapidly and modulate their activity in 
response to external cues. This empowers neurons with extraordinary computation 
capacity necessary for higher cognitive functions. Deeper understanding of these 
processes is essential to fully comprehend normal brain function, and how it is affected 
in disease. 
 
1.1. Synaptic Function & Plasticity 
 
1.1.1. Neurotransmission is a powerful mode of neural communication 
The brain is specialized in processing information. Neurons are dedicated 
communicators, and their synapses are the main neuronal structures where 
information transfer takes place. During synaptic transmission neurons communicate 
with each other via chemical and electrical signals, at an extraordinary speed and 
precision. Given the importance of neural communication for brain function its 
mechanisms have been the focus of extensive research. Bernard Katz received the 
Nobel Prize of Medicine in 1970 for his work demonstrating that synaptic transmission 
can occur at single ‘quantal’ events, corresponding to the fusion of a single vesicle 
containing neurotransmitters. Since then, extensive research has been conducted, 
and in 2013 the Nobel Prize of Medicine was awarded to Thomas Südhof, James 
Rothman, and Randy Schekman for their discoveries on the release machinery of 
synaptic vesicles. These scientific efforts unraveled, at astonishing detail, the process 
of neurotransmission (Box I). There are several modes of neurotransmission, broadly 
subdivided into two categories: evoked and spontaneous. Evoked neurotransmission 
is triggered by action potentials and results in the synchronized release of synaptic 
vesicles from the pre-synapse. Spontaneous neurotransmission, as Katz and 
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colleagues observed, occurs in ‘quantal’ units and in the absence of an action potential 
7. Even though these two modes of neurotransmission share common features, they 
may also have relevant differences: SNARE complex composition, calcium sensors, 
pool of origin, place of release, and postsynaptic targets may all differ between the 
two (reviewed in 8). These differences make it likely that spontaneous and evoked 
neurotransmission fulfill different functions in cells (reviewed in 8), and so it is relevant 
to study both in order to fully understand neuronal connectivity.  
 
 
BOX I - Molecular Mechanisms of Neurotransmission 
 
Neurotransmission is a process of neural communication occurring at the synapse, 
between a pre-synaptic neuron sending information and a post-synaptic neuron 
receiving it. At the presynaptic site, synaptic vesicles containing neurotransmitters are 
partly clustered by liquid-phase separation mediated by the vesicle protein synapsin 
9, of which a subset is physically docked with a specialized region, the active zone. 
When an action potential arrives at the pre-synapse, voltage-gated calcium channels 
open, allowing influx of calcium ions 10,11. These calcium ions bind to synaptotagmin, 
inducing zippering of the SNARE (for soluble N-ethylmaleimide-sensitive factor (NSF) 
attachment protein receptor) complex thus triggering fusion of synaptic vesicles 10,11. 
Upon synaptic vesicle exocytosis, neurotransmitters are released in the synaptic cleft 
and bind to receptors at the post-synapse, triggering ion influx and inducing a post-
synaptic current that may trigger an action potential in the post-synaptic neuron to 
propagate information. Neurotransmission is a strikingly fast process, and upon 
milliseconds of calcium entering in the presynaptic a postsynaptic current can be 
detected 8. Importantly, lipid fusion is energetically very costly, and an energy barrier 
for fusion between the synaptic vesicle and the pre-synaptic membrane exists 8. 
Zippering of the SNARE complex – formed by vesicle bound VAMP2 (vesicle-
associated membrane protein 2, or synaptobrevin-2), and the two membrane bound 
proteins, syntaxin-1 and SNAP25 (synaptosome associated protein 25) – is a highly 
exergonic reaction sufficient to induce membrane fusion in vitro 8,11. In addition, 
calcium positive charges interacting with the negative charges of phospholipids are 
also sufficient to induce fusion in vitro 8,12. In vivo, both SNAREs and calcium binding 
to synaptotagmin lower the energy barrier facilitating fusion 8,11,12. These components, 
together with a handful of other essential proteins like e.g. STXBP1/MUNC18, 
MUNC13, and RIMs tightly regulate fusion, allowing for fast and synchronous release 
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1.1.2. Neuronal communication is plastic 
Neurotransmission has a high degree of flexibility, which is imperative for proper brain 
function. This flexibility can be achieved through different mechanisms ranging from 
changes in neural morphology – named structural plasticity – to alterations in synaptic 
strength – called synaptic plasticity. Modulation of synaptic strength can be achieved 
for example by regulating the number of vesicles in the readably releasable pool, the 
size of the synapse or the presynaptic pool of proteins (reviewed in 13). Importantly, 
vesicle release probability, which determines synaptic strength, can be regulated at 
individual synapses, allowing flexibility and optimization of each synaptic connection 
(reviewed in 14). In addition to this local form of plasticity, changes in dendritic and 
axonal arbors of neurons, synaptic density, and spine structure may affect neuronal 
connectivity (reviewed in 14,15). This form of structural plasticity varies between 
neuronal type and brain regions (reviewed in 15). Collectively, these mechanisms allow 
neurons to compute information with astonishing degrees of freedom, both spatially 
and temporally, which is fundamental for the high cognitive capacities of the brain. 
 
1.2. The Primary Cilium 
 
1.2.1. Primary cilia are specialized organelles projecting from the basal body to the 
extracellular milieu 
Cilia are specialized organelles composed of microtubules that anchor in basal bodies 
and project outwards from the cell membrane (Fig.1.1). The basal body is a modified 
centriole, originating from the mother centriole, containing specialized components for 
ciliary function (reviewed in 16). Transition fibers at the base of the ciliary axoneme 
connect the basal body to the ciliary membrane, and form the transition zone (Fig. 
1.1), which helps separating the ciliary content from the rest of the cell (reviewed in 
17,18). Cilia can be divided into motile and non-motile, primary, cilia. Motile cilia are 
responsible for movement of cells and fluids, and multiple can be present on a single 
cell. They are composed of nine microtubule doublets surrounding a central pair (9+2 
arrangement). This composition allows motile cilia to beat regularly, and coordinate 
fluid flow in several organs including the respiratory and reproductive system, and the 
brain (reviewed in 19). In contrast, primary cilia are signaling organelles and only one 
cilium is present per cell. Primary cilia lack the central pair in the axoneme 
arrangement, rendering them non-motile (9+0 arrangement; Fig.1.1). Motile cilia are 
only present in specific brain areas, such as ventricles –  where they contribute to flow 
of the cerebral spinal fluid – whereas primary cilia are present in all brain areas, both 
on neurons and astrocytes (reviewed in 20).  
 
Primary cilia are regarded as the “cell’s antenna” (reviewed in 6) and have several 
characteristics of a signaling hub (Fig.1.1): they extend into the extracellular milieu, 
have a high surface-to-volume ratio, and their membrane and cytoplasmic content are 
isolated from the rest of the cell (reviewed in 6). Several mechanisms control ciliary 
content (reviewed in 17). First, transition fibers at the base of the cilia function as a 
barrier, preventing membrane proteins and large soluble proteins (> 100KDa) to freely 
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diffuse in and out of the cilia (reviewed in 17). Second, cilia can locally produce 
components. For example, adenyl cyclases localizing to the cilia are responsible for 
production of the second messenger cAMP (reviewed in 6,17). In addition, inositol 
polyphosphate 5-phosphatase E (INPP5E) catalyzes the production of PI4P 
(phosphatidylinositol 4-phosphate) from PI(4,5)P2 (phosphatidylinositol (4,5)-
bisphosphate), bestowing cilia a lipid composition distinct from the plasma membrane 
21,22. Third, cilia possess a specialized transport system, the intraflagellar transport 
(IFT) system (reviewed in 17). The IFT-A, IFT-B and the BBSome are components of 
this system that, in conjugation with the motor proteins kinesin-2 and dynein-2, traffics 
specific cargoes in and out of the cilia (Fig. 1.1 and reviewed in 16,17). Fourth, cilia can 
discard their contents by releasing ciliary vesicles through exocytosis (Fig. 1.1 and 
reviewed in 17). Importantly, cilia composition is dynamic, giving cilia the unique ability 
to adapt their signaling capacities to the necessities of the cell (reviewed in 16). 
Together these characteristics allow cilia to maintain their identity and function as the 
cell’s “antennae”. 18 
 
 
  Figure 1.1 – The neuronal primary cilium is a signaling hub. 
Image depicting a neuron (yellow) and a primary cilium (blue) emanating from the basal body 
localized in the soma (left). Zoom of the cilium structure (right). The non-motile cilium, present in 
most neurons, is composed of nine microtubule doublets that emanate from modified centrioles, the 
basal body. The membrane and content of the cilium is isolated from the rest of the cell, and 
transitions fibers and a transition zone at the base of the cilium limit diffusion in and out of the cilium. 
Intraflagellar transport of cargo in and out of the cilia involves specialized components, and is driven 
by kinesin 2 and dynein 2. This specialized form of transport also ensures that cilia composition is 
controlled. Cilia can also regulate their content and length by releasing ectosomes. The cilia 
membrane is enriched in several G protein-coupled receptor to transmit signals from the 
environment. Figured inspired by 16,18. 
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1.2.2. Primary cilia are signaling hubs 
Primary cilia are dynamic signaling hubs of most cells, including neurons. One famous 
signaling pathway that accumulates in the cilia is the Hedgehog (Hh) cascade (Box II). 
A genetic forward screen in 2003, identified several IFT components required for Hh 
signaling 23, and since then additional studies confirmed cilia as the center for Hh 
signaling in mammals (reviewed in 24). The components of Hh pathway accumulate in 
cilia and as this pathway is key to brain development, primary cilia are believed to play 
a key role in neurodevelopment. 
 
BOX II – Sonic Hedgehog Signaling Cascade 
 
Mammals express three Hh paralogues, Desert, Indian and Sonic Hh (SHH), but SHH 
is the most widely studied. All play important roles in organ development and 
homeostasis, including in the brain (reviewed in 25). In the absence of SHH, its receptor 
protein patched homolog 1 (PTCH1) is enriched in cilia, which in turn inhibits 
Smoothened (SMO) from targeting to cilia. In this state the G protein-coupled receptor 
(GPCR), GPR161 is active, and promotes cAMP production by adenyl cyclases 5 or 
6 in the cilium. Increase in ciliary concentration of cAMP activates protein kinase A, 
which phosphorylates GLI2 and GLI3 and results in their proteolytic cleavage into 
repressed forms. Once SHH binds to its receptor, PTCH1 is removed from the cilia, 
resulting in GPR161 depletion from cilia and SMO accumulation. This, in turn, results 
in inactivation of the adenyl cyclases, and GLI2 and 3 enrich in their active forms. 
These activated GLI proteins can then promote the transcription of target genes, 
including Gli1 and Ptch1 (reviewed in 16,17,24,25). Interestingly, a recent paper 
demonstrated that PTCH1 mediates the cholesterol distribution in the lipid bilayer in a 
SHH dependent manner, and that this might be a mechanism through which PTCH1 
regulates SMO levels at the cilium 26. 
 
 
Another important group of molecules contributing to the ciliary signaling capacities 
are the G protein-coupled receptors (GPCRs), which are the largest signaling receptor 
family in the human genome (reviewed in 16). GPCRs respond to a wide variety of 
signals, and mediate numerous functions. However, they all share a common 
mechanism of activation/deactivation, dependent on Guanosine-5'-triphosphate 
(GTP). In the inactive state, the receptor is bound to a G-protein of 3 subunits – Gα, 
Gβ and Gγ – and Gα is bound to GDP. When the agonist binds to the receptor, GDP is 
replaced by GTP, and the G-protein dissociates in a Gα, subunit now bound to GTP 
and Gβγ dimer, which can activate downstream effectors. GPCRs that accumulate in 
the ciliary membrane in neurons include the Somatostatin receptor subtype 3 27,28, 
neuropeptide Y receptor subtype 2 and 5 29, melanocortin 4 receptor 30 and GPR161 
31. somatostatin receptor subtype 3 depletion impairs memory and synaptic plasticity 
28. Ciliary localization of both melanocortin 4 and neuropeptide Y receptors are 
important for controlling food intake, and both are linked to obesity 29,30. As noted 
above, GPR161 is important for SHH signaling and brain patterning during 
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development 31. Other signaling pathways, like WNT and transforming growth factor- 
β (TGFβ)/bone morphogenetic protein (BMP) pathways have also been linked to cilia; 
however, their ciliary mechanisms are less clear (reviewed in 16). In conclusion, cilia 
are plastic organelles, and their unique characteristics make them excellent neuronal 
signaling hubs. 
 
1.2.3. Cilia are important for brain function 
The importance of cilia function is highlighted by the association of ciliary disfunction 
with human diseases, affecting multiple organs, including the brain. Genetic disorders 
affecting the motile cilia result in a group of diseases named primary ciliary dyskinesia, 
characterized by interfertility and respiratory symptoms and occasionally 
hydrocephalus (reviewed in 32,33). Genetic disorders affecting the structure or function 
of primary cilia, are called ciliopathies and can result in dramatic impairments of brain 
function (reviewed in 32,34). A functional genomic analysis by Guo and colleagues 
identified ciliary and centrosomal genes, and from those more than 85% were 
associated with ciliopathies resulting in brain-related deficits in humans 35. Three of 
the most widely studied ciliopathies in this category are Joubert’s, Bardet-Biedl, and 
Meckel’s syndromes. Joubert syndrome is a heterogeneous disorder, including 
symptoms such as ataxia and intellectual disability, which hallmark is the presence of 
a brain malformation designated “molar tooth sign” (reviewed in 33,34). Several genes 
are associated with this disorder, and all of them target ciliary proteins, predominantly 
at the transition zone (reviewed in 33). Bardet-Biedl syndrome is a heterogenous 
disorder characterized mostly by obesity, retinal dystrophy, renal deficits and 
polydactyly, and most of the genes affected in this disorder target components of the 
BBsome (reviewed in 33,34). Finally, the Meckel syndrome is a group of disorders with 
severe symptoms and classically diagnosed by polycystic kidneys, polydactyly and 
brain malformations, with genetic overlap with Joubert’s and Bardet-Biedl’s syndromes 
(reviewed in 33,34). Together, the severity and heterogeneity of these disorders 
strengthen the importance of better characterizing cilia function in the brain, to identify 
novel targets for treatments.  
 
In addition to disease, primary cilia have been shown to control several neuronal 
functions in both the developing and mature brain (reviewed in 16,36). First, ciliary 
functioning is tightly related to SHH signaling, and cilia are required for patterning of 
the mouse brain 23,37. Second, cilia have been extensively linked to cell division and 
conditional knock-out (cKO) of ciliary genes that ablate cilia, affect proliferation of 
neuronal progenitors in the hippocampus and cerebellum 38-41. Importantly, cKO of 
genes in adult-born neurons still impacts neurogenesis in the hippocampus, indicating 
that cilia are important beyond development 38,40. Third, cilia have been linked to 
neuronal migration. Conditional removal of Arl13b – a ciliary GTPase – in postmitotic 
interneurons disrupts their migration in the developing cortex 42. Baudoin and 
colleagues demonstrated that migrating GABAergic neurons assemble a primary 
cilium, and its disruption by mutations in Ift88 or Kif3a genes, disrupts neuronal 
migration 43. Silencing of Ift172 ablates cilia and impairs radial migration in the cortex 
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during early development 44. Fourth, disruption of ciliary integrity by overexpression of 
dominant negative, or conditional KO of ciliary genes impairs dendritic outgrowth and 
synaptic connectivity 45-49. Finally, mouse models with abnormal cilia show behavior 
deficits such as memory and motor impairments or depression like behaviors 
28,38,46,48,50.  
 
All of the above implicate neuronal cilia in development and neurogenesis, but the 
importance of cilia in postmitotic neurons has also been demonstrated. Conditional 
KO of the ciliary gene Arl13b in interneurons, after their generation and placement, 
resulted in a decrease in parvalbumin processes and vGAT+ puncta 49. In addition, 
conditional KO of both Ttbk2 and Ift88, after cerebellum morphogenesis, resulted in 
decreased percentage of ciliated neurons, reduced molecular layer thickness, reduced 
vGlut2 puncta, decreased number of Purkinje cells in the cerebellum, and motor 
deficits 48. Conditional KO of adenylyl cyclase 3 III in adult mice induces depression-
like behaviors 46. Even more strikingly, Guo and colleagues demonstrated in a recent 
paper that acute regulation of ciliary signaling using opto and chemogenetics, affects 
axonal growth dynamics within minutes 51, suggesting that cilia can modulate neurons 
quickly. Even though it is difficult to distinguish between effects of ciliary proteins and 
the cilia organelle per se, multiple studies, affecting a diverse range of ciliary proteins 
and processes, point towards a role for cilia in the brain. Taken together, these studies 
implicate cilia in neuronal division, migration, outgrowth, synaptic connectivity and 
memory formation.  
 
1.2.4. The structure of the primary cilium is plastic  
Cilia are dynamic organelles, and both their assembly and disassembly are highly 
regulated. Ciliogenesis starts after cell cycle arrest and involves several processes: 1. 
development of basal bodies from the mother centriole, which then dock in the cell 
surface; 2. nucleation of axonemal microtubules, 3. IFT mediated transport of proteins 
to the cilia, 4. vesicle trafficking and fusion, 5. enlargement of lipid bilayer ensheathing 
the axoneme (reviewed in 52,53). Ciliogenesis is tightly coordinated with the cell cycle, 
as the centrosome is necessary for formation of both mitotic spindle and the primary 
cilium. This relationship is observed bidirectionally, as for example aberrant increase 
in cell division in cancer prevents ciliogenesis, and mutations that impair ciliary 
formation can induce cyst formation in kidneys in some ciliopathies (reviewed in 54). 
Deciliation can occur either by microtubule severing or by microtubule destabilization 
and ciliary resorption (reviewed in 52). A key player in the mechanism of ciliary 
disassembly is aurora a kinase, as its activation promotes, and its inactivation prevents 
ciliary disassembly 55. Several activators of aurora a kinase also lead to ciliary 
disassembly, such as HEF1 55, calmodulin 56, trichoplein 57 and pitchfork  58. Aurora a 
kinase probably acts on ciliary disassembly through activation of Histone Deacetylase 
6 (HDAC6), which in turn deacetylates axoneme microtubules, and destabilizes them 
55. HDAC6 might also induce ciliary dynamics by deactivation of cortactin, which leads 
to increase in actin polymerization and promotes ciliary disassembly 59. Actin is 
another component consistently linked to ciliary dynamics. Depolymerization of actin 
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increases cilia length 60. Interestingly, in more recent years actin has been shown to 
be necessary for ciliary ectocytosis, a mechanism through which actin might influence 
ciliary length 61,62. It is important to state that even though ciliogenesis and ciliary 
disassembly are related processes, they are not exclusively dependent on similar 
mechanisms. Several proteins have been shown to promote ciliary disassembly when 
overexpressed, without affecting ciliogenesis: aurora a kinase, PLK1, HDAC6, TCTEX 
and NEK2 55,59,63-66. 
 
Cilia dynamics is not only important in mitotic cells, as postmitotic neurons also have 
a cilium and disruptions in its structure or signaling can result in neuronal disfunction 
48,49,51. Beyond cell cycle, several other processes have been shown to influence cilia 
size, including organization of the centrosome, posttranslational modifications of 
tubulin, IFT, signal transduction and environmental cues (reviewed in 67). In neurons 
both developmental stage and final layer position of the cell can interfere with ciliary 
structure 68,69. In addition, migrating cortical interneurons have a dynamic cilia length 
42, and olfactory neurons in C. elegans remodel their cilia in a sensory signaling-
dependent manner 31. This suggests the presence of machinery that senses 
extracellular cues and modulates ciliary architecture. However, the mechanisms that 
regulate cilia structure in neurons, remain mostly elusive.  
 
In summary, the primary cilium is a dynamic organelle, whose impairments have been 
consistently linked to neuronal disfunction and brain abnormalities. Further exploring 
the mechanisms that regulate ciliary structure and signaling in postmitotic neurons is 
crucial for our capacity to target and treat ciliopathies.  
 
1.3. Development of the Dentate Gyrus 
Brain development is an orchestrated process, and its disruption can have long term 
consequences in brain function. The hippocampus is a brain structure linked to 
learning and memory formation, and is subdivided into the Cornu Ammonis areas (CA) 
CA1, CA2 and CA3 and the dentate gyrus. The dentate gyrus is the major input of 
information to the hippocampus, and one of the two brain areas where neurogenesis 
occurs in adulthood 70. As such, dentate gyrus function is important for the cognitive 
tasks mediated by the hippocampus (reviewed in 71). The dentate gyrus is a well-
defined structure composed of several layers: the granule cell layer (the principal cell 
layer made up of densely packed granule cells), the hilus (a layer ensheathed by the 
granule cell layer and composed of diverse cell types), and the molecular layer (an 
outer layer mostly cell free) (reviewed in 72). Finally, the sub-granular zone is a thin 
layer of cells in the adult dentate gyrus where neurogenesis occurs, in the border 
between the granule cell layer and the hilus. Given the role of cilia in cell division, 
including in the neural stem cell population, the dentate gyrus has been the focus for 
cilia studies in the brain 38,40. In addition, the characteristic layered structure of the 
dentate gyrus, which forms during the first postnatal weeks, makes it a prime area for 
developmental studies during early postnatal development.  
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1.3.1. Dentate gyrus development involves cell migration, division and differentiation 
The development of the dentate gyrus follows a well-characterized sequence of 
events, described in rodents first in a hallmark study by Altman & Bayer (Fig. 1.2). This 
developmental process starts embryonically and continues until the two first postnatal 
weeks 1,2. First, the neuroepithelium develops, from where the dentate gyrus cells 
originate (reviewed in 73). Then, the radial glial pool of cells forms, and sequential 
waves of migration occur. The first wave comprises cells originating from the dentate 
neuroepithelium, which mostly populate the granule cell layer (Fig. 1.2A). The second 
wave of migration establishes a pool of proliferative cells in the hilus (Fig. 1.2B and  
1,2). Then, the hilus becomes organized with radial cells projecting processes from the 
cell body in the hilus, to the molecular layer 74,75. At this point, a third wave of migration 
begins, of cells moving from the hilus to the granule cell layer (Fig. 1.2C 1,2). Finally, 
these cells differentiate into dentate granule cells (Fig. 1.2D and reviewed in 73).  
 
 
  Figure 1.2 – Dentate gyrus development starts embryonically and ends at early postnatal 
stage. 
Scheme depicting stages of dentate gyrus formation. Figure inspired by 1,2. 
(A) During embryonic stages cells migrate from the neuroepithelium to the nascent dentate gyrus. 
First, dividing cells from the neuroepithelium (primary matrix), migrate and start to mature and form 
the granule layer. During this stage the typical compact granule cell layer starts to form (yellow), 
while other cells are still proliferating and differentiating (primary matrix – blue).  
(B) Second, dividing cells (secondary matrix) migrate in a parallel route from the neuroepithelium to 
the hilus. These cells populate the forming hilus, where they continue to divide and differentiate 
(tertiary matrix – pink) 
(C) Third, dividing cells at the hilus (tertiary matrix) differentiate and migrate to the granule cell layer. 
(A-C) These events occur during the first two postnatal weeks. 
(D) Finally, around P14 in rodents, cell division ceases in most of the dentate gyrus, where it is 
restricted to the sub granular zone (border between granule cell layer and hilus). At this stage the 
dentate gyrus is formed with it three distinct layers: hilus, granule cell layer (yellow) and molecular 
layer. The pyramidal layer of the hippocampus (CA1-3 – green) is also formed at this stage. 
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During these processes of migration and cell organization, radial glial cells seem to 
play an important role. Cells with radial processes, and that stain for the glial marker 
GFAP (glial fibrillary acidic protein), are visible since early embryonic stages in the 
brain 74. They are thought to guide neuronal migration, first from the neuroepithelium 
to the developing dentate gyrus, and then from the hilus to the granule cell layer 74,75. 
These radial-glial like cells also divide and so are sources of newly formed neurons. 
In the developed dentate gyrus, they project from the cell body in the hilus, through 
the granule cell layer, until the molecular layer, where they branch and finally terminate 
at the pial surface 74. Even though their numbers decrease over time, they are still 
present in the adult dentate gyrus 74.  
 
The emergence of new neurons, termed neurogenesis, is very important during 
embryonic development, but in the dentate gyrus it persists into adulthood (reviewed 
in 71). Of note, the relevance of adult neurogenesis in humans is still controversial 76. 
The stages of adult neurogenesis are well defined 77. First, stem cells divide and give 
rise to highly proliferative progenitor cells. These progenitors both multiply further and 
differentiate into neurons. Finally, postmitotic neurons go through a process of 
maturation where they are selected and start connecting into networks 77. Each of 
these stages in the neurogenic process are associated with specific cell markers. 
Among others, the original stem cells, are radial glial-like cells, positive for GFAP, the 
immature neurons for doublecortin (DCX) and the mature neurons for NEUN 77.  
 
Adult and embryonic neurogenesis in the dentate gyrus overlap in time, as well as in 
some pathways (reviewed in 78), but they also have important distinctions. For 
example, neurogenesis in adult dentate gyrus is restricted to the subgranular zone 70, 
and is much less frequent. Not surprisingly, the same markers for adult neurogenesis 
are visible during development, but with a different spatial distribution 79. A study by 
Nicola and colleagues in the mouse brain demonstrated that Ki67, a marker of cell 
division, is spread out in the dentate gyrus, accumulating in the hilus at early postnatal 
stages, and being restricted to the subgranular zone in adults 79. In addition, GFAP+ 
cells accumulate in the dentate gyrus, and their radial organization in this region starts 
to become apparent after P7. Finally, the DCX intensities are also diffuse in the 
developing dentate gyrus and become restricted to the sub-granular zone in adulthood 
79. In conclusion, the development of the dentate gyrus is a well-defined process. 
Newly formed cells migrate and differentiate, both embryonically and postnatally, to 
originate the highly organized structure of the dentate gyrus. This makes it a highly 
suitable model for neurodevelopmental studies.  
 
1.3.2. “Developing networks play a similar melody” 3 
After neurons form and migrate to their proper location, they connect in order to form 
functional networks. During development, important patterns of spontaneous 
synchronous network activity arise, which are believed to be important for sensory 
map formation and network maturation (reviewed in 3,80). These activity patterns are 
Chapter 1 
 12  
observed in several species and brain areas, including the hippocampus, and have 
been recorded both in slices and in vivo (reviewed in 3,80). In addition, these patterns 
are transient and can propagate within and in-between structures (reviewed in 3,80). In 
the hippocampus this type of activity was first documented using electrophysiological 
recordings in the rat CA3 during the first postnatal week, and termed giant depolarizing 
potentials (GDP) 81. GDPs are thought to originate in the CA3, and involve pyramidal 
cells from both CA1 and CA3 as well as GABAergic interneurons (reviewed in 80). 
GABAergic activity has long been known to influence GDPs, and a recent paper 
showed that blocking Glutamatergic and GABAergic activity did not influence 
spontaneous network activity in the CA1 at P0-P2, but did so at P6-10 81-83. In addition, 
after birth. GABA is temporarily excitatory – due to the increased concentrations of 
chloride ions inside the neuron – and GDP activity correlates in time with GABA being 
excitatory (reviewed in 84). Importantly, the spontaneous network activity is correlated 
with increased concentration of calcium inside neurons, and calcium dyes have been 
used to study this type of network activity 83,85,86. A study by Crepel and colleagues 
using calcium imaging leads to a more detailed characterization of spontaneous 
network activity in the hippocampus. In short, the first recorded activity occurs 
embryonically, and the prevalent type of events are calcium spikes. At E16-E19 only 
a small percentage of cells is active and this activity is not synchronous 82. At P0 the 
synchronous plateau assemblies (SPA) are most prevalent. These last longer than 
calcium spikes (9 seconds) and occur in few pyramidal cells simultaneously 82. Finally, 
around P6-P10 the prevalent events are GDPs. These are synchronous and fast (2 
seconds) events involving the majority of the cells in the network 82. This activity stops 
after P14 82. To our knowledge, such detailed characterization of developing network 
activity using calcium dyes was never performed in the dentate gyrus. However, 
recordings in both rat and rabbit revealed that GDPs can occur in the dentate gyrus, 
and that in the rabbit the frequency of these events is lower in the dentate gyrus than 
in the CA1 or CA3 87,88. 
 
In summary, the development of the dentate gyrus involves cell migration, 
neurogenesis, and finally establishment of proper neuronal connectivity. All of these 
are complex and highly regulated processes, and their disturbances can greatly 
impact brain function. As detailed studies on network activity in the dentate gyrus are 
scarce, more studies on the factors that mediate these processes are essential for a 
complete understanding of the formation of the hippocampus, a crucial brain region.  
 
1.4. Ubiquitin Proteasome System (UPS) 
 
1.4.1 Ubiquitination controls protein levels and function 
Ubiquitination is a posttranslational modification in which ubiquitin is added to a target 
protein, thereby regulating its fate (Box III). Ubiquitination has been extensively linked 
to neural development, including in processes such as neurogenesis, neural 
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 BOX III – The Ubiquitin Code 
 
Ubiquitin is a 76 amino acid 
protein, and its name 
derives from its ubiquitous 
expression in most 
eukaryotic tissues. In 2004 
Aaron Ciechanover, Avram 
Hershko and Irwin Rose 
were awarded the Nobel 
Prize in chemistry for their 
studies on the mechanisms 
of ubiquitination and their 
relation to proteasomal 
degradation. A seminal 
paper in 1993 by Hershko, 
Ciechanover and 
colleagues described that 
3 enzymes are required for 
ubiquitination, which they 
called E1, E2, and E3 as 
they were eluted from 
affinity columns using 
different solvents 90. 
Nowadays, it is well established that the sequential action of E1-activating, E2-
conjugating enzymes and E3-ubiquitin ligase, results in an isopeptide bond between 
the carboxyl end of ubiquitin and the primary amine in the target protein. In general, 
this bond is made between ubiquitin and the amino acid lysine of the target protein.  
90,91. This reaction requires adenosine triphosphate (ATP), and results in a single 
molecule of ubiquitin being bound to the target protein (reviewed in 90,91). Ubiquitin has 
additional lysine residues, where other ubiquitin molecules can bind, resulting in a 
polyubiquitin chain. In addition, the polyubiquitination chain can have different 
conformations, and ubiquitin can be bound to different residues on the target protein. 
Finally, ubiquitination can be reversed by deubiquitination enzymes. All of these allow 
for a plethora of ubiquitination signals, creating a “ubiquitin code” (reviewed in 92). 
Given that ubiquitination can determine protein function, degradation or localization, 
the “ubiquitin code” empowers cells to determine protein fate with great flexibility 
(reviewed in 92). One of the most well-characterized ubiquitin signals is a polyubiquitin 
chain linked through lysine 48 of ubiquitin, which targets proteins for proteasomal 
degradation 92,93. There is a close link between ubiquitination and proteasomal 
degradation, and even though not all ubiquitinated proteins are target to the 
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From the enzymes involved in the ubiquitination cascade, E3 ubiquitin ligases are the 
most abundant, and are responsible for its selectivity. There are approximately 600 
E3 ligase genes in the human genome 95, from which the cullin/RING ubiquitin ligases 
(CRL) are the largest subfamily. These are characterized by a core containing a 
protein from a Really Interesting New Gene (RING) family and a cullin. There are 
innumerous RING proteins and only 7 cullins in the human genome. The cullin-RING 
core can bind to different substrate receptors, so that several E3 ubiquitin ligases can 
be formed, sharing a catalytic core, but with different substrate affinities (reviewed in 
96). The archetypical CRL are the SKP1-Cul1-F-box (SCF) proteins. In this multiproteic 
complex a cullin 1 scaffold binds via its N-terminus to Ring-Box protein 1 (RBX1), a 
RING protein that directs the E2 enzyme to the E3 ligase, and via its C-terminus to a 
SKP1 adaptor and an F-box protein 97. In these complexes, the F-box proteins are 
generally the ones that interact with the substrates (reviewed in 98,99). Note that there 
are exceptions to this typical organization. For example FBXW8 has been described 
to form an atypical SCF complex with cullin 7, instead of the canonical cullin 1 100.  
 
F-box proteins are characterized by a 40 amino acid F-box domain, which is critical 
for their interaction with SKP 
1 and hence their participation in the UPS cascade (reviewed in 98,99). The F-box 
domain was first identified in the protein Cyclin F (hence the name F-box), and later in 
other proteins, such as CDC4P and SK2P 101. All these proteins were found to interact 
with SKP1 and the F-box domain in CDC4P was determined to be essential for this 
interaction 101. Since then, several studies on F-box proteins were conducted, and now 
more than 60 human F-box proteins have been identified 102. These have been further 
divided in sub-families depending on their additional domains 102. FBXW proteins 
contain a WD-40 repeat domain, a structural domain often terminating in a tryptophan-
aspartic acid (W-D) dipeptide 102. FBXL proteins contain leucine reach repeats, a 
protein sequence motif containing regular occurrences of the amino acid leucine 102. 
The remaining proteins, without these domains were named F-box only or other 
(FBXO) proteins (reviewed in 99). The great diversity of F-box proteins allows them to 
interact with a wide range of substrates and modify cellular mechanisms such as cell 
division, cell death and signaling (reviewed in 99). Notably, some F-boxes execute 
SCF-independent functions 103,104. Arguably, the competition of F-box proteins for the 
Cullin scaffold means that at any given time there are unengaged F-box proteins in 
the cell available for SCF independent functions 104. Such functions have been mostly 
described in yeast, but there are also examples in mammals. FBXO38 (MoKA) 
interacts with KLF7 – a protein involved in the development of the brain – and functions 
as a its co-activator, regulating gene expression independently of ubiquitination 105. In 
conclusion, the UPS and F-box proteins are flexible regulators of cell’s proteome, and 
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1.4.2. UPS has been extensively linked to brain function 
Given the dynamism and power of the UPS, its extensive link to brain development 
and function is unsurprising. The UPS can regulate neuronal migration, neurite 
formation, synaptic function and development (reviewed in 89,106). Perhaps even more 
relevant, mutations in the UPS have been linked to neurological disorders, for example 
Parkinson’s disease and Angelman Syndrome. Mutations in both Parkin, (an E3 
Ubiquitin ligase), and Ubiquitin C-Terminal Hydrolase L1 (Deubiquitinating enzyme) 
impact the prevalence of Parkinson’s disease 107,108. Mutations in the Ubiquitin Protein 
Ligase E3A (an E3 Ubiquitin ligase), cause Angelman syndrome, a severe 
neurodevelopmental disorder 109,110.  
 
One of the first associations between synaptic plasticity and the UPS was found in 
Aplasia, where inhibition of a deubiquitinating enzyme prevented long-term facilitation 
111. Since then, innumerous studies strengthened this relation (reviewed in 89,106). 
Famous examples of F-box proteins involved in neuronal functions include 
SCRAPPER, FBX2, and Beta-Transducin Repeat Containing E3 Ubiquitin Protein 
Ligase (β-TRCP), which affect synaptic function and neuron differentiation. 
SCRAPPER ubiquitinates the presynaptic protein RIM1, and by controlling its levels 
affects synaptic strength 112. β-TRCP ubiquitinates RE1-silencing transcription factor 
(REST) thereby controlling its level and regulating neural differentiation 113. FBX2 
ubiquitination of GluN1/NR1 receptors depends on its F-box domain and increases 
with neuronal activity. In addition, FBX2 is involved in activity dependent changes in 
NMDA currents 114. Even though F-box proteins can greatly influence brain function, 
there are still a lot of F-box proteins with unknown function. Better understanding of 
their function will help understand the mechanism that render the brain so plastic. 
 
1.5. FBXO41 
Given the extensive literature linking the UPS with brain development and function we 
set out to determine novel players in this pathway. An early candidate screen in our 
lab identified FBXO41 as a novel F-box protein potentially regulating neuronal function 
(Box IV). FBXO41 was selected for further studies because it is a brain enriched F-
box protein of unknown function, and was initially found to interact with MUNC18-1 – 
a pre-synaptic protein essential for neurotransmission 115 – even though we did not 
confirm that MUNC18-1 was ubiquitinated by FBXO41.  
 
Studies on FBXO41 structure or function are scarce, but information is available in 
public databases. Fbxo41 is not present in Drosophila or C. elegans but it is found in 
more developed animals such as Danio rerio (zebra fish), Mus Musculus (mouse) and 
Homo Sapiens (humans). In humans, the FBXO41 gene is located on chromosome 2 
and in the mouse on chromosome 6. In the mouse, Fbxo41 gene has 14 exons, and 
the coding sequence of Fbxo41 starts in exon 3 and ends in exon 14. In the mouse 3 
splice variants of Fbxo41 were identified, two of them missing the non-coding exon 2, 
and all of which codify an 873 amino acid protein. No crystal structure of FBXO41 was 
Chapter 1 
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determined so far, but FBXO41 has been predicted to have 2 domains in addition to 
the F-box domain (Fig. 1.3): 1. a C2H2 zinc finger domain (ZnF), which is present in 
an abundant range of proteins and mediate interactions with DNA, RNA and other 
proteins (reviewed in 116), and 2. a Coiled Coil domain, which are, among others, linked 








Fbxo41 mutations have been linked to neurological abnormalities. Fbxo41 KO mice 
showed neuronal migration defects, signs of neurodegeneration and severe motor 
deficits, resembling ataxia 119. A study analyzed exome-sequencing data of 356 
patients with epileptic encephalopathies and their parents (trios), and identified an 
excess of exonic de novo mutations, compared to their matched controls 120,121.  One 
of these mutations was a stop gain mutation in FBXO41, which predicts nonsense 
mediated decay or a truncated protein lacking the C-terminal half of the protein 
(including the F-box domain) 121. A follow-up analysis analyzed the co-expression of 
all genes in Allen Brain Atlas with 51 reference genes for epileptic encephalopathy, 
and of the 297 top-ranked genes, 9 had been linked to epileptic encephalopathy in the 
previous study, and Fbxo41 was one of those genes 122. Finally, FBXO41 single-
nucleotide polymorphisms (SNPs) were considered to be associated with Parkinson’s 
disease in a population of Chinese patients 123, but this finding was not replicated in a 
larger study 124. Taken together these data beg the question of what is the role of 
FBXO41 in neuronal function and how its mutations can lead to disease. 
 
1.6. General aim of the thesis  
The general aim of this thesis was to understand the role of FBXO41, a component of 
the ubiquitin proteasome system, in neuronal communication and brain development. 
For that, we first tested the intracellular localization of FBXO41 in neurons. Second, 
given the severe phenotype of Fbxo41 KO mice we tested the hypothesis that FBXO41 
affects neurotransmission in excitatory and inhibitory neurons. Third, given the early 
phenotypes in Fbxo41 KO mice we tested if FBXO41 is required for hippocampal 
development and network activity during early postnatal development. Finally, we 
developed a conditional KO model to better characterize the effects of acute FBXO41 
depletion. 
 
In chapter 2 we investigate FBXO41 location in neurons. We find that FBXO41 
accumulates in centrosomes from which primary cilia emanate, and identify the 
Figure 1.3 – FBXO41 contains a Zinc Finger, coiled coil and F-box domain. 
Scheme depicting the exons that code for FBXO41 and its predicted domains.  
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domains required for centrosomal targeting of FBXO41. FBXO41 accumulation in 
centrosomes, but not a mutant lacking the F-box domain, disassembles neuronal 
primary cilia in a dose-dependent manner. In contrast, FBXO41 depletion does not 
affect cilia length, showing that FBXO41 is sufficient but not required for cilia 
disassembly. In addition, we report that drugs that modulate neuronal activity do not 
impact cilia length, except for the phorbol ester PDBU, which disassembles cilia in a 
FBXO41-independent manner. In addition, we show that a canonical aurora a kinase 
dependent mechanism of ciliary disassembly is essential for FBXO41-induced ciliary 
disassembly in mitotic cells, but not in neurons. In contrast, rearrangements of actin 
cytoskeleton influence ciliary disassembly in both. Finally, we report that FBXO41 
modulates sonic hedgehog signaling, a pathway that requires neuronal primary cilia.  
 
Chapter 3 characterizes the effect of FBXO41 deficiency on neuronal morphology and 
synaptic transmission. We show that FBXO41 is present in the striatum and 
hippocampus and that its expression levels in the hippocampus increase with 
postnatal age. Fbxo41 KO does not affect dendritic length or branching, axonal length, 
or synaptic density in glutamatergic hippocampal neurons or GABAergic striatal 
neurons in culture.     
 
In chapter 4 we study the role of FBXO41 in brain development by focusing on dentate 
gyrus development during early postnatal days. We show that FBXO41 depletion 
results in a smaller dentate gyrus with fewer GFAP+ radial glial-like cells and DCX+ 
immature neurons. In addition, neuronal migration from the hilus to the granule cell 
layer is delayed. Finally, we report deficits in network activity during early postnatal 
development in the absence of FBXO41 without affecting the GABA excitation-
inhibition switch. 
 
In chapter 5 we develop a conditional KO model of Fbxo41. By flanking exon 4 of 
Fbxo41 with loxP sites, we were able to prevent translation of full length FBXO41 upon 
Cre expression. However, a smaller variant arose, likely due to exon-skipping. Isolated 
hippocampal neurons lacking full length Fbxo41 have longer axons, and no other 
morphological alterations. Interestingly, these neurons also show a tendency for 
decreased synaptic transmission, strengthening the effects observed in chapter 3. 
 
Chapter 6 summarizes the results presented in this thesis, and discusses these 
results in relation to each other and to existing literature. In this chapter overall 
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Neuronal primary cilia are signaling organelles with crucial roles in brain development 
and disease. Cilia structure is decisive for their signaling capacities but the 
mechanisms regulating it are poorly understood. We identify FBXO41 as a novel 
SKP1/Cullin1/F-box (SCF) E3-ligase complex subunit that targets to neuronal 
centrioles where its accumulation promotes disassembly of primary cilia, and affects 
sonic hedgehog signaling, a canonical ciliary pathway. FBXO 41 targeting to centrioles 
requires its Coiled-coil and F-box domains. Levels of FBXO 41 at the centrioles 
inversely correlate with neuronal cilia length, and mutations that disrupt FBXO41 
targeting or assembly into SCF-complexes also disturb its function in cilia disassembly 
and signaling. FBXO41 dependent cilia disassembly in mitotic and post-mitotic cells 
requires rearrangements of the actin-cytoskeleton, but requires aurora a kinase 
activation only in mitotic cells, highlighting important mechanistical differences 
controlling cilia size between mitotic and post-mitotic cells. Phorbol esters induce 
recruitment of overexpressed FBXO 41 to centrioles and cilia disassembly in neurons, 
but disassembly can also occur in absence of FBXO41. We propose that FBXO41 
targeting to centrosomes regulates neuronal cilia structure and signaling capacity in 
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2.2 Introduction  
Primary cilia are antennae-like sensory organelles that project from the plasma 
membrane of a wide variety of cells, including neurons. They are composed of a 
microtubule-based core structure that elongates from a membrane-anchored modified 
centriole, the basal body 1. Both primary cilia membrane and cytosol content are 
isolated from the rest of the cell. This allows cilia to concentrate several signaling 
pathways, and act as a sensory organelle for extracellular and intracellular cues 2. For 
example, the Sonic hedgehog (SHH) cascade, a key signaling pathway during brain 
development, has been shown to depend on ciliary integrity 3,4. Mutations disrupting 
ciliary structure can lead to debilitating disorders, referred to as ciliopathies, which 
have pleiotropic clinical features 5-7. Among the 87 genes associated with ciliopathies, 
77 genes have been linked to neurological deficits in humans 8, such as altered brain 
anatomy, obesity, and intellectual disability 9.  
 
Cilia structure is dynamically modulated in both mitotic cells and neurons, with 
important functional consequences. As such, cilia assembly and disassembly are 
highly regulated processes, and can be induced by several signaling cues 10 in mitotic 
cells. The most well-studied cue is cell cycle entry where cilia disassemble before cell 
division and re-assemble after the end of the cell cycle 11-13. One canonical mechanism 
of ciliary disassembly in mitotic cells, is through the centrosomal kinase aurora a: 
activation of aurora a kinase leads to activation of HDAC6, which deacetylates and 
destabilizes axonemal microtubules 14. Primary cilia are also present in post-mitotic 
cells, such as neurons. Neuronal cilia structure is dynamic, and depends on 
developmental stage and final layer position of the cell 15,16. In migrating cortical 
interneurons, cilia length is highly dynamic 17 and cilia of olfactory neurons in C. 
elegans remodel in a sensory signaling-dependent manner 18. This implies the 
presence of machinery that senses extracellular cues and modulates ciliary 
architecture. So far, however, the mechanisms through which neuronal primary cilia 
length is regulated remain elusive. 
 
One powerful modulatory system to control cilia structure and function is the ubiquitin 
proteasome system (UPS). The UPS selectively modulates the cellular protein pool to 
temporally and spatially control cellular activities. UPS components have been shown 
to accumulate at the centrosome 19-21, and are able to control ciliary length 22,23. F-box 
proteins are substrate binding adaptors of a SKP1/Cullin1/F-box (SCF) E3-ligase 
complex 24 that confer selectivity to the UPS by selecting the target of ubiquitination. 
FBXO41 is a brain enriched F-box protein, with high expression in hippocampal 
neurons, where it accumulates in centrioles from which primary cilia emanate 25, 
making it a prime target for regulating neuronal primary cilia.   
 
In this study we show that FBXO41 assembles into an SCF complex, targets to 
neuronal centrioles, and its accumulation promotes disassembly of primary cilia. 
FBXO41 requires its coiled-coil and F-box domains for targeting to centrioles. 





mutants with disrupted FBXO41-SKP1 interaction. We show, for the first time, that 
neurons treated with the phorbol ester PDBU, but not canonical network-activity 
modulators (Gabazine, APV, DNQX or TTX) have shorter cilia and increased 
centrosomal FBXO41 expression. However, ciliary disassembly induced by PDBU 
also occurs in absence of FBXO41. The effect of FBXO41 in cilia disassembly in 
mitotic cells can be rescued by inhibiting the canonical aurora a kinase pathway, or 
perturbating actin dynamics by cytochalasin D. The latter compound also prevents 
FBXO41-dependent cilia shortening in neurons. Finally, we show that FBXO41 
disturbs SHH signaling, a prominent ciliary pathway. We propose a mechanism where 
neurons can shorten their cilia by regulating centriolar levels of FBXO41, which affects 
ciliary signaling capacity. 
  




2.3.1. FBXO41 is an SCF-complex subunit that targets to neuronal centrioles 
Generally, F-box proteins are modular substrate binding adaptors of a SKP1/Cullin 
1/F-box (SCF) E3-ligase complex 24. Since this has not been established for every F-
box protein family member 26-28, we tested whether FBXO41 assembles into a SCF-
complex by expressing EGFP- or FLAG-tagged FBXO41, SKP1 and Cullin 1 in 
HEK293T cells, and performing immunoprecipitation experiments. Indeed, FBXO41 
associated with SKP1 and Cullin 1, albeit less efficiently than FBXO21 which was 
included as a positive control. Deleting (FBXO41ΔF-box) or mutating (FBXO41W577A) the 
F-box domain abolished these interactions, confirming that, like other F-box proteins, 
FBXO41 assembles into SCF-complexes via an essential F-box domain (Fig. 2.1A 
and Supplementary Fig. S2.1). 29 
 
 
Figure 2.1. FBXO41 assembles into SCF-complexes and targets to centrioles. 
(A) FBXO41 assembles into SCF-complexes. HEK293T cells were transfected with the indicated 
constructs and subjected to immunoprecipitation with empty beads (EB), FBXO41 or FBXO21 
antibody. Deleting (DF-box) or mutating (W577A) FBXO41’s F-box domain prevented SCF-complex 
assembly. FBXO21 was included as a positive control. Gel was cropped for clarity (full length blot 
available in Supplementary Fig. S5). 
(B) FBXO41 is increasingly expressed in brain throughout development. Mouse brains were 
extracted at the indicated ages and immunoblotted with the indicated antibodies. Syntaxin1a was 
included as a positive control 29. Gel was cropped for clarity (full length blot available in 





In the brain FBXO41 is exclusively expressed in neurons and FBXO41 levels increase 
with age in the cerebellum 25. We confirmed that FBXO41 expression increases in 
whole-brain lysates throughout development (Fig. 2.1B), and show that FBXO41 is 
expressed in cultured neurons, but not in astrocytes (Fig. 2.1C). SKP1 and Cullin 1 
are enriched at centrosomes of dividing cells where their ubiquitin-ligase activity is 
essential for many centrosomal functions controlling cell division 1,20,30,31. Although our 
antibodies did not allow immunoprecipitation of sufficient amounts of FBXO41 from 
brain lysate (Supplementary Fig. S2.1), we could assess the presence of FBXO41 at 
centrosomes in primary hippocampal neurons. Endogenous FBXO41 located 
throughout the cytosol with distinctive enrichments in the soma, which co-localized 
with the pericentriolar protein Pericentrin (Fig. 2.1D), but FBXO41-EGFP did not 
colocalize with several other somatic organelles (Supplementary Fig. S2.2). Super-
resolution stochastic optical reconstruction microscopy (STORM) revealed that 
FBXO41-EGFP resides adjacent to centrosomal protein 135 (CEP135), a centriole 
proximal-end protein 32-34 (Fig. 2.1E-F). Hence, FBXO41 is a neuronal protein that 
targets to centrioles. 
 
2.3.2. Centrosomal targeting of FBXO41 requires its F-box and Coiled-coil domains  
The closest homologue of FBXO41, ZNF365, is a brain-enriched zinc finger protein 
that targets to centrosomes via its Coiled-coil domain 35. In addition, FBXO41 was 
shown before to require its Coiled-coil domain to target to centrosomes 25. We further 
characterized the FBXO41 domains required for centrosomal targeting by quantifying 
centrosomal enrichment of several other FBXO41 mutants in neurons and HEK293T 
cells (Fig. 2.2 and Supplementary Fig. S2.3). Indeed, in HEK293T cells mutants with 
a deleted Coiled-coil domain (FBXO41ΔCC, FBXO41RH, FBXO41C-term and FBXO41N-
term) did not target to centrosomes, regardless of an intact F-box domain, indicating 
that the coiled-coil domain is indeed necessary for FBXO41 centrosomal targeting 
(Fig. 2.2G and Supplementary Fig. S2.3). However, mutants with a deleted 
(FBXO41ΔF-box) or  mutated (FBXO41W577A) F-box  domain were also diffusely located  
  
(C) FBXO41 is expressed in neurons and not in astrocytes. High-density astrocyte or neuronal 
cultures were lysed at DIV11 and subjected to immunoblotting. βIII-tubulin was included to 
demonstrate the presence of primary cortical neurons. Gel was cropped for clarity (full length blot 
available in Supplementary Fig. S5). 
(D) Example of a primary hippocampal neuron fixed at DIV15 and immunostained with FBXO41 
(red), Pericentrin (green) and MAP2 (blue) antibodies. Endogenous FBXO41 was observed in 
enrichments in the soma (open arrowhead). In a subset of neurons (such as this example), FBXO41 
was enriched at the pericentriolar region as indicated by Pericentrin (arrowhead). Scale bars, 5 and 
2 μm. 
(E) Widefield fluorescence image of a primary DIV15 hippocampal rat neuron expressing FBXO41WT-
FLAG and immunostained with antibodies for FLAG (green) and CEP135 (red). Imaging was 
performed with FLAG-tagged FBXO41WT due to antibody incompatibility. Scale bar, 1 μm. 
(F) Super-resolution dSTORM image of boxed region in (E). Scale bar, 500 nm.  





Figure 2.2. FBXO41 is enriched in neuronal centrioles. 
(A-D) Primary hippocampal neurons were infected at DIV9 with GFP or the indicated FBXO41 
mutants, and fixed at DIV14. Centrioles were marked with Pericentrin antibody (red), neurons with 
MAP2 antibody (blue) and EGFP-FBXO41 mutants with GFP (green). FBXO41WT (A), and 
FBXO41ΔCΔF (D) were enriched at pericentrin-positive centrioles, whereas GFP (B), and 
FBXO41W577A (C) were not. Scale bars, 5 μm.  
(E) Ratio of centrosomal over cytoplasmatic intensity was quantified for each FBXO41 mutant and 
GFP. FBXO41WT and FBXO41ΔCΔF have a significantly higher enrichment at centrosomes, compared 
to GFP and FBXO41W577A.  
(F) As a control, the ratio of centrosomal over cytoplasmatic intensity of MAP2 was quantified in the 
same neurons. MAP2 does not enrich in the centrosomes, indicating that the centrosomal 






throughout the cytoplasm (Supplementary Fig. S2.3). Together, this suggests that 
both the Coiled-coil and the F-box domains are required for centrosome targeting. A 
truncation containing only the right half of the protein (FBXO41RH), which includes the 
F-box domain but lacks the Coiled-coil domain, failed to target to centrosomes 
(Supplementary Fig. S2.3) showing that the F-box domain is not sufficient for 
centrosomal targeting. Unexpectedly, a mutant that lacked the F-box domain and the 
C-terminus (FBXO41ΔCΔF) did target to centrosomes. Finally, deletion of the zinc-finger 
domain (FBXO41ΔZnF) did not affect centrosomal targeting.  
 
To verify FBXO41 centrosome-targeting domains in neurons, we assessed the co-
localization of several FBXO41 mutants with pericentrin, an endogenous centrosomal 
protein (Fig. 2.2). We expressed FBXO41WT (Fig. 2.2A), GFP (Fig. 2.2B), and FBXO41 
mutants (Fig. 2.2C-D) and quantified their centrosomal enrichment in primary 
hippocampal neurons (Fig. 2E). Both FBXO41WT, and FBXO41 lacking the F-box 
domain and the C-terminus of the protein (FBXO41ΔCΔF) were enriched at the 
centrosome; in contrast, FBXO41 with a mutated F-box domain (FBXO41W577A) was 
diffusely located throughout the cytoplasm, corroborating our findings in HEK293T 
cells. The neuronal protein MAP2 did not accumulate at the centrosome in neurons 
expressing GFP or FBXO41 constructs (Fig. 2.2F), indicating that FBXO41 
accumulation at the centrosome is specific. 
 
Collectively, these results are compatible with a model in which both FBXO41’s Coiled-
coil and F-box domains are required for centrosomal targeting. The C-terminal 
prevents centrosomal targeting of FBXO41, possibly through steric hindrance of the 
coiled-coil domain, that can be released by the F-box domain.  
 
2.3.3. FBXO41 promotes disassembly of primary cilia 
Given the presence of FBXO41 at neuronal centrioles (Fig. 2.1D and Fig. 2.2E), we 
tested whether FBXO41 plays a role in the regulation of cilia structure. Primary 
neurons were infected with shRNAs or EGFP-tagged FBXO41 constructs at day in 
vitro 1 (DIV1, Fig. 2.3A), and cilia length was measured at DIV15 (Fig. 2.3B) using the 
endogenous ciliary marker Type III adenylyl cyclase (ACIII) 36. Fbxo41 silencing was 
effective (Fig. 2.3C) but had no effect on cilia length or the percentage of ciliated 
neurons, indicating that FBXO41 is not essential for neuronal ciliogenesis (Fig. 2.3D-
F). However, FBXO41WT expression in wild type neurons drastically reduced cilia 
length as well as the percentage of ciliated neurons (Fig. 2.3D-F). To discriminate 
whether elevated 37,38 
(G) Scheme of EGFP-fused FBXO41 mutants used for domain mapping. Colored boxes depict 
predicted domains: Zinc-finger (ZnF, dark blue), Coiled-coil (orange) and F-box domain (red). White 
asterisk represents W577A mutation. Centrosomal enrichment of the first three mutants (FBXO41WT, 
FBXO41W577A and FBXO41 ΔCΔF, inside the green box) was tested in neurons and HEK293T cells, 
whereas the other mutants were studied in HEK293T cells (see Supplementary Fig. S3). Data from 
4 experimental weeks are represented as mean ± SEM. ****p<0,0001 Kruskal-Wallis Test, followed 
by a post-hoc Dunn's multiple comparisons test. 
	




levels of FBXO41 impair ciliogenesis or promote cilia disassembly (Fig. 2.3B), we also 
performed these experiments at a later time point. Neurons infected after ciliogenesis 
(DIV13) 15 and fixed at DIV21 showed the same reduction in cilia length (Fig. 2.3F), 
suggesting FBXO41 expression promotes cilia disassembly rather than inhibiting 
ciliogenesis (Fig. 2.3B). Similar results were obtained in human retinal pigment 
epithelial cells (hTERT-RPE1). Using either ARL13B or acetylated tubulin as cilia 
Figure 2.3. FBXO41 promotes disassembly of primary cilia.  
(A) Typical examples of images used to quantify cilia length.  
(B) Primary hippocampal neurons were infected with the indicated constructs at DIV1 or 13, and 
fixed at DIV15 or 21, and immunostained with GFP (green), ACIII (red) and MAP2 (blue) antibodies.  
(C) Immunoblot of primary cortical neurons infected with the indicated constructs at DIV1 and lysed 
at DIV16. Manipulating FBXO41 expression does not alter ACIII or Arl13b expression levels. Note 
the diffuse ACIII band is caused by variable glycosylation 37, 38. Gel was cropped for clarity (full length 
blot available in Supplementary Fig. S5). 
(D) Percentage of ciliated neurons infected at DIV 1 and fixed at DIV 15.  FBXO41 accumulation, but 
not depletion, significantly affects the percentage of ciliated neurons. Data from three independent 
experiments.  
(E) Quantification of cilia length from neurons in (D).  
(F) Cilia length in neurons infected with the indicated constructs at DIV 13 and fixed at DIV21. 






marker, we observed a significant decrease in ciliation upon expression of FBXO41WT 
(Supplementary Fig. S2.4). FBXO41 expression or silencing in high-density neuronal 
cultures did not affect total protein levels of ACIII or ARL13B, verifying that the 
decreased length measured with these ciliary markers was not due to a reduction in 
their expression levels (Fig. 2.3C). Taken together, using two independent model 
systems and three different cilia markers, we demonstrate that increased FBXO41 
expression robustly disassembles primary cilia. 
 
2.3.4. Centrosomal levels of FBXO41 correlate with cilia length 
To further investigate the role of FBXO41 in ciliary disassembly, we tested whether 
FBXO41 levels at the centrosome correlate with cilia length (Fig. 2.4A-C). Indeed, 
neurons with low FBXO41WT expression at centrosomes had normal cilia length (Fig. 
2.4A), whilst neurons with high levels of FBXO41WT at centrosomes generally had no 
visible cilia (Fig. 2.4B). We quantified FBXO41WT levels at the centrosome and 
detected a significant inverse correlation between cilia length and centrosomal 
FBXO41WT expression (Fig. 2.4D). The fact that cilia length gradually declines with 
FBXO41WT intensity is compatible with a model in which cilia are disassembled, 
instead of a binary model such as cilia shedding. This observation raised the possibility 
that FBXO41 promotes cilia disassembly by sequestering, hindering or competing for 
proteins locally at centrioles. For this reason, we also tested the effect of FBXO41ΔCΔF 
(Fig. 2.4C), which does target to centrioles but lacks the F-box domain essential for 
SCF-complex assembly (Fig. 2.2G). No correlation between cilia length and 
centrosomal expression was observed for FBXO41ΔCΔF (Fig. 2.4E), despite the fact 
that FBXO41ΔCΔF targets to centrosomes (Fig. 2.2E and 2.4F) and showed similar 
expression levels compared to FBXO41WT (Fig. 2.2E and 2.4E-F). The fact that 
expression of FBXO41ΔCΔF had no effect on cilium length, shows that a functional F-
box domain is required for the dosage-dependent relation between centrosomal 
FBXO41 levels and neuronal cilia length. To further explore the mechanism by which 
FBXO41 reduces cilia length, we infected primary neurons with various FBXO41 
mutants lacking a functional F-box domain (Fig. 2.4G). Unlike FBXO41WT, expression 
of FBXO41ΔF-box or FBXO41W577A had no effect on cilia length (Fig. 2.4G). Collectively, 
these results demonstrate that FBXO41 requires a functional F-box domain for 
centriole targeting and cilia disassembly. 
 
2.3.5. Phorbol esters but not neuronal activity affects neuronal cilia length 
As the mechanisms that modulate cilia length in neurons remain elusive, we set out to 
identify physiological stimuli that can induce cilia disassembly. As such, we tested if 
altering neuronal activity or modulating synaptic pathways in high density cultures 
induces cilia re-modeling. The stimuli we used to modulate neuronal activity had no 
effect on cilia length: inhibiting post-synaptic activity by blocking NMDA and AMPA 
receptors (using APV and DNQX, respectively), inhibiting neuronal activity (using 
Tetrodotoxin) or increasing network activity (using the GABA-A receptor antagonist 
Gabazine) for 48 hours had no effect on cilia length (Fig. 2.5A). Hence, changes in 
neuronal network activity do not affect cilia morphology. However, treating neurons 




Figure 2.4. Cilia length inversely correlates with centriolar FBXO41 levels and requires a 
functional F-box domain. 
(A-C) Primary hippocampal neurons were infected with the indicated constructs at DIV1, fixed at 
DIV15, and immunostained with GFP (green), ACIII (red) and MAP2 (blue) antibodies. FBXO41WT, 
but not FBXO41ΔCΔF mutant levels at centrosome correlate with cilia length: (A) neuron with low 
FBXO41WT expression (green) and long cilia (red), (B) neuron with high FBXO41WT expression and 
small/no cilia, and (c) neuron with high expression of FBXO41ΔCΔF mutant and a long cilium. The 
bottom panel is a pseudo color image of EGFP-FBXO41 to emphasize the difference in FBXO41 
expression. Calibration bar illustrates color-coded signal intensity. Scale bars, 2 μm. 
(D) Cilia length inversely correlates with centriolar FBXO41 levels. Scatterplot displays the 
relationship between FBXO41WT intensity at the centrioles and cilia length. Each dot represents a 
single measurement from an individual neuron (n = 55 cells). The black line shows a linear fit through 
the data. Inset displays the Spearman correlation coefficient (rs) and significance (p-value). 
(E) Cilia length does not correlate with centriolar FBXO41ΔCΔF levels. Scatterplot displays the lack of 
relationship between FBXO41ΔCΔF intensity at the centrioles and cilia length. Each dot represents a 
single measurement from an individual neuron (n = 73 cells). The black line shows a linear fit through 






with the diacylglycerol analog PDBU, an activator of protein kinase C (PKC), a well-
known modulator of synaptic plasticity 39, decreased cilia length (Fig. 2.5A). 
Importantly, the PDBU-induced reduction in cilia length correlated with increased 
centrosomal expression of FBXO41-EGFP (Fig. 2.5B-C). The effect of PDBU and 
FBXO41 on cilia length were not additive (Fig. 2.5C), indicating that PDBU and 
FBXO41 may act on a similar pathway. In order to test if FBXO41 is required for PDBU-
dependent cilia disassembly, we tested if PDBU also reduced cilia length in the 
absence of FBXO41 (Fig. 2.5D). DIV11 neurons treated with PDBU showed a 
decrease in cilia length in the presence or absence of FBXO41 (Fig. 2.5D). PDBU 
induces cilia disassembly and increased FBXO41 centrosomal expression in cultured 
neurons, but PDBU-dependent cilia disassembly is not dependent on FBXO41.  
 
(F) Similar mean centriolar intensity between neurons infected with FBXO41WT or FBXO41 ΔCΔF. Data 
from (D) and (E). Mann-Whitney Test, p = 0.155.  
(G) Cilia length was reduced by FBXO41WT, but not by FBXO41 with a deleted or mutated F-box 
domain. Kruskal-Wallis Test, *** p < 0.001. Data was pooled from two independent experiments. 
Data are represented as mean ± SEM. 
Figure 2.5. Phorbol Esters, but not neuronal activity, promote ciliary disassembly. 
(A) In neurons at DIV 16 cilia length is unchanged by decreasing (using APV & DNQX or TTX) or 
increasing neuronal activity (using Gbz), but it is significantly lower in neurons treated with Phorbol 
ester (PDBU). Data from five independent experiments. 
(B-C) At DIV 16 the decrease in cilia length caused by 6h treatment with PDBU correlates with an 
increase in centrosomal accumulation of FBXO41. Data from two independent experiments. 
(D) Neurons treated at DIV 11 with PDBU also show a decrease in ciliary length. This decrease is 
also observed in neurons lacking FBXO41 (expressing shRNA against FBXO41 since DIV1). 
** p<0,01 **** p<0,0001 Kruskal-Wallis Test, followed by a post-hoc Dunn's multiple comparisons 
test. Data are represented as mean ± SEM. 
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2.3.6. FBXO41-dependent cilia disassembly mechanisms differ between mitotic cells 
and neurons 40 41 
Cilia have been extensively studied in mitotic cells, where both aurora a kinase and 
actin have emerged as key regulators of cilia structure 14 ,38. Aurora a kinase is a 
centrosomal kinase that plays a pivotal role in cilia disassembly, whereas the absence 
of actin polymerization increases cilia length and numbers (14 ,38 and Fig. 2.6A). We 
tested whether FBXO41 promotes cilia disassembly through aurora a kinase activation 
by expressing FBXO41WT in RPE1 cells in the presence of aurora a kinase inhibitor 
PHA-680632 (Fig. 2.6B-C). As described above, cilia length and number were reduced 
by FBXO41WT expression (Fig. 2.6B-C). However, in mitotic cells FBXO41-mediated 
cilia disassembly was rescued by inhibiting aurora a kinase activity (Fig. 2.6B-C). 
Drugs that perturb rearrangements of the actin-cytoskeleton also have a strong effect 
on cilia structure 41,42, and these drugs have been shown to rescue disrupted cilia 
structure in several null mutants 41-45. We assessed the importance of the actin-
network in FBXO41-mediated cilia disassembly by treating RPE1 cells and neurons 
with Cytochalasin D (CytoD), an actin filament polymerization inhibitor. In control RPE 
cells expressing only GFP, CytoD increased ciliary length, without affecting the 
percentage of ciliated cells. In FBXO41 expressing RPE cells, CytoD rescued cilia 
length and percentage of ciliated cells (Fig. 2.6B-C). In neurons, the effect of CytoD 
and  aurora a  kinase  on  cilia  length  has not been studied. In contrast to its effect in  
  
Figure 2.6. Fbxo41-dependent cilia disassembly mechanisms differ between mitotic cells and 
neurons  
(A) Scheme showing previously described effects of aurora a kinase and actin on cilia integrity in 
RPE1 cells. Aurora a kinase is required for ciliary disassembly, and inhibition with PHA prevents 
ciliary disassembly in mitotic cells 40. In addition, inhibiting actin polymerization with CytoD, increases 







mitotic cells, CytoD does not increase cilia length in neurons (Fig, 2.6F). However, 
CytoD treatment of FBXO41-expressing neurons rescued cilia length, but not 
percentage of ciliated neurons, to DMSO control neurons (Fig. 2.6E-F). Inhibiting 
aurora a kinase failed to rescue the percentage of ciliated neurons and cilia length in 
FBXO41-expressing neurons (Fig. 2.6E-F). Neither of the drugs did affect FBXO41 
targeting to centrosomes (Fig. 2.6D), indicating that the rescued cilia structure is not 
due to displacement of FBXO41 from centrosomes. Moreover, these data show that 
centrosomal targeting of FBXO41 occurs independently of aurora a kinase activity and 
the actin-cytoskeleton. Overall, our results indicate that rearrangements of the actin-
cytoskeleton are required for FBXO41 mediated cilia disassembly, and that ciliary 
disassembly occurs via different mechanisms in mitotic cells and neurons. 
 
2.3.7. FBXO41-dependent cilia shortening impairs Sonic hedgehog signaling 
After establishing the role of FBXO41 on cilia structure, we investigated its functional 
consequences, by studying Sonic hedgehog (SHH) signaling, a ciliary pathway 3,4. At 
the basal state, the SHH receptor PTCH1 is in the cilium. Upon SHH binding, PTCH1 
releases its inhibition of SMO, allowing it to target to the cilium. There SMO allows GLI 
proteins to go from a repressor to an activated form, promoting the expression of target 
genes such as Gli1 and Ptch1 (46, and Fig. 2.7A). To study the effect of FBXO41 on 
the SHH cascade, we expressed GFP, or FBXO41 constructs in RPE1 cells and 
neurons, activated the SHH cascade, and assessed Ptch1 and Gli1 expression. 
FBXO41WT, but not FBXO41W577A and FBXO41ΔCΔF, reduced the percentage of ciliated 
RPE1 cells (Fig. 2.7B and Supplementary Fig. S2.4), and cilia length (Fig. 2.7C), as 
observed before. RPE1 cells were treated with conditioned media (CM) from 
HEK293T cells expressing N-terminal Shh (SHH-N) to activate the SHH cascade, or 
an empty vector (EV) as control. SHH cascade activation resulted in a significant 
increase in the levels of Gli1 mRNA levels in control cells and cells expressing 
FBXO41W577A or FBXO41ΔCΔF, but not in cells expressing FBXO41WT (Fig. 2.7D). In 
addition, the ratio of Gli1 expression between cells treated with SHH-N and EV was 
significantly lower in FBXO41 expressing cells (Fig. 2.7E). To assess if the SHH 
cascade is also affected in neurons in the presence of FBXO41, we activated the 
(B-D) RPE1 cells were infected with EGFP or EGFP-FBXO41WT, and treated with either DMSO, 
PHA-680632 (0.5 μM) or CytoD (0.5 μM) for 18h.  FBXO41-mediated decrease in cilia length and 
percentage of ciliated cells was rescued by inhibition of aurora a kinase and inhibition of actin 
polymerization. 
(D) Ratio of centrosomal over cytoplasmic FBXO41 intensity quantified in EGFP-FBXO41WT 
expressing RPE1 cells for each experimental condition in (H). No difference in centrosomal 
enrichment was observed.  
(E) Neurons were infected with EGFP or EGFP-FBXO41WT, and treated with either DMSO, PHA-
680632 (0.5 μM) or CytoD (0.5 μM) for 48h. FBXO41-mediated decrease in percentage of ciliated 
neurons was not rescued by inhibition of aurora a kinase or inhibition of actin polymerization. 
(F) Cilia length (in cells containing cilia) in EGFP-FBXO41WT expressing neurons was rescued by 
CytoD but not PHA-680632. Note that in neurons CytoD does not increase cilia length. 
Data from two independent experiments. Kruskal-Wallis Test, *** p < 0.001 **** p<0.0001. Data are 
represented as mean ± SEM. 
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cascade using the Smoothened agonist SAG, as neurons did not tolerate HEK293T 
CM, and measured mRNA levels of Ptch1 and Gli1 (Fig. 2.7F-G). SHH pathway 
activation with SAG in neurons was much less efficient than SHH-N in RPE cells and 
Gli1 mRNA levels were not significantly upregulated upon SAG treatment in all groups 
(Fig. 2.7F). The other major downstream SHH gene Ptch1 was significantly 
upregulated upon SAG treatment in GFP expressing neurons, but not in those 
expressing FBXO41 (Fig. 2.7G). Ptch1 response in neurons expressing FBXO41 ΔCΔF 
did not reach statistical significance. Collectively, these data indicate that FBXO41-
induced cilia disassembly affects their signaling capacity in mitotic cells and, albeit to 
a lesser extent, in neurons. 3 46 
Figure 2.7. FBXO41 regulates sonic hedgehog signaling.  
(A) Scheme depicting sonic hedgehog cascade, which in mammals concentrates in the cilium 3. In 
the basal state, the PTCH1 receptor is in the cilium, and inhibits SMO targeting to cilium. Upon 
binding of sonic hedgehog (SHH) to PTCH1, Smo can target to the cilium and induces the conversion 
of the GLI proteins from a repressed (GLIRep) to an activated (GLIActv) form. Once activated, GLI 







(B-E) RPE1 cells were infected with the indicated constructs for three days and then fixed for 
quantification of percentage of ciliated cells (B) and cilia length (C), or treated with SHH-conditioned 
media to study sonic hedgehog cascade activation (D,E).  
(B) Cells expressing FBXO41 had significantly less cilia than the cells in other conditions. Data from 
2 experimental weeks.  
(C) Cilia length determined in the same cells as in (B), showed significantly smaller cilia in cells 
expressing FBXO41WT but not in cells expressing FBXO41W577A or FBXO41 ΔCΔF.  
(D) FBXO41 overexpression prevents the increase in Gli1 expression in cells stimulated with SHH-
N condition media. Data from 4 or 5 experimental weeks.  
(E) The ratio of Gli1 mRNA levels between cells stimulated with SHH-N CM and control condition 
media is significantly lower in cells overexpressing FBXO41, compared to cells expressing GFP, 
other FBXO41 mutants and uninfected cells (same cells as in (D)).  
(F) Gli1 mRNA level increase in response to SAG treatment is not statistically significant in any 
condition.   
(G) Neurons expressing GFP but not those expressing FBXO41, show increased Ptch1 mRNA levels 
in response to SAG treatment. 
Data are represented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 ****p<0.0001 Kruskal-Wallis 
test followed by a Dunn's multiple comparison post-hoc test 




Although the presence of primary cilia in most neuronal cell types is now well 
established, and it is widely recognized that defective cilia signaling contributes to 
brain dysfunction, many questions about the structural regulation of these dynamic 
organelles remain. We identified a neuron-specific F-box protein, FBXO41, which 
assembles into SCF-complexes and targets to centrosomes. Its accumulation in 
centrosomes promotes disassembly of neuronal primary cilia and affects their 
signaling capacity.  
 
Like other F-box proteins, FBXO41 assembles into SCF-complexes by interacting with 
SKP1 and Cullin 1 through its F-box domain (Fig. 2.1A and Supplementary Fig. S2.1). 
Interestingly, deleting (FBXO41ΔF) or mutating (FBXO41W577A) the F-box domain 
abolishes SCF-complex formation as well as centrosomal targeting. SKP1 and Cullin 
1 are highly enriched at centrosomes 20, but interaction with these proteins is 
insufficient for centrosomal targeting of FBXO41, since truncation mutants containing 
an intact F-box domain but lacking the Coiled-coil domain (FBXO41ΔCC and 
FBXO41RH) do not enrich at centrosomes (Fig. 2.2 and Supplementary Fig. S2.3). 
Interestingly, the F-box domain is not required for centrosomal targeting in a mutant 
lacking the C-terminal domain (FBXO41ΔCΔF). Therefore, our data support a 
mechanism whereby the C-terminal domain of FBXO41 functions to inhibit 
centrosome targeting, probably through steric hindrance of the Coiled-coil domain, 
and the F-box domain releases this inhibition, likely through SKP1-dependent 
mechanisms. 
 
Centrosomal expression of FBXO41 robustly reduced primary cilia length (Fig. 2.3, 
Fig. 2.4, Fig. 2.7 and Supplementary Fig. S2.4). Mutants impaired in SCF-complex 
formation, FBXO41ΔF-box, FBXO41W577A and FBXO41ΔCΔF, fail to promote cilia 
disassembly (Fig. 2.4), indicating that FBXO41 requires engagement into- and 
possibly ubiquitin ligase activity of- SCF-complexes to promote cilia disassembly. 
Importantly, FBXO41ΔCΔF does target to centrioles, but increased centrosomal levels 
of FBXO41ΔCΔF do not reduce cilia length, which indicates that the effect of FBXO41 
on cilia length is not a result of build-up of protein at the centrosome but requires 
functional FBXO41. Similar mechanisms have been shown for other centrosomal 
proteins, as overexpression of active PLK1 reduces the percentage of ciliated cells, 
but not overexpression of kinase dead PLK1 47. Similarly, overexpressed wildtype and 
catalytically dead NEK2 target to centrosomes, but only wildtype NEK2 reduces cilia 
length 48. Hence, our data shows that the engagement of FBXO41 in SCF complexes, 
and not its centriolar targeting per se, affects cilia size. This is in line with reports that 
implicate the ubiquitin system in disassembly of cilia 23,49. Although FBXO41 
expression in the brain is restricted to neurons (Fig. 2.1C and 25), we also observed 
cilia disassembly in non-neuronal cells upon overexpression of FBXO41 (Fig. 2.7 and 
Supplementary Fig. S2.4), suggesting FBXO41-mediated cilia disassembly in neurons 






Recent work in RPE1 cells has revealed proteins involved in cilia disassembly. These 
include aurora a kinase, PLK1, HDAC6, TCTEX1, and NEK2 14,45,47,48,50,51. None of 
these proteins are required for ciliogenesis but overexpression induces robust 
disassembly of primary cilia. We found similar phenotypes for FBXO41 in neurons, 
where FBXO41 silencing (Fig. 2.3 and 2.5) or expression of dominant-negative 
mutants (Fig. 2.4G) does not disrupt ciliogenesis or ciliary maintenance, but 
overexpression promotes cilia disassembly. Clearly, maintaining cilium size (and 
hence its signaling capacity) is essential for cellular viability, which may explain why 
the structure of this organelle is maintained upon depletion of a single centrosomal 
protein. 
 
Accumulation of catalytically-active FBXO41 at centrioles is sufficient to disassemble 
neuronal primary cilia, but can ciliary disassembly in neurons occur in the absence of 
FBXO41? In contrast to well-studied mechanisms of cilia disassembly in mitotic cells, 
mechanistic insight in cilia disassembly in post-mitotic neurons is generally lacking. 
We therefore tested several stimuli that could promote ciliary disassembly in neurons 
and observed that PKC activation by phorbol esters reduced cilia length, while 
modulation of neuronal network activity did not. The latter implies that neuronal cilia 
maintain their signaling capacity independent of network activity status. This 
robustness may be indicative of the importance of cilia signaling for neuronal function. 
In fact, to our knowledge in addition to the effects of PDBU reported here only brain 
ischemia results in cilia length reductions 52. Although there was no additive effect of 
PDBU on FBXO41-mediated cilia shortening, PDBU-dependent cilia length reduction 
in neurons was independent of FBXO41. Hence, although increased centriolar 
FBXO41 levels leads to disassembly of cilia, FBXO41 is not required during PDBU 
induced ciliary disassembly in neurons. This indicates that PDBU also triggers 
FBXO41-independent pathways to reduce cilia size.    
 
How does FBXO41 promote disassembly of primary cilia? In dividing cells, timely 
disassembly of cilia is required for liberation of the centrioles and mitotic spindle 
formation. The molecular mechanisms underlying cilia disassembly are not completely 
understood but in mitotic cells involve aurora a kinase activation 14,53,54, intraflagellar 
transport 14, rearrangements of the actin cytoskeleton 41,42 and/or modulation of 
(axonemal) microtubule stability14. CytoD blocks rearrangements of the actin 
cytoskeleton and increases cilia length in several cell types 41-45, but not in neurons 
(Fig. 2.6). CytoD increased cilia length in RPE1 cells in both control and FBXO41-GFP 
expressing cells, indicating that this mechanism is not affected by FBXO41. In 
neurons, CytoD rescued FBXO41-mediated ciliary shortening without affecting cilia 
length in control neurons. Together these data argue for a role of actin polymerization 
in the mechanism of FBXO41-dependent ciliary disassembly. Aurora a kinse is a 
centrosomal kinase that plays a pivotal role in cilia disassembly during the cell cycle. 
aurora a kinase, which itself is activated through many different pathways 47,14,53,54, 
phosphorylates HDAC6, which in turn deacetylates and destabilizes axonemal 
microtubules 14. We found that FBXO41 promotes cilia disassembly through activation 
FBXO41 Promotes Disassembly of Neuronal Primary Cilia	
	 43	
2 
of the aurora a kinase pathway in RPE cells, but not in neurons, and that FBXO41 
expression leads to a decrease in acetylated axonemal microtubules (Supplementary 
Fig. S2.4). This suggests that there are important differences between mechanisms 
regulating ciliary structure in mitotic cells and post-mitotic neurons. Further elucidation 
of these differences is pivotal for understanding ciliopathies and their effects on the 
brain.  
 
Importantly, we found that FBXO41 regulation of ciliary length impacts SHH signaling, 
a canonical ciliary pathway in mitotic cells. RPE1 cells and, albeit to a lesser extent, 
neurons respond to SHH cascade activation by increasing mRNA levels of Gli1 and 
Ptch1 respectively, but not in the presence of FBXO41. This indicates that cilia length 
impacts ciliary signaling. In line with the notion that defective cilia signaling in neurons 
contributes to brain dysfunction, a recent study showed that absence of FBXO41 
affects neuronal migration of granule neurons in the developing cerebellum 25. Future 
studies will address the question whether defective cilia signaling in the absence of 
FBXO41 underlies these defects in cerebellar development. 
 
Overall, our study sheds light on a molecular mechanism that controls primary cilia 
structure and signaling in neurons and highlights potential differences in cilia size 
modulation in mitotic and post-mitotic cells. We describe a role for FBXO41 in this 
process and show that this requires rearrangements of the actin cytoskeleton in mitotic 
and post-mitotic cells. Primary cilia and SHH signaling have been shown to be 
important for crucial processes such as brain development and regulation of neural 
stem cell populations. By unraveling a new process through which neural cilia can be 
regulated this study contributes to a better understanding of these processes, and its 





2.5. Materials and Methods 
2.5.1. Laboratory animals.  
Animal experiments were approved by the animal ethical committee of the VU 
University/VU University Medical Centre (license number: FGA 11-03) and are in 
accordance with Dutch governmental guidelines and regulations. 
 
2.5.2. Cell culture and transfection 
Primary neurons were prepared from embryonic day 18 mice as previously described 
55. Hippocampi were dissected in Hanks Buffered Salt Solution (Sigma-Aldrich) 
buffered with 7 mM HEPES (Invitrogen) and digested with 0.25% trypsin (Invitrogen) 
for 20 minutes at 37°C. Hippocampi were washed and triturated with fire-polished 
Pasteur pipettes, counted, and plated in Neurobasal medium (Invitrogen) 
supplemented with 2% B-27 (Invitrogen), 1.8% Hepes, 0.25% GlutaMAX (Invitrogen), 
and 0.1% penicillin-streptomycin (GE Healthcare). High-density cultures (25,000 or 
600,000 neurons/well) were plated on pregrown cultures of rat glia cells (25,000 or 
50,000 cells/well) on 18 mm glass coverslips or directly onto Poly-L-Ornithine coated 
plastic for 12-well plates (for imaging experiments) or 6-well plates (for biochemical 
experiments), respectively. 
 
HEK293T and hTERT-RPE1 (gift from Rob Wolthuis, VUmc, Amsterdam) cells were 
cultured in DMEM (Gibco) supplemented with 10% fetal bovine serum (Gibco), 
penicillin-streptomycin and non-essential amino acids (Gibco). HEK293T cells were 
transfected at ~70% confluency in serum free DMEM using the calcium phosphate 
method 56. RPE1 cells were infected with lentivirus in serum free medium. All DNA 
vectors used were from mouse origin. HEK293T cells were cultured on Poly-D Lysine 
(Sigma) coated 18 mm glass coverslips (for imaging experiments) or directly on plastic 
(for biochemical experiments). 
 
2.5.3. Immunoprecipitation experiments 
Forty hours post-transfection, HEK293T cells were washed in ice-cold PBS, harvested 
in Lysis buffer (50 mM Tris pH 7.5, 1% Triton X-100, 1.5 mM MgCl2, 5.0 mM EDTA, 
100 mM NaCl2 and phosphatase/protease inhibitor cocktails (Santa Cruz and Sigma) 
and tumbled for 1 hour to ensure complete lysis. The mouse brain was collected and 
immediately lysed in Lysis buffer. Lysates were then centrifuged at 10,000xg for 10 
minutes and pellets were discarded. Bradford assays were performed to determine 
protein concentrations. Antibodies were added to lysates and gently tumbled 
overnight. Agarose beads (Vector Laboratories) were washed twice in Lysis buffer, 
added to the samples, and tumbled for 1 hour. Samples were spun down at 4000xg 
for 5 minutes and washed in Wash buffer (50 mM Tris, 0.1% Triton X-100, 1.5 mM 
MgCl2, 5.0 mM EDTA, 250 mM NaCl2 and phosphatase/protease inhibitor cocktails) 
three times. Lysates were kept on ice or at 4°C throughout the entire experiment. 
Beads were boiled for 10 minutes in 2xLSB and samples were run on SDS-PAGE. 
 
2.5.4. Generation of shRNA lentivirus particles 
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Fbxo41 shRNA target sequences were selected using iRNAi (Mekentosj, v2.0) and 
cloned into the pLL3.7 backbone 57 with a Synapsin promoter driving EGFP 
expression. Oligonucleotides were designed with target sequences separated by a 




target sequences are underlined). 
 
2.5.5. Immunocytochemistry 
Cultured cells were fixed at indicated ages with 3.7% formaldehyde in PBS, pH 7.4, 
for 10 minutes at room temperature. For some of the experiments with centriolar 
antibodies, cells were fixed with an ice-cold Methanol and Acetone solution (1:1) at -
20°C for 10 minutes. Cells were washed three times in PBS, permeabilized in 0.1% 
Triton X-100 (Sigma-Aldrich) in PBS for 10 minutes, and incubated with blocking 
solution (PBS containing 2% normal goat serum, and 0.1% Triton X-100) for 40 
minutes at room temperature. Cells were then incubated with primary antibodies in 
blocking solution for 2 hours, washed three times with PBS, and incubated with 
secondary antibodies conjugated to Alexa Fluor in blocking solution for 1 h at room 
temperature (1:1000; Invitrogen). Primary antibodies used were rabbit polyclonal ACIII 
(1:1000; Encor), rabbit polyclonal ARL13B (1:500; ProteinTech), rabbit polyclonal 
CEP135 (1:500, Sigma), rabbit polyclonal FBXO41 (1:500; Synaptic Systems, 6897), 
mouse monoclonal FLAG (1:4000; Sigma), rabbit polyclonal GFP (1:2000; GeneTex), 
chicken polyclonal GFP (1:2000; AVES), mouse monoclonal HA (1:1000; Roche), 
chicken polyclonal MAP2 (1:20,000; Abcam), mouse monoclonal Myc (1:1000; 
Roche), mouse monoclonal Pericentrin (1:1,500; BD Transduction Laboratories), 
mouse monoclonal γ-tubulin (1:500; Sigma, clone GTU-88), rabbit polyclonal EEA1 
(1:100; CellSignaling), mouse monoclonal GM130 (1:1000; Transduction Labs), rabbit 
polyclonal LIMPII (1:200; Novus Biologicals), polyclonal rabbit Chromogranin B 
(1:500; SySy), polyclonal guinea pig Synaptophysin 1 (1:1000; SySy). Finally, cells 
were washed three times in PBS and coverslips were mounted in Mowiol (Calbiochem) 
on glass slides. For visualization of nuclei, TO-PRO3 (1 μM, Invitrogen) was added to 
the secondary antibody mixture.  
 
2.5.6. Microscopy 
Confocal images were acquired on an LSM 510 Meta Carl Zeiss microscope using a 
63× oil objective lens, NA 1.4. Z-stacks were acquired with an interval of 0.5 μm and 
were maximally projected for analysis and display.  
 
2.5.7. Image analysis 
Experimenter was blind during image acquisition and analysis. Cilia length was 
measured with ImageJ (National Institutes of Health) plugin Neuron J 59. Cells were 
considered ciliated if ciliary structure was longer than 1.3 μm) For each image of RPE 





infected ciliated cells, by the total number of infected cells. The efficiency of FBXO41 
was lower, and so more images were analyzed to obtain similar numbers of cells. 
Centrosomal intensity was quantified by placing circular regions of interest (ROIs) in 
the centrosome channel. For centrosomal enrichment quantification, for each image, 
the average intensity of three to five ROIs placed outside the cell was used to 
determine background intensity. One ROI was placed over the pericentrin or γ-tubulin 
indicated centrosome and this signal was divided by the average signal of three to six 
ROIs placed randomly throughout the cytoplasm after background subtraction. 
Percentage of cells with centriolar enrichment of FBXO41 mutants was determined by 
visual scoring. Percentage of ciliated cells was determined by counting the total 
number of cells in each image, and determining which of those cells were ciliated.  
 
2.5.8. Two color dSTORM imaging 
Prior to staining and imaging, DIV11 hippocampal neurons were infected for 4 to 7 
days with Fbox41WT-FLAG. Neurons were fixed in MeOH for 10 minutes, 
permeabilized for 7 minutes using 0.25% Triton X-100 in PBS, washed and incubated 
for 30 minutes in blocking solution (2% BSA + 0.2% gelatin, 10mM glycine + 50mM 
NH4Cl in PBS, pH 7.4). Neurons were incubated with primary and secondary 
antibodies in the blocking solution. For Fbox41-FLAG, antibodies against Flag tag 
(Sigma, clone M2, 1:400 dilution) was used followed by anti-mouse coupled to A647 
(Invitrogen, A-21236). For CEP135, rabbit anti CEP135 (Sigma, clone SAB4503685, 
1:250 dilution) was used followed by anti-rabbit coupled to A488 (Invitrogen, A-11034). 
Stained neurons were post-fixed for 10 minutes using 2% PFA in PBS. Imaging was 
performed using 5mM MEA, 10% w/v glucose, 700 µg/ml glucose oxidase, 40 µg/ml 
catalase in PBS. dSTORM microscopy was performed on a Nikon Ti microscope 
equipped with a 100x Apo TIRF objective (NA. 1.49), a Perfect Focus System, a 2.5x 
Optovar (to achieve an effective pixel size of 64 nm) and an Andor DU-897D EMCCD 
camera. Sequential imaging of Alexa Fluor 647 and A488 was performed by 
continuous oblique laser illumination with 640 nm diode laser and 491 nm DPSS laser, 
respectively. For A488 the sample was also illuminated with 405 nm diode laser. 
Between 5000 and 15000 frames were recorded per acquisition with exposure times 
of 30ms. Single molecule localization was performed as previously described 60. A 
particle table with molecule coordinates and errors was used to reconstruct a super 
resolution image. 10 nm pixel size was used for super-resolution image display. For 
two-color imaging, chromatic corrections obtained from images with multichromatic 
100 nm-beads (Tetraspeck, Invitrogen) were applied to the A488 particle table. For 
sample drift during acquisition, a correction algorithm was applied 61. 
 
2.5.9. Drug treatments 
For modulating neuronal activity high density continental neuronal cultures (40K 
neurons per well) were treated for 48h with compounds known to increase or decrease 
neuronal activity and then fixed at DIV 16 for analysis: Gabazine (Gbz, 10µM), APV 
(50µM) and 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20µM), tetrodotoxin (TTX; 1µM). 
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For experiments with Phorbol 12,13-dibutyrate (PDBU; 1µM) neurons were treated for 
6 hours and fixed at the indicated time points. For experiments testing the effect of 
aurora a kinase and actin in ciliary disassembly RPE1 cells were seeded in DMEM 
(Gibco) supplemented with 10% fetal bovine serum, and one day later the medium 
was replaced for DMEM without serum. After 2 days cells were infected with the 
indicated constructs, and 2h after treated for 18h with either DMSO, 0.5µM of PHA-
680632 (PHA) or 0.5µM CytoD. Neurons were infected at DIV 9 with the indicated 
constructs and treated one day later with either DMSO, 0.5µM of PHA or 0.5µM CytoD, 
and fixed at DIV 12 for analysis. Neurons were infected for one day before treatment 
with PHA and CytoD.  
 
2.5.10. SHH Conditioned Media  
SHH-N and EV condition media were generated as previously described 62. Briefly, 
HEK293T cells grown to 70% confluency were transfected (calcium transfection using 
1µg DNA, 125mM CaCl2 and HEPES buffered saline) with either empty vector or the 
N-terminus of rat SHH (gift from Lotte Bang Pedersen, University of Copenhagen). 
The following day cells were changed to serum free medium, and after 1 day the 
medium was collected, centrifuged (5 min at 1200rpm) and filtered (0.2µm filter). The 
medium was kept at -80oC and used at 1:1 for 14 to 16h, as previously described 63.  
 
2.5.11. RT-qPCR 
RPE1 cells were seeded in DMEM (Gibco) supplemented with 10% fetal bovine 
serum, and one day later the medium was replaced for DMEM without serum. After 2 
days cells were infected with the indicated constructs, and 3 days afterwards treated 
with conditioned media for 15 hours. Neurons were infected at DIV1 with the indicated 
constructs and treated with 300-400nM SAG (Enzo Lifesciences) for 24h, as done 
before 64. Total RNA was isolated using TRIzol reagent (Life Technologies), phase 
lock gel tubes and ISOLATE II RNA Mini Kit (Bioline) according to manufacturer's 
instructions. The purity and quantity of RNA was assessed on a NanoDrop 
spectrophotometer, and RNA was reversed transcribed into cDNA with SensiFASTTM 
cDNA Synthesis Kit (Bioline). The resulting cDNA was quantified using the 
SensiFAST™ SYBR No-ROX Kit (Bioline) in the LightCycler 480 (Roche Life 
Sciences). Analysis was performed using the Advanced Relative Quantification option 
in the LightCycler 480 software (the Cp value was determined using the second 
derivative maximum method). The cDNA was quantified in triplicates, and 
quantification was only considered valid when the Cp values determined did not differ 
for more than 1 unit among the triplicates. The relative mRNA quantity was normalized 










Table 1: Primers used in qPCR 
Primer Sequence Forward Primer (5’-3’) Sequence Reverse Primer (5’-3’) Cell type Reference 
Gli1 CAGGGAGTGCAGCCAATACAG GAGCGGCGGCTGACAGTATA RPE 63 
18S AGTCCCTGCCCTTTGTACACA CGATCCGAGGGCCTCACTA RPE 65 
Ptch1 AAAGAACTGCGGCAAGTTTTTG CTTCTCCTATCTTCTGACGGGT Neurons 65 
Gli1 CCAAGCCAACTTTATGTCAGGG AGCCCGCTTCTTTGTTAATTTGA Neurons 65 
 
 
2.5.12. Data representation and statistics 
In all graphs, data is presented as mean values ± SEM. Differences between two 
groups were tested for significance using a Student’s t test for unpaired data when 
data passed normality test (Kolmogorov-Smirnov) or a Mann-Whitney test when it did 
not. For multiple group comparisons, one-way ANOVA was used if allowed otherwise 
the non-parametric Kruskal-Wallis test was used. P-values below 0.05 are considered 
significant.  
 
2.5.13. Data availability 
All the data generated during this work is presented in the paper. Datasets are 
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Supplementary Figure S2.1. FBXO41 F-box domain mutations disrupt SCF-complex 
assembly. 
(A) Sequence alignment highlighting conserved amino acids in the F-box domains of five F-box 
proteins (made with Geneious, ClustalW, Blosum62, threshold = 1). Numbers indicate amino acid 
residues in FBXO41. Amino acids that have previously been shown to ablate SKP1 binding when 
mutated to Alanine in other F-box proteins are depicted in red 66, 67. Asterisks indicate FBXO41 
residues that were mutated to Alanine in this study. 
(B) HEK293T cells were transfected with the indicated constructs, immunoprecipitated with empty 
beads (EB) or Myc antibody and immunoblotted with the indicated antibodies. Of all mutants tested 
in this experiment, SKP1 binding was most severely abolished in the FBXO41W577A mutant. 
(C) Quantification of SKP1 binding from four independent experiments. SKP1 binding to FBXO41WT 
was set to 100%. Binding was reduced by 95.9% in FBXO41W577A. Mann-Whitney Test, *** p < 0.001. 
Error bars represent SEM. 
(D) FBXO41 assembles into SCF-complexes regardless of epitope tag size or orientation. HEK293T 
cells were transfected with the indicated constructs, lysed 40 hours post-transfection and subjected 
to immunoprecipitation with FLAG antibody. Mutating FBXO41’s F-box domain abolished SCF-
complex assembly. In contrast to the experiment depicted in Fig. 1a, where EGFP was fused to the 
n-terminus of FBXO41, FLAG was fused to the c-terminus of FBXO41. Gel was cropped for clarity 









(E) Immunoprecipitation of endogenous FBXO41 from adult brain is not efficient. Both FBXO41 and 
Skip1 are present in input, but only a very small amount of endogenous FBXO41 is 
immunoprecipitated using FBXO41 antibodies, not enough to detect Skip1.  
(F) HEK293T cells were transfected with the indicated constructs (see Fig. 2G) and subjected to 
immunoprecipitation with empty beads (EB) or FLAG-antibody. Membranes were immunoblotted 
with indicated antibodies. Only FBXO41 mutants containing an intact F-box domain 
immunoprecipitated with SKP1. 





Supplementary Figure S2.2. FBXO41 enriches at the ciliary base. 
Cortical neurons were infected at DIV 9 with FBXO41-GFP, fixed 3 days later and stained for several 
somatic organelles. Neurons were stained with markers for cilia (ACIII), early endosome (EEA1), 
Golgi (GM130), dense core vesicles (CHGB), and synapses (Synaptophysin 1). Although FBXO41 
is not only present at the centrosome, FBXO41 did not colocalize with any other somatic organelle 






Supplementary Figure S2.3. The F-box and Coiled-coil domains are essential for centrosome 
targeting of FBXO41.  
(A) HEK293T cells expressing EGFP-fused mutants for domain mapping. Centrosomes were 
visualized with γ-tubulin antibody (red). TO-PRO3 DNA staining (blue) is included in the merged 
images. White arrowheads emphasize centrosomes. Cell were fixed 20 hours post-transfection and 
only cells with low expression levels are depicted. Scale bars, 5 μm.  
(B) Ratio of centrosomal over cytoplasmic intensity was quantified for each FBXO41 mutant. 
Centrosomal enrichment of FBXO41 was significantly affected in mutants lacking the Coiled-coil 
domain or mutants in which SKP1 binding was impaired with the c-terminal domain present.  
(C) Immunoblot of HEK293T cells expressing the indicated EGFP-fused FBXO41 mutants. 
Immunoblotting was performed with GFP antibody.  
Data are represented as mean ± SEM. Kruskal-Wallis Test, ** p < 0.01, *** p < 0.001.  




Supplementary Figure S2.4. FBXO41 impairs ciliation of RPE1 cells. 
(A) Typical examples of RPE1 cells infected with EGFP-control or EGFP-FBXO41WT. Cells were 
serum starved for 48 hours to induce ciliation. Primary cilia (arrowheads) were visualized with 
ARL13B antibody (red) and DNA with TO-PRO3 (blue). Like in neurons and HEK293T cells, EGFP-
FBXO41WT targets to centrosomes of RPE1 cells (open arrowheads). Scale bars, 10 μm. 
(B) Quantification of ciliation in RPE1 cells from (A). Counting the number of nuclei and dividing this 
by the number of cilia determined percentage of ciliation. Ciliation differed significantly between 
EGFP-control (87.9% ciliated, n = 247 cells) and EGFP-FBXO41 (22.8% ciliated, n = 254 cells) 
expressing RPE1 cells χ2(1) = 213.8, *** p < 0.001. 
(C) Typical examples of RPE1 cells infected with EGFP-control or EGFP-FBXO41WT. Cells were 
serum starved for 48 hours to induce ciliation. Primary cilia (arrowheads) were visualized with 
Acetylated-tubulin antibody (red) and DNA with TO-PRO3 (blue). Scale bars, 10 μm. 
(D) Quantification of ciliation in RPE1 cells from (C). Counting the number of nuclei and dividing this 
by the number of cilia determined percentage of ciliation. Ciliation differed significantly between 
EGFP-control (77.7% ciliated, n = 265 cells) and EGFP-FBXO41 (15.9% ciliated, n = 251 cells) 
expressing RPE1 cells χ2(1) = 63.7, *** p<0.001. 
(E) Immunoblot of RPE1 lysates from an experiment performed in parallel with (A and C), 
demonstrating effective expression of lentiviral constructs. Gel was cropped for clarity (full length blot 






Supplementary Figure S5. Original uncropped blots. 
Original blots from Fig. 2.1A, B and C; Figure 2.3C; Supplementary Fig. S2.1D and Supplementary 
Fig S2.4E. 
Fig. 2.1A 
Fig. 2.1B Fig. 2.1C 
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Ubiquitination has been extensively linked to synaptic transmission and FBXO41 is a 
neuron-specific E3 ligase subunit that targets proteins for ubiquitination. Fbxo41 null 
mutant (KO) mice show early lethality and brain abnormalities but it is unknow whether 
FBXO41 controls neurotransmission. Here, we show that FBXO41 affects synaptic 
transmission in both hippocampal excitatory and striatal inhibitory neurons. Fbxo41 
KO did not affect neuronal survival, morphology and synapse density in isolated 
neurons in culture. However, hippocampal excitatory neurons showed a lower release 
probability and increased paired pulse ratio. Striatal inhibitory neurons exhibited 
reduced expression of the synaptic vesicle protein synaptophysin, a smaller readily 
releasable vesicle pool, and decreased charge transfer during high frequency 
stimulation. We conclude that FBXO41 deficiency impairs neurotransmission in 
excitatory and inhibitory neurons with a more significant impact on inhibition. This may 
contribute to the behavioral deficits observed in Fbxo41 KO mice.  
 
  





Synaptic transmission occurs through a well-regulated process, which is key for fast 
neuronal communication (reviewed in 1). Synaptic transmission can be regulated at 
multiple steps, for example by changing synaptic vesicle numbers, calcium signaling 
or release probability at the pre-synapse, receptor density and sensitivity at the post-
synapse or synaptic protein composition (reviewed in 2,3). Dysregulated synaptic 
transmission may cause imbalance of excitation and inhibition underlying various 
neurological and psychiatric diseases (reviewed in 4), highlighting the importance of 
this process for proper brain function. The ubiquitin proteasome system (UPS) allows 
spatial and temporal control of protein levels in cells, including neurons. It has been 
extensively linked to synaptic plasticity, particularly in the hippocampus, where it 
controls memory formation, pre and postsynaptic protein levels, and responds to 
neuronal activity 5,6. However, insight in the specific UPS components that target 
synaptic proteins for ubiquitination is scarce.  
 
E3 ubiquitin ligases are the UPS components that confer target selectivity. The Skip-
Cullin1-F-box proteins (SCF) complex is a multimeric E3 ligase in which the scaffold 
protein cullin 1 connects SKP1 with one of many F-box proteins that select targets for 
ubiquitination (reviewed in 7). FBXO41 is a neuron-specific F-box protein, enriched in 
the hippocampus. Fbxo41 knock-out (KO) mice have severe behavioral phenotypes 
and suffer from early lethality 8. But whether FBXO41 directly controls 
neurotransmission is unknown.  
 
Here, we characterize synaptic transmission in hippocampal excitatory and striatal 
inhibitory neurons from Fbxo41 KO mice. Fbxo41 KO neurons cultured from both 
these regions had normal neurite length and synaptic density. However, 
neurotransmission was less efficient in both neuronal populations. Excitatory neurons 
lacking FBXO41 showed a lower release probability and increased paired pulse ratio, 
while inhibitory neurons had reduced levels of the synaptic vesicle protein 
synaptophysin at synapses, a smaller readily releasable pool and decreased charge 
transfer during high frequency stimulation. Hence, these data show that Fbxo41 KO 
affects excitatory and inhibitory neurotransmission. This may result in dysregulation of 






3.3.1. FBXO41 is expressed in most brain areas and its expression increases over 
time  
To study the role of FBXO41 in neuronal morphology and synaptic transmission, we 
first assessed FBXO41 expression in the brain. FBXO41 was enriched in the cortex 
around birth (P1) and detected in several other brain regions, including the 
hippocampus and striatum, except for the olfactory bulb (Fig. 3.1A). In addition, 
FBXO41 expression increased over time in the hippocampus, similarly to what was 
previously reported in the cerebellum Fig. 3.1B, 8. Fbxo41 KO animals were born at 
the expected Mendelian ratio (Fig. 3.1C). So, FBXO41 is a developmentally expressed 





3.3.2. FBXO41 deficiency does not affect neuronal morphology but reduces 
synaptophysin expression in striatal neurons 
To test if FBXO41 is important for neuronal development, we assessed morphology of 
day in vitro (DIV) 14 hippocampal neurons grown in isolation on glia micro-islands 9-
11. Neurons were stained with dendritic (MAP2), axonal (SMI-312) and synaptic 
(synaptophysin) markers (Fig. 3.2A). Neurite length (Fig. 3.2B-C), dendritic complexity 
(Fig. 3.2D), synapse number (Fig. 3.2E) and density (Fig. 3.2F), and the intensity of 
synaptophysin  puncta  (Fig. 3.2G)  were  all  similar between  WT  and  Fbxo41  KO  
 
Figure 3.1 - FBXO41 is present in several brain areas including the striatum and hippocampus 
(A) Western blot from P1 WT mice showing the presence of FBXO41 in several brain areas, including 
the cerebellum (Cereb), cortex, hippocampus (HPC), hypothalamus (Hypot), striatum (Striat), and 
olfactory bulb (Olf. B.). Actin was used as loading control. 
(B) Western blot depicting the increasing levels of FBXO41 in the hippocampus of WT mice from P1 
to 15. FBXO41 was not detected in the hippocampus of Fbxo41 KO mice. 
(C) Mendelian ratios calculated by diving the total number of animals from a certain genotype by the 
total number of animals. For calculation of these ratios, 256 animals were considered from a total of 
34 nests.  














Figure 3.2 - Fbxo41 KO hippocampal neurons have normal morphology. 
(A) Representative images and zooms of DIV14 hippocampal neurons stained for dendritic (MAP2), 
axonal (SMI-312) and synaptic (synaptophysin) markers, from control (WT) and Fbxo41 null (KO) 
mice. Scale bar = 20μm. 
(B-C) Dendritic and axonal length are similar between WT and Fbxo41 KO neurons. 
(D) Dendritic arborization (Sholl analysis) is not altered in the absence of FBXO41.  
(E) Total number of synapses, detected using synaptophysin, is not affected in KO neurons.  
(F) Synapse density is unaltered in KO neurons. 
(G) The synaptic intensity of synaptophysin is similar between WT and KO neurons. 
Data from 3-5 independent experimental weeks, and represent average ± SEM. Numbers in bars 




neurons. As the majority of hippocampal neurons are excitatory, we also tested the 
role of FBXO41 in striatal neurons, which are mostly inhibitory (Fig. 3.3). Also in these 
neurons,  neurite  length  (Fig.  3.3A-C),  dendritic  complexity  (Fig.  3.3D),  synapse  
  
Figure 3.3 - Fbxo41 KO striatal neurons have reduced levels of synaptophysin at synapses 
(A) Representative images and zooms of DIV14 WT and KO striatal neurons stained for dendritic 
(MAP2), axonal (SMI-312) and synaptic (synaptophysin) markers. Scale bar = 20μm. 
(B-C) Dendrites and axons have normal length in the absence of FBXO41. 
(D) The number of dendritic branches (Sholl analysis) is not altered in Fbxo41 KO.  
(E-F) The number of synapses, detected inside the dendritic mask using synaptophysin, is not 
affected in KO neurons, which is reflected in both the total number of synapses (E) and synapse 
density (F).  
(G) The fluorescence intensity of synaptophysin-positive puncta is reduced in Fbxo41 KO neurons. 
Data from 3 independent experimental weeks, and represent average ± SEM. Numbers in bars are 
neurons, dots represent individual neuron data. For statistical details see Supplementary Table 3.1. 




number (Fig. 3.3E), and synapse density (Fig. 3.3F) were unchanged. However, the 
intensity of synaptophysin puncta was decreased (Fig. 3.3G). Hence, FBXO41 
deficiency does not affect hippocampal and striatal neuron morphology, but reduces 
synaptophysin expression at synapses in striatal neurons.  
 
3.3.3. FBXO41 deficiency decreases synaptic vesicle release probability in excitatory 
hippocampal neurons 
Next, we tested if FBXO41 is important for synaptic transmission in single isolated 
glutamatergic hippocampal neurons using whole-cell voltage clamp electrophysiology 
9,11. Spontaneous excitatory postsynaptic current (mEPSC) amplitude and frequency 
Figure 3.4 - FBXO41 deficiency decreases vesicular release probability in glutamatergic 
hippocampal neurons.  
Voltage-clamp recordings from isolated hippocampal excitatory WT and Fbxo41 KO neurons. 
(A) Representative spontaneous mEPSC traces for Fbxo41 KO and WT. 
(B-C) Spontaneous mEPSC amplitude (B) and frequency (C) are not significantly different in Fbxo41 
KO neurons compared to WT.  
(D) Average EPSC charge is not affected in Fbxo41 KO neurons.  
(E) Kinetics of high frequency release upon 100 action potentials at 40Hz, followed by 14 action 
potentials at 0.2Hz are similar between KO and WT. Inset shows example traces of responses 
induced by single action potentials. 
Chapter 3 
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were similar between Fbxo41 KO and WT littermate controls (Fig. 3.4 A-C). Evoked 
EPSC charge and amplitude were reduced in Fbxo41 KO, but did not reach statistical 
significance (Fig. 3.4D and Supplementary Fig. S3.1A). To test transmission during 
prolonged activity, neurons were stimulated with 100 action potentials at 40Hz, a 
stimulus known to deplete the readily releasable pool RRP; 12, followed by 14 recovery  
 
pulses (RP) at 0.2 Hz (Fig. 3.4E-F). No significant differences were observed between 
WT and KO neurons in rundown kinetics, cumulative charge released during the train, 
or RRP recovery (Fig. 3.4E-G and Supplementary Fig. S3.1B-C). The size of the RRP, 
estimated by back-extrapolating the cumulative charge of the 40Hz train (Fig. 3.4F), 
was also similar between WT and KO neurons (Fig. 3.4H). However, synaptic vesicle 
release probability, calculated by dividing the EPSC charge by the total charge of the 
RRP was reduced in Fbxo41 KO neurons (Fig. 3.4I). Paired pulse ratios, determined 
by two consecutive pulses at different time intervals, were higher in KO neurons for 
the 50, and 200 millisecond (msec) intervals (Fig. 3.4J). Hence, glutamatergic 
hippocampal neurons lacking FBXO41 have a decreased vesicular release probability. 
In addition, FBXO41 deficiency reduces responses to single or repetitive stimulation, 
even though these differences did not reach statistical significance.  
 
3.3.4. FBXO41 deficiency in GABAergic neurons affects RRP size and charge transfer 
during high frequency stimulation   
We next tested the effect of FBXO41 deficiency on inhibitory, GABAergic, 
neurotransmission in striatal neurons. FBXO41 deficiency did not significantly affect 
the frequency or amplitude of spontaneous release events (mIPSC) (Fig. 3.5A-C). 
Evoked IPSC charge was significantly lower in neurons lacking FBXO41 compared to 
WT (Fig. 3.5D). The same trend was observed for IPSC amplitude, but below the 
threshold for significance (Supplementary Fig. S.3.1D). In striatal neurons, the RRP 
depletes upon 50 action potentials at 20 Hz, a milder stimulation compared to 
hippocampal neurons 13. Charge transfer during this stimulation was reduced in 
Fbxo41 KO neurons (Fig. 3.5E-G), without affecting rundown or recovery kinetics 
(Supplementary Fig. S3.1E-F). RRP size, estimated by back extrapolating the 
cumulative charge released during the 20Hz train (Fig. 3.5F), was smaller in Fbxo41 
KO neurons (Fig. 3.5H). Finally, vesicular release probability and paired pulse ratio 
(F) Cumulative charge release during the 100 action potentials at 40Hz depicted in (E). Dashed lines 
represent linear fits to the last 25 action potentials to back extrapolate to y-intercept to calculate the 
RRP.  
(G) The total charge released during the 100 action potentials at 40Hz – depicted in E and F – is not 
affected in Fbxo41 KO. 
(H) The size of the RRP is not different between WT and KO cells (see lines in F). 
(I) The vesicular release probability – calculated by dividing the total charge of the first single action 
potential and the total charge of the RRP – is significantly lower in neurons lacking FBXO41. 
(J) Paired pulse ratio assessed by stimulating neurons with two consecutive pulses with varying 
intervals is increased in Fbxo41 KO neurons for pulses with intervals of 50, 200 and 1000 msec. 
Data from 4 independent experimental weeks, and represent average ± SEM. Numbers in bars are 
neurons, dots represent individual neuron data. For statistical details see Supplementary Table 3.1. 




were not affected (Fig. 3.5I-J). Together these data show that GABAergic Fbxo41 KO 
neurons transfer less charge, both upon single and repetitive stimulation, probably 
from a smaller RRP. 
 
  
Figure 3.5 – Fbxo41 KO GABAergic striatal neurons have a smaller RRP and reduced charge 
transfer during repetitive stimulation. 
Voltage-clamp recordings from isolated striatal inhibitory WT and Fbxo41 KO neurons. 
(A) Representative spontaneous mIPSC traces for Fbxo41 KO and WT. 
(B-C) Spontaneous mIPSC frequency and amplitude is not significantly different in Fbxo41 KO 
compared to WT.  
(D) Average IPSC charge is reduced in Fbxo41 KO neurons.  
(E) Total charge transfer during high frequency release upon 50 action potentials at 20Hz (which 
depletes the RRP), followed by 13 action potentials at 0.2Hz in Fbxo41 KO and WT neurons. Inset 
represents example traces of IPSCs. The total charge of the first IPSC in this train, and the first 
recovery pulse is significantly smaller in the KO compared to WT (also Supplementary Fig. S3.1F). 
(F) Cumulative charge release during the 50 action potentials at 20Hz depicted in (E). The lines 
represent the back extrapolation to calculate the RRP.  
(G) The total charge released during the train of 50 action potentials at 20Hz – depicted in (E) – is 





  (H) The RRP, assessed by back extrapolating the cumulative IPSC charge in a 20Hz train to the Y 
axis (see F), is smaller in KO cells. 
(I) The vesicular release probability calculated by dividing the total charge of the first single action 
potential (depicted in D) and the total charge of the RRP (depicted in H) is not altered in neurons 
lacking FBXO41. 
(J) The paired pulse ratio assessed by stimulating neurons with two consecutive pulses with a 20 
msec interval is not affected in the KO neurons. 
Data from 4 independent experimental weeks. Data is represented as mean ± SEM. Numbers in 
bars are neurons, dots represent individual neuron data. For statistical details see Supplementary 
Table 3.1. 





Genetic mutations in E3 ligases have been linked to neuropsychiatric disorders, but a 
comprehensive understanding the function of most E3 ligases is lacking. Here, we 
studied the effect of Fbxo41 KO on GABAergic and glutamatergic synaptic 
transmission in isolated striatal and hippocampal neurons, respectively. WT and 
Fbxo41 KO neurons had similar morphology with lower synaptophysin levels only in 
striatal neurons (Figs. 3.2 and 3.3). RRP size and charge transfer during single and 
repetitive stimulation was impaired in Fbxo41 KO striatal neurons (Fig. 3.5), and 
hippocampal neurons showed reduced synaptic vesicle release probability (Fig. 3.4). 
We conclude that Fbxo41 KO decreases the efficacy of neurotransmission, with a 
more significant impact on GABAergic transmission. This may result in neuronal 
network dysfunction and contribute to the behavioral phenotype of Fbxo41 KO mice. 
 
3.4.1. Fbxo41 KO neurons develop normally in culture  
Fbxo41 KO mice were born at the expected Mendelian ratios (Fig. 3.1). However, 1-
month-old mice show increased numbers of apoptotic markers in cerebellum and 
hippocampus 8. This suggests that lack of FBXO41 results in neurodegeneration. Our 
data shows that single isolated hippocampal and striatal neurons in culture develop 
normally in absence of FBXO41 with axon and dendrite length, synapse density, and, 
for hippocampal neurons, synaptic vesicle marker expression comparable to WT (Fig. 
3.2 and 3.3). Together, these observations suggest that the neurodegenerative 
phenotypes observed in postnatal Fbxo41 KO brains do not result from cell intrinsic 
deficits but rather arise from network related dysfunction, such as the reported 
neuronal migration deficits 8, or that neurodegeneration only occurs at postnatal 
stages concomitant with increased FBXO41 expression in WT brains (Fig. 3.1B). 
However, we cannot exclude that our assays in isolated neurons lacks resolution to 
detect small effects on neuronal death.  Apoptotic marker expression was observed in 
mass cultured cerebellar neurons upon shRNA-mediated depletion of Fbxo41 8. In 
contrast, in our experiments mass cultured hippocampal neurons develop normally 
upon shRNA-mediated Fbxo41 depletion, with no signs of degeneration (Chapter 2). 
Combined, these data indicate that FBXO41 depletion differentially affects cell survival 
of different neuronal populations in culture.      
 
3.4.2. FBXO41 affects synaptic transmission in GABAergic and glutamatergic neurons 
FBXO41 deficiency resulted in less efficient synaptic communication in striatal 
inhibitory and hippocampal excitatory neurons, with more significant effects in 
GABAergic neurons. The overall effect in hippocampal neurons lacking FBXO41 was 
a slightly lower vesicular release probability and concomitant paired pulse facilitation, 
that did not significantly impair spontaneous mini frequency. In these neurons, the 
EPSC charge was reduced, but this did not reach statistical significance. Fbxo41 KO 
in GABAergic striatal neurons had a more significant impact with reduced IPSC charge 
transfer during single and repetitive stimulation, a smaller readily releasable vesicle 





So, how does FBXO41 control synaptic transmission? Synaptic transmission is a 
tightly regulated multi-step process (reviewed in 14), and all these steps are potential 
points of regulation by FBXO41. Based on the extensive body of literature on the 
protein machinery involved in synaptic vesicle release, it is unlikely that FBXO41 plays 
a previously unidentified role as part of the release machinery. Instead, as a substrate 
recognizing E3 ligase component of the UPS, FBXO41 likely acts by targeting synaptic 
proteins for ubiquitination, as previously shown for other E3 ligases (reviewed in 5,6. 
Ubiquitination changes protein function or targets proteins for degradation by the 
proteasome, and in this way E3 ubiquitin ligases can regulate the synapse proteome 
and function. Our data provide several insights into the potential FBXO41 targets 
affecting neurotransmission. First, Fbxo41 KO leads to reductions in synaptic 
transmission with similar effect sizes in glutamatergic and GABAergic neurons. 
However, the most significantly affected aspects of neurotransmission differ between 
these two neural populations. The reason for these differences may be that there is 
more variability in the data of glutamatergic hippocampal neurons. Alternatively, 
FBXO41 might affect different synaptic components of neurotransmission in the two 
cell types or similar components with slightly different roles in GABAergic and 
glutamatergic neurons. In any case, FBXO41-mediated modification of these synaptic 
targets only has a limited effect on synaptic transmission. Second, as gross neuronal 
morphology and synapse density are not affected in Fbxo41 KO neurons, structural or 
synapse adhesion molecules are unlikely targets. Third, striatal neurons have 
decreased levels of synaptophysin intensity at synapses and a decreased RRP size, 
which indicates a decreased number of vesicles at the synapse. Hence, a FBXO41 
substrate may influence vesicle or protein traffic to synapses in striatal neurons. Based 
on these criteria, several protein families could serve as candidate targets with 
examples including the synaptotagmin1, SNAREs, MUNC13, and RIM1 15-17, which 
can both affect release probability as well as the RRP. Preliminary proteomic analysis 
of differential expression in WT and Fbxo41 KO brains did not reveal significant 
upregulation of any synaptic protein that could explain the observed phenotypes (data 
not shown). Hence, FBXO41 may regulate the function of synaptic proteins without 
affecting their levels.  
 
Mutations in UPS components have been shown to affect synaptic transmission and 
even to regulate excitatory and inhibitory neurons differently 18-20. For instance, null 
mutations in autism linked Cullin 3 lead increased anxiety and decreased social 
interest in mice, and impaired neurotransmission with increased EPSC/IPSC ratio 18. 
Parkin overexpression – an E3 ligase linked to Parkinson’s disorder – affects mEPSC 
frequency and amplitude as well as the number of vGlut puncta, while mIPSC and 
vGAT puncta are unaffected 19. Mutations in the E3 ligase UBE3A cause Angelman 
syndrome, and mice carrying these mutations show defects in neurotransmission in 
excitatory and inhibitory neurons, with stronger effects observed in inhibitory neurons 
20. The mechanisms of such differential regulation are not yet fully understood, but it 




has been suggested that UPS components might target proteins that are expressed 
differently in inhibitory and excitatory neurons 20.  
 
In conclusion, in the present study we uncover a role for FBXO41 in excitatory and 
inhibitory neurotransmission from hippocampal and striatal neurons, respectively. We 
find a more significant effect in GABAergic neurons and in chapter 4, we test whether 
this leads to imbalanced network activity. Although our study unveiled FBXO41 as a 
novel UPS component controlling synaptic transmission, more studies are necessary 





3.5. Materials and Methods 
 
3.5.1. Animals 
All experimental animals were handled according to VU University Animal Ethics and 
Welfare Committee protocols, and housed and bred according to Dutch governmental 
guidelines. Fbxo41 KO mice were generated as previously described 8.  
 
3.5.2. Western Blot 
To test FBXO41 expression levels at different postnatal days and brain areas, brain 
samples were isolated at different time points, weighted and triturated in ice-cold PBS 
(phosphate-buffered saline, 137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM 
KH2PO4) with protease inhibitors (SIGMAFAST™ Protease Inhibitor; Sigma-Aldrich). 
Samples were centrifuged for 5 min at 4oC, the supernatant discarded and 100 μl of 
Laemmli sample buffer added per 0.01g of brain (2% w/v sodium dodecyl sulfate 
(SDS), 10% v/v Glycerol, 0.26 M β-mercaptoethanol, 60 mM Tris-HCl pH 6.8, and 
0.01% w/v Bromophenolblue). Samples were heated for 5 min at 90oC, then 
homogenized using insulin needles, and kept at -20oC until further use.  Samples were 
boiled for 5 min at 90oC, homogenized and loaded on an 8% SDS-polyacrylamide gels 
with 2,2,2-Trichloroethanol and transferred to Polyvinylideenfluoride (PVDF) 
membranes (Bio-rad) (1 hour, 0.3 mA, 4oC). Blots were blocked in a solution of PBS 
containing 0.1% Tween-20, 2% milk and 0.5% normal goat serum, and incubated with 
primary antibodies overnight at 4oC under medium agitation. The following antibodies 
were used, all dissolved in blocking solution: monoclonal mouse anti Actin (1:10,000; 
Chemicon, MAB1501), polyclonal rabbit anti FBXO41 (1:500; ProteinTech, 24519-1-
AP). Blots were washed with PBS containing 0.1% Tween-20 and then incubated with 
alkaline phosphatase conjugated secondary antibodies (dissolved in blocking solution) 
for 1h at room-temperature, in the dark and under medium agitation. After blots were 
washed in PBS containing 0.1% Tween-20, incubated for 5 minutes with AttoPhos 
(Promega) and scanned using a FLA-5000 fluorescent image analyzer (Fujifilm). 
 
3.5.3. Neuronal micro-dot culture 
Glial micro-islands were obtained as previously described 10,11. Briefly, glass 
coverslips were etched in 1M HCl for at least 2h, followed by washes with water, and 
1h incubation in 1M NaOH. Coverslips were sterilized in 70% EtOH, put in 12-well 
plates and treated with 1.5 mg/ml Agarose for 30 min. Afterwards, coverslips were 
stamped with poly-D-lysine (Sigma, P6407)-collagen (0.5 mg/ml, 3.66 mg/ml collagen 
in 17 mM acetic acid), and sterilized with UV light for 20 minutes. Glia cells were 
obtained from P0-1 rat pups. Rat cerebral cortex was incubated 45 min at 37 oC with 
Enzyme Solution (DMEM + Glutamax (Gibco, 31966-021)), 0.2 mg/ml of L-cysteine 
(Sigma, C7352), 100 mM CaCl2 (Sigma, C7902), 50 mM EDTA (AppliChem, 
A2937.0500) and 20-25 units/ml of papain; solution was bubbled with carbogen and 
filtered before use), and then incubated for 15 minutes at 37 oC with inhibitor solution 
(DMEM + Glutamax, 10% heat-inactivated fetal bovine serum (Gibco, 10270), 2.5 
mg/ml Albumine (Bovine Fraction V; Applichem, A1391.0100) and 2.5 mg/ml Trypsin 




Inhibitor (Type II-O, Chicken Egg; Sigma, T9253)). Solution was replaced with DMEM 
culture medium (DMEM + Glutamax, 10% heat-inactivated fetal bovine serum, 1x non-
essential aminoacids (Sigma M7145), and 1x and 0.1% Penicillin-Streptomycin 
(Gibco, 15140-122)). Cells were triturated with a fired polished pasteur pipette, 
counted and plated at a density of 8000/well.  
 
Neurons were obtained from Fbxo41 KO P1 pups, after genotype was confirmed, from 
either hippocampus or striatum. Isolation of both neuronal types was similar. Brains 
were isolated in Hanks’ balanced salt solution (Sigma, H9394) supplemented with 10 
mM HEPES (Gibco, 15630-056) and hippocampi and striatum removed. They were 
then incubated 0.25% Trypsin (Gibco, 15090-046) in Hanks-HEPES for 20 min at 
37°C. Trypsin was removed with 3x washes of Hanks-HEPES solution and triturated 
in DMEM culture medium with a fired polish pasteur pipette. Triturated cells were spun 
down for 5 minutes at 800 rpm, the pellet resuspended in Neurobasal medium (Gibco, 
21103-049) supplemented with 2% B-27 (Gibco, 17504-044), 1.8% HEPES, 0.25% 
glutamax (Gibco, 35050-038) and 0.1% Penicillin-Streptomycin, and cells counted. 
Hippocampal and striatal neurons were plated in 12-well plates at density of 1400 
cells/well on 18mm coverslips with rat glia micro-dot cultures prepared 3 days before.  
 
3.5.4. Immunocytochemistry and confocal microscopy 
Neurons were fixed at DIV 14 using 3.7% formaldehyde (Electron Microscopies 
Sciences, 15680) for 15 minutes at room temperature. Neurons were washed with 
PBS, and permeabilized for 8 minutes at room temperature using PBS containing 
0.2% Triton X-100 (Fisher Chemical, T/3751/08). Afterwards neurons were incubated 
for 40 minutes in blocking solution (PBS containing 2% normal goat serum (Gibco, 
16210-072) and 0.1% Triton X-100) and then for 2 hours in primary antibodies, both 
at room temperature. The following primary antibodies were used, all diluted in 
blocking solution: polyclonal chicken anti MAP2 (1:20000, Abcam, ab5392), 
monoclonal mouse anti SMI-312 (1:1000, Biolegend, Smi-312R), polyclonal guinea 
pig anti synaptophysin 1 (1:1000, Synaptic Systems, 1011004). Coverslips were 
washed in PBS and incubated in secondary antibody. Secondary antibodies were 
conjugated with AlexaFluor dyes (1:1000, Invitrogen) and diluted in blocking solution. 
Finally, coverslips were washed, mounted in Mowiol-Dabco (Invitrogen) and kept at 
4oC. Image acquisition was performed with a confocal A1R microscope (Nikon) using 
a 40x oil immersion objective (NA = 1.3). Images were acquired as single z stack and 
neuronal morphology was analyzed blindly using automated image analysis software 
21 
 
3.5.5. Electrophysiological Recordings 
Electrophysiological recordings were obtained at room temperature from DIV13-18 
isolated neurons, using whole-cell voltage clamp (holding potential -70mV), as 
previously described 11. Neurons were kept in a bath of extracellular solution 
containing 140mM NaCl, 2,4 mM KCl, 4mMCaCl2, 4mM MgCl2, 10mM HEPES and 
10mM Glucose (pH = 7.3 and Osmolarity 300). The intracellular solution used in the 
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patching pipettes contained 125mM K+-Gluconic acid, 10mM NaCl, 4,6mM MgCl, 
4mM K2-ATP, 15 mM Creatine Phosphate, 20U/ml Phosphocreatine Kinase and 1mM 
EGTA. (pH = 7.3 and Osmolarity 300). Stimulus were induced by a 30mV 
depolarization of 0.5ms, and given in increasing order of magnitude. In glutamatergic 
neurons, spontaneous recordings were followed by paired pulse measurements, 10Hz 
train and finally a 40Hz train with recovery pulses. In GABAergic neurons, 
spontaneous recordings were followed by single EPSC, paired pulse measurements, 
and finally a 20Hz train with recovery pulses. The experimenter was blinded to 
genotype during recordings and recordings were only analyzed when the estimated 
series resistance was lower than 12 mΩ and leak current lower than 500pA, and cells 
responded to all protocols. Spontaneous events were only considered for amplitude 
analysis when more than 5 events could be detected per cell. First EPSC was 
calculated form the single EPSC in the striatal neurons, and the first pulse of the 10Hz 
train in the hippocampal neurons. The readily releasable pool was estimated by back-
extrapolation of the cumulative charge from the last 30 pulses of 100 pulses at 40Hz 
or 20Hz train. Release probability was calculated by dividing the first charge of the 
train used to calculate the RRP, by the total RRP charge. Recordings were obtained 
using a MultiClamp 700B amplifier, Digidata 1440 A, and pCLAMP 10.3 software 




Statistical analysis was performed using GraphPad Prism 8.0 software, and all 
statistical details can be found in Supplementary Table S3.1. Normality was tested 
using D’Agostino & Pearson test. A p value of ≤ 0.05 was considered statistically 
significant. The following code was used to signify significance: * ≤ 0.05; ** ≤ 0.0021; 
*** ≤ 0.0002; *** ≤ 0.0001. 
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Supplementary Figure S3.1 – Charge transfer during 20Hz stimulation is lower in Fbxo41-KO 
animals compared to WT littermates 
Voltage clamp recordings from the same neurons plotted in (A-C) Figure 3.4 (Hippocampal 
Glutamatergic neurons) and (D-F) Figure 3.5 (Striatal GABAergic neurons). 
(A) EPSC amplitude of the first pulse of a 10Hz train is not affected by FBXO41 deficiency (same 
neurons as depicted in Fig. 3.4D) 
(B) Normalized amplitude during repetitive stimulation (depicted in Fig. 3.4E) shows that release 
kinetics are similar between WT and KO neurons, and that amplitude recovers to WT levels after 
depletion of the RRP (recovery pulses). 
(C) The amplitude of the first recovery pulse after RRP depletion is not affected in Fbxo41 KO 
neurons. 
(D) IPSC amplitude of a single action potential is not significantly different between neurons lacking 
Fbxo41 and the WT controls (same neurons as depicted in Fig. 3.5D).  
(E) Normalized peak amplitude of same traces (depicted in Fig. 3.5E) shows that kinetics of charge 
transfer is similar between KO and WT neurons throughout the train.  
(F) The amplitude of the first recovery pulse after RRP depletion is smaller in KO neurons; however, 
when the amplitude is normalized to the first pulse there is no differences in recovery between WT 
and KO (E). 
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Supplementary Table 3.1 – Statistical details from data presented. 
Fig Measured Variable Grou
p 




3.2B Dendritic Length (mm) 
[Hippocampal neurons] 
WT 1.52 0.06 5 128 No Mann-Whitney 
(U= 8089; p= 0.780) KO 1.58 0.07 5 129 No 
3.2C Axon Length (mm) 
[Hippocampal neurons] 
WT 4.76 0.32 3 92 No Mann-Whitney 
(U= 3598; p= 0.101) KO 5.37 0.33 3 91 No 
3.2E Synapse Number 
[Hippocampal neurons] 
WT 268.9 21.9 3 46 No Mann-Whitney 
(U=977; p=0.648) KO 306 29.6 3 45 No 
3.2F Synapse/µm 
[Hippocampal neurons] 
WT 0.178 0.009 3 46 No Mann-Whitney 





WT 8.03 0.61 3 46 No 
Mann-Whitney 
(U=884; p=0.233) 
KO 8.63 0.52 3 45 Yes 
3.3B Dendritic Length (mm) 
[Striatal neurons] 
WT 1.60 0.14 67 3 No Mann-Whitney  
(U=2323; p=0.0839) KO 1.37 0.11 83 3 No 
3.3C Axon Length (mm) 
[Striatal neurons] 
WT 3.33 0.41 67 3 No Mann-Whitney  
(U=2574; p=0.5927) KO 2.87 0.26 81 3 No 
3.3E Synapse Number 
[Striatal neurons] 
WT 205.5 24.22 58 3 No Mann-Whitney  
(U=1838; p=0.158) KO 163.8 15.92 74 3 No 
3.3F Synapse/µm 
[Striatal neurons] 
WT 0.113 0.005 58 3 Yes Unpaired t-test 





WT 4.60 0.36 58 3 No Mann-Whitney  
(U=1623; *p=0.0162) 
KO 3.36 0.26 74 3 Yes 
3.4B mEPSC Amplitude (pA) 
WT 24.32 1.5 17 4 No Mann-Whitney 
(U=157; p=0.408) KO 23.70 1.7 22 4 No 
3.4C mEPSC Frequency (Hz) 
WT 13.15 3.1 17 4 No Mann-Whitney 
(U=177; p=0.790) KO 14.82 3.6 22 4 No 
3.4D EPSC Charge (pC) 
WT 180.4 45.4 23 4 No Mann-Whitney 
(U=276; p=0.221) KO 117.2 23.9 30 4 No 
3.4G Cumulative Charge 
40Hz train (nC) 
WT 5.77 1.4 24 4 No Mann-Whitney 
(U=312; p=0.411) KO 3.74 0.6 30 4 Yes 
3.4H RRP Charge (nC) 
WT 1.40 0.36 23 4 No Mann-Whitney 
(U=318; p=0.6344) KO 0.96 0.18 30 4 No 
3.4I Release Probability (%) 
WT 16.18 1.58 22 4 No Mann-Whitney 
(U=223; p=0.0478) KO 12.43 0.82 30 4 Yes 
3.4J 
Paired Pulse Ratio (20msec) 
WT 0.74 0.05 21 4 Yes Unpaired t-test 
(t(45)=1.62; p=0.112) KO 0.85 0.04 26 4 Yes 
Paired Pulse Ratio (50msec) 
WT 0.82 0.03 21 4 Yes Unpaired t-test 
(t(45)=2.08; *p=0.044) KO 0.92 0.04 26 4 Yes 
Paired Pulse Ratio 
(100msec) 
WT 0.85 0.03 21 4 Yes Unpaired t-test 
(t(45)=1.81; p=0.078) KO 0.93 0.04 26 4 Yes 
Paired Pulse Ratio 
(200msec) 
WT 0.83 0.02 21 4 Yes Unpaired t-test 
(t(45)=2.61; *p=0.012) KO 0.92 0.02 26 4 Yes 
WT 0.84 0.02 21 4 Yes Unpaired t-test 




Paired Pulse Ratio 
(500msec) 
KO 0.89 0.02 26 4 Yes (t(45)=1.785; p=0.081) 
Paired Pulse Ratio 
(1000msec) 
WT 0.86 0.02 21 4 Yes Mann-Whitney 
(U=201; p=0.127) KO 0.92 0.02 26 4 No 
3.5B mIPSC Amplitude (pA) 
WT 10.54 0.69 4 12 yes Unpaired t-test 
(t(22)=2.064; p=0.0510) KO 8.64 0.61 4 12 yes 
3.5C mIPSC Frequency (Hz) WT 1,77 0,86 4 13 no Mann-Whitney 
(U=57.50; p=0.108) KO 0.44 0.11 4 14 no 
3.5D IPSC Charge (pC) 
WT 117.5 18.53 4 18 yes Mann-Whitney 
(U=234; p=0.1982) KO 83.11 12.88 4 22 no 
3.5G Cumulative Charge 
20Hz train (pC) 
WT 677.9 74.9 4 18 Yes Unpaired t-test 
(t(38)=2.710; *p=0.01) KO 436.2 52.7 4 22 Yes 
3.5H Readably Releasable Pool 
(pC) 
WT 245,70 32,67 4 18 no Mann-Whitney 
(U=100; *p=0.0114) KO 145,00 20,21 4 21 yes 
3.5I Release Probability (%) 
WT 15,79 1,19 4 18 yes Unpaired t-test 
(t(37)=1.174; p=0.2479) KO 17,61 1,02 4 21 yes 
3.5J Paired Pulse Ratio (20msec) 
WT 0,19 0,04 4 17 yes Mann-Whitney 
(U=142; p=0.732) KO 0,24 0,06 4 18 no 
S3.1
A 
EPSC Amplitude (nA) 
[Hippocampal Glut.] 
WT 11.33 2.3 23 4 No Mann-Whitney 
(U=288; p=0.313) KO 8.53 1.7 30 4 No 
S3.1
C 
1st Recovery Pulse Amplitude 
(nA) [Hippocampal Glut.] 
WT 7.64 1.4 24 4 No Mann-Whitney 
(U=304; p=0.44) KO 6.06 1.0 29 4 No 
S3.1
D 
IPSC Amplitude (nA) 
[Striatal GABA.] 
WT 1.34 0.2 18 4 Yes Mann-Whitney 
(U=129; p=0.0621) KO 0.89 0.2 22 4 No 
S3.1
F 
1st Recovery Pulse Amplitude 
(nA) [Striatal GABA.] 
WT 0.73 0.1 4 18 No Mann-Whitney 
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Hippocampal dentate gyrus (DG) development is a highly structured process crucial 
for brain function. Here, we study the role of the centrosomal E3 ligase component 
FBXO41 in DG development at postnatal day 2 (P2), P6 and P9. From P6, the DG in 
Fbxo41 null mutant (KO) mice was smaller with reduced hilar region and granule cell 
layer (GCL), fewer radial-glial like (RGL) cells and immature neurons compared to WT 
littermates. The number of mature neurons and dividing cells were mostly unaffected 
at all timepoints. However, migration of mature neurons to the GCL was delayed. Two-
photon calcium imaging showed a delayed increase in network activity and 
synchronous neuronal firing compared to WT, without affecting the timing of GABA 
excitation to inhibition switch. Together our findings uncover a novel role for FBXO41 
in DG development controlling both mitotic and post-mitotic aspects: in its absence 
cell migration and network maturation is delayed, and the RGL cell population 
reduced.  
  





Brain development is a complex and highly regulated process, essential for long-term 
brain function 1. The dentate gyrus (DG), the primary afferent pathway into the 
hippocampus, is an important brain area for learning and memory formation, and its 
development has been extensively described 2-5. During embryonic to early postnatal 
stages, neural progenitors proliferate and migrate along the dentate migratory stream 
from the neuroepithelium to the dentate primordium, giving rise to the three distinct 
layers of the DG: 1) the molecular layer occupied by dendrites of the dentate granule 
cells, 2) the granule cell layer (GCL) composed of densely packed granule cells, and 
3) the hilus, containing several cell types, and enclosed by the GCL 2-6. After 
proliferation and migration, neurons integrate in networks with temporally and spatially 
fine-tuned activity patterns. Immature patterns of spontaneous activity during 
development are believed to be fundamental for proper network maturation (reviewed 
in 7). As such, perturbing key processes of DG development, such as structure and 
activity, results in long lasting deficits (reviewed in 7,8). However, knowledge of the 
mechanisms that regulate network refinement in the hippocampus, and in particular 
the DG, is still incomplete. 
 
The ubiquitin proteasome system (UPS) is a powerful regulator of cell function that 
has been extensively linked to brain development and neural connectivity (reviewed 
in 9,10). The UPS catalyzes the binding of ubiquitin to a target protein, altering its 
function or directing it for degradation by the proteasome. E3 ligases are crucial 
components of the UPS that confer target specificity. In multi-subunit SKP1/Cullin 1/F-
box (SCF) E3 ligase complexes, F-box proteins select targets for ubiquitination 
(reviewed in 11). Knocking out of the brain specific F-box protein FBXO41 results in 
neuronal migration defects in the cerebellum 12. In addition, accumulation of FBXO41 
at centrosomes disassembles primary cilia and impairs ciliary sonic hedgehog 
signalling (Chapter 2), crucial for neuronal migration and brain development (reviewed 
in 13). Finally, FBXO41 deficiency affects inhibitory and excitatory neurotransmission 
(Chapter 3), which may lead to disturbed network signalling properties. Hence, Fbxo41 
may play a role in several aspects of brain development.  
  
Here, we tested the role of FBXO41 in DG development and network activity at early 
postnatal day 2 (P2), P6 and P9. We found that Fbxo41 null mutants (KO) have a 
smaller DG, with fewer cells both in hilus and GCL, already at P6. Characterization of 
the cellular composition of the DG revealed that the number of GFAP-positive RGL 
cells, and immature doublecortin-positive (DCX+) neurons was reduced in Fbxo41 KO, 
whereas mature neurons (NEUN+) and dividing cells (Ki67+) were mostly unaffected. 
In addition, at P6, NEUN+ cells concentrated closer to the hilus in Fbxo41 KO 
compared to WT, indicating a migration defect. Two-photon calcium imaging showed 
that development of network activity is delayed in Fbxo41 KO DG with less active and 
synchronous neuronal firing compared to WT littermates. Collectively, our data show 
that FBXO41 controls several aspects DG development. In its absence DG size, 
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composition and network activity are affected, already early in postnatal development, 
before any reported behavioral phenotypes.  
 




4.3. Results 14 
4.3.1. Fbxo41 mice have a smaller dentate gyrus with fewer cells 
To evaluate the role of FBXO41 in hippocampal development, we first assessed 
hippocampal architecture in brain slices of Fbxo41 KO mice and wild-type (WT) 
littermates at three time points during early postnatal development (P2, P6 and P9). 




Figure 4.1 – Fbxo41 KO animals have a smaller dentate gyrus 
Immunohistochemistry analysis of WT and Fbxo41 KO hippocampus at P 2, 6, and 9. At P2 the GCL 
was defined as the cluster of cells accumulated at the DG, and that will later form the GCL 14. 
(A) Example figures of DAPI staining in the DG of P2, P6 and P9 WT (top) and KO animals (bottom) 
with overlay showing the granule cell layer (GCL, white) and the hilus (red); scale bar 40µm. Images 
without masks are depicted in Supplementary Fig. S4.1. 
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was not affected in Fbxo41 KO mice (Fig. 4.1A), in line with previous observations 12. 
To study DG architecture in more detail, we used the nuclear marker DAPI to 
determine the area and cell numbers of the GCL and hilus, which is surrounded by the 
GCL (Fig. 4.1A and Supplementary Fig. S4.1). In WT hippocampi, GCL area (Fig. 
4.1B) and number of DAPI+ nuclei (Fig. 4.1C) – calculated by dividing total DAPI 
intensity by single cell intensity – increased from P2 to P9, while cell density – number 
of cells divided by total area – remained constant (Fig. 4.1D). Fbxo41 KO hippocampi 
showed a similar increase in GCL area and number of DAPI+ nuclei over time, but 
GCL area (Fig. 4.1B) and the number of DAPI+ nuclei (Fig. 4.1C) were reduced 
compared to WT. The hilus area in WT slices strongly increased between P2 and P6, 
and declined between P6 and P9 (Fig. 4.1E) reflecting the main cellular migration 
pattern from the neuroepithelium to the DG during early postnatal development, 
followed by migration from the hilus to GCL 2,3. While the hilar area at P2 was similar, 
the increase between P2 and P6 was much less pronounced in Fbxo41 KO slices, 
resulting in a smaller hilus at P6 (Fig. 4.1E). In both genotypes, cell number and 
density in the hilus decreased with time, as previously observed (Fig. 4.1, 
Supplementary Fig. S4.1 and 14), with slightly lower cell numbers in Fbxo41 KO slices 
throughout development (Fig. 4.1F). The cell density in the hilus at P6 and P2 was 
higher in Fbxo41 KO compared with WT (Fig. 4.1G). Together, these data show that 
during early postnatal development hippocampal layering is not affected in Fbxo41 KO 
mice, but from P6 onward, the DG is smaller with reduced GCL and hilus size and 
fewer cells. Finally, the accumulation of cells in the hilus may indicate reduced 
migration from the hilus to the GCL during early postnatal development. 
15-18 
4.3.2. Fewer GFAP+ radial glia-like and DCX+ cells in Fbxo41 KO granule cell layer  
Next, we tested DG cellular composition using markers of cell division and neuronal 
maturity (Fig. 4.2 A-B). During neurogenesis, RGL stem-cells proliferate into 
intermediate neural progenitors that mature into neurons (Fig. 4.2B and16,18). As 
previously shown14,in WT slices the density of cells expressing a marker of cell division 
(B) The granule cell layer (GCL) area, determined using DAPI staining, is smaller in Fbxo41 KO and 
increases with postnatal day in WT and KO.  
(C) The estimated number of DAPI positive cells in the GCL, calculated by dividing the total DAPI 
intensity in the GCL mask by the total intensity of a single DAPI+ cell, is lower in the hippocampus 
lacking FBXO41, and increases with postnatal day. 
(D) The DAPI+ cell density, number of cells per area, is not different between WT and KO, and is not 
affected by time.  
(E) The hilus area increases from postnatal day 2 to 10, and is significantly smaller at P6 in KO 
animals compared to the WT controls. 
(F) The estimated number of DAPI positive cells in the hilus decreases from P2 to P9 and is smaller 
in Fbxo41 KO.  
(G) The DAPI+ cell density in the hilus decreases from P2 to P10, and is higher in KO compared to 
WT at P2 and P6.  
Data from 3 (P2 and P10) or 2 (P6) independent weeks. Data is represented as mean ± SEM. 
Numbers in figures are slices. For statistical details see Supplementary Table 4.1. 





Figure 4.2 – Fbxo41 KO animals have less GFAP+ and DCX+ cells in the granule cell layer. 
Immunohistochemistry analysis of WT and Fbxo41 KO hippocampus at P2, 6, and 9. Estimates of 
cell/processes numbers were obtained by dividing the total intensity of the marker inside a mask by 
the total intensity of that same marker in a single cell. Density was calculated by dividing cell 
numbers per area. Note that due to small differences in single cell detection accuracy, cell numbers 
between different markers are not comparable. 
(A) Example images of WT P9 hippocampal slices stained for DAPI, NEUN and GFAP (left), and 
DAPI, DCX and Ki67 (right); scale bars 60µm.  
(B) Schematic representation of the different markers used. In the DG, mitotic GFAP+ radial glial-
like cells (RGLs) generate neuronal precursors. Ki67 is a marker of cell division 15. Newborn neurons 
first express markers of immaturity (doublecortin, DCX), and later markers of maturity (NEUN). 
Scheme adapted from studies on adult neurogenesis 16-18. 
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(Ki67) and markers of immaturity (GFAP and DCX) decreased over time, while mature 
neuronal markers (NEUN) increased (Fig. 4.2C–L). Glial fibrillary acidic protein 
(GFAP) is a widely used marker for RGL cells, which in the mature DG organize in 
such a way that cell bodies are present in the hilus, while radial processes project into 
the GCL (reviewed in 16,18). The density of GFAP+ processes in the GCL decreased 
from P2 to P9 in both genotypes (Fig. 4.2D). However, both the number and density 
of GFAP+ processes were lower in Fbxo41 KO (Fig. 4.2C-E). As RGL cells proliferate 
in the GCL, we tested whether the reduction of GFAP+ cells correlated with a reduction 
of Ki67-positive cells (Fig. 4.1F-G). Fbxo41 KO sections had less Ki67+ cells and a 
decreased cell density, although the effect size of this difference was small (Fig. 4.2F-
G). RGL cells give rise to immature (DCX+), and mature (NEUN+) neurons (Fig. 4.2B). 
DCX+ cell density decreased over time in both genotypes, as expected (Fig. 4.2I). Both 
the number and density of DCX+ cells were lower in Fbxo41 KO compared with WT 
(Fig. 4.2H-I). Hence, in Fbxo41 KO the number of RGL-like cells and immature (DCX+) 
neurons is reduced compared with WT. In the final stage of neuronal maturation, 
NEUN+ neurons integrate into networks (Fig. 4.2B). At P2, NEUN+ neurons distributed 
across the DG, and at P6 and P9 they accumulated in the outer edge of the GCL (Fig. 
4.2A and Supplementary Fig. S4.2). The number of NEUN+ neurons increased over 
time similarly in WT and Fbxo41 KO mice (Fig. 4.2J-K) with a slightly smaller NEUN+ 
area at P6 in Fbxo41 KO (Fig. 4.2L). In conclusion, the number of immature but not 
mature neurons is decreased in the developing GCL in Fbxo41 KO. 
 
4.3.3. Delayed neuronal migration in Fbxo41 KO hippocampus 
To further characterize the effect of FBXO41 in DG development, a similar 
quantification was performed in the hilus. As observed in the GCL, GFAP+ cell number 
and density were decreased in Fbxo41 KO (Fig. 4.3A-B). In addition, the total number 
of Ki67+, DCX+ and NEUN+ cells were slightly reduced in Fbxo41 KO (Fig.4.3C, E and 
G). While DCX+ and Ki67+ cell density was unaffected (Fig. 4.3D and F), the density 
of NEUN+ cells at P6 was higher in the hilus in Fbxo41 KO compared to WT littermates 
(Fig. 4.3H),  similarly  to  what  was  observed for DAPI+  nuclei  (Fig.  4.1G).  Mature  
(C) The number of GFAP+ processes is significantly smaller in animals lacking FBXO41. GFAP+ 
cells in the dentate gyrus have their cell body at the hilus while their processes project to the GCL. 
(D) The density of GFAP processes decreases with time and is significantly smaller at P2 in KO 
animals compared to WT littermates.  
(E) The number of GFAP processes counted in 150 µm line profiles is smaller at P6 and P9 in 
animals lacking FBXO41.  
(F-G) Both the total number (F) of Ki67+, as well as density (G) inside the GCL decreases over time, 
and is slightly reduced in Fbxo41 KO animals. 
(H) The number of DCX+ cells is smaller in animals lacking FBXO41. 
(I) DCX+ cells per µm2 decreases with time and is lower in the absence of FBXO41. 
(J-K) Both the number (J) and density (K) of NEUN+ cells increase with time and are not different 
between WT and Fbxo41 KO. 
(L) The area, occupied by NEUN+ cells, increases from P6 to P10 and is smaller in KO at P6.  
Data is represented as mean ± SEM. Numbers in figures are slices. For statistical details see 
Supplementary Table 4.1. 







(NEUN+) neurons were present at the hilus at P2 and accumulated at the outer edge 
of the GCL at P6 and P9 in WT and KO hippocampi (Fig. 4.2A and Supplementary 
Fig. S4.2), in line with canonical neuronal migration patterns in the DG during 
development 2-4. The increase in NEUN+ cell density in the hilus at P6 in Fbxo41 KO 
(Fig. 4.3H), suggests a delayed neuronal migration from the hilus to the GCL. To test 
this, intensity profiles of DAPI+ and NEUN+ cells in the GCL were analyzed (Fig 4.4A). 
At P6, the distribution of both NEUN+ and DAPI+ cells showed a leftward shift (toward 
the hilar region) in Fbxo41 KO sections, with reduced distance to peak (Fig. 4.4B-C). 
At this stage, the width of the DAPI+ and NEUN+ layers was similar in both genotypes 
(Fig. 4.4B-C). At P9, the intensity profile and layer width of NEUN+ area was similar to 
WT (Fig 4.4E), whereas the DAPI+ area was not shifted but showed a reduced width 
in the Fbxo41 KO sections (Fig. 4.4D). Hence, these data indicate that cell migration 
from the hilus to the GCL is delayed in Fbxo41 KO hippocampi at P6, when cells 
accumulate closer to the hilus. This observation correlates with the reduced width of 
the GCL layer at P9. 
 
4.3.4. Reduced network activity in Fbxo41 KO DG at P6 
FBXO41 affects neurotransmission in inhibitory and excitatory neurons in culture 
(Chapter 3). We hypothesized that this, together with the delayed neuronal migration, 
could lead to disturbed network activity that may impact network maturation. 
Spontaneous network activity during development has been extensively studied using 
calcium imaging, and patterns of activity have been described in several brain areas, 
including the hippocampus 19. To study these patterns, we labelled hippocampal 
coronal slices at postnatal day 2-3 (P2), 6-7 (P6), and 10-11 (P10) with the calcium 
indicator fura2-AM and recorded calcium dynamics in the DG (Fig. 4.5A). Network 
activity increased in WT slices over time, as observed in the percentage of active cells 
(Fig. 4.5B) and event frequency (Fig. 4.5C). In Fbxo41 KO slices, this increase 
appeared to be delayed (Fig. 4.5C). Synchronous events were not detected at P2 in 
WT or KO slices (Fig. 4.5D). At P6, the number of cells engaging in synchronous firing 
increased in WT and stabilized at P10 (Fig. 4.5D). In Fbxo41 KO slices, this increase  
Figure 4.3 – Less GFAP+ and DCX+ cells in Fbxo41 KO hilar region with increased NEUN+ cell 
density at P6 
Immunohistochemistry analysis of WT and Fbxo41 KO hippocampus at P 2, 6, and 9.  
(A-B) Both the total number of GFAP+ cells (A), and the GFAP density (B) in the hilus are decreased 
in the absence of FBXO41, already at P2, and decrease with time in both genotypes. GFAP+ cells in 
the dentate gyrus have their cell body at the hilus while their processes project to the GCL.  
(C) The total number of Ki67+ cells inside the hilus changes over time and is reduced in Fbxo41 KO. 
(D) The density of Ki67+ cells inside the hilus changes over time, and is not affected in Fbxo41 KO.  
(E) The number of DCX+ cells in the hilus, decreases from P2 to P9 and is smaller in Fbxo41 KO.  
(F) DCX density decreases with postnatal age in the hilus and is not affected in Fbxo41 KO.  
(G) The total number of NEUN+ cells in the hilus increases over time and is smaller in Fbxo41 KO. 
(H) NEUN density is affected by time and changes differently over time in WT and KO hilar region. 
At P6, NEUN density is significantly higher in animals lacking FBXO41.  
Data is represented as mean ± SEM. Numbers in figures are slices. For statistical details see 
Supplementary Table 4.1. 








appeared slower, but not significantly different (Fig. 4.5D). However, the frequency of 
synchronous events increased in KO later than in WT (Fig. 4.5E). Hence, the 
emergence of synchronous activity, a sign of network maturity, is delayed in Fbxo41 
KO hippocampal slices.  
 
  
Figure 4.4 – Migration of NEUN+ cells is reduced at P6 in DG of Fbxo41 KO 
The intensity distributions of DAPI and NeuN across the DG were analyzed in P6 and P9 slices. 
(A) The intensity profiles of NEUN and DAPI were analyzed along lines of 150µm, starting at the 
hilus (see Methods section); scale bars 60µm. Insets depict the intensity profile of DAPI (center) and 
NEUN (left) across the depicted line in yellow. Examples figures show P6 WT (top) KO slice (bottom). 
(B-C) At P6, both DAPI and NEUN intensity profiles are left-shifted with intensity peak closer to the 
hilus. The width at half maximum is not affected. 
(D) At P9, distance to peak of the DAPI intensity is similar and width at half maximum is significantly 
lower in Fbxo41 KO.  
(E) At P9, distance to peak of the NEUN intensity and width at half maximum are not statistically 
different from WT. 
Data from 3 (P9) or 2 (P6) independent weeks. Data is represented as mean ± SEM. Numbers in 
figures are slices. For statistical details see Supplementary Table 4.1. 
Figure 4.5 – DG network activity is affected at P6 Fbxo41 KO slices. 
Two-photon calcium imaging in acute DG slices of Fbxo41 KO and WT littermates. 
(A) Example images of P6 WT (black) and KO (blue) slices. Left panel, collapsed z-stack showing 
fura2-labeled neurons (scale bar 60µm). Middle panel, mask depicting all neurons, and right panel 
shows activity measured inside each detected neuron summarized in raster plots showing the 
cumulative number of active cells with the threshold for synchronous event detection (green line), 
and synchronous events (red lines). Typical example traces of neuron activity shown on the right. 





Similar to what was reported in CA1 19, different types of calcium signals, with different 
kinetics, were detected in DG (Fig. 4.5A – right panel). FBXO41 deficiency mostly did 
not affect event duration (Supplementary Fig. S4.3). In WT and KO slices, fast events 
(<2s) were absent at P2 and increased to ±5% of events at P10. Most events lasted 
between 2-10s in both genotypes. However, while in WT these events increased from 
P2 to P6 and stabilized at P9, in Fbxo41 KO slices, this percentage was stable at all 
timepoints (Supplementary Fig. S4.3B). In WT and KO slices, the GABA-A receptor 
antagonist gabazine increased the percentage of active cells and the frequency of 
synchronous events at P10 but not at P2 or P6 (Fig. 4.6). Finally, we tested network  
  
(B) The percentage of active cells increases over time, and is not affected in Fbxo41 KO. 
(C) The frequency of events in active cells increases at P6 in the WT slices, but only at P10 in Fbxo41 
KO. Of note, the difference in number of events per second between WT and KO is only visible at 
P6, and, statistical analysis using a two-way ANOVA has less power to detect effects that occur only 
at one timepoint. However, there is an interaction effect between time and genotype (p=0.058), 
indicating a delay in increase in events/second, the post-hoc test at P6 has a trend for significance 
(p=0.085), and a t-test comparing only differences at P6 is highly significant (p= 0.0097). 
(D) At P2 no synchronous events are detected in WT and KO slices. Synchronous events increase 
between P6 and P10 in WT and KO conditions equally. 
(E) The number of synchronous events per second decreases from P6 and P10 in WT slices, and 
increases in Fbxo41 KO.  
Data from 3 (P2/3) and 4 (P6/7 and P10/11) independent experimental weeks. Data is represented 
as mean ± SEM. Numbers in figures are slices. For statistical details see Supplementary Table 4.1. 
Figure 4.6 – Gabazine affects network activity at P10 in both WT and KO hippocampal slices.  
Two-photon calcium imaging in acute DG slices of Fbxo41 KO and WT littermates before and after 
treatment with the GABA A receptor antagonist gabazine (Gabz). These data represent the same 




activity at P10 also in the CA3 region. Event frequency and percentage of synchronous 
cells was higher in WT CA3 than in DG (Fig. 4.7), consistent with previous 
observations 19,20. The events were also faster, with the majority lasting less than 2 
seconds (Fig. 4.7F). Similar trends were observed between WT and KO. Taken 
together, our results show that the occurrence of network synchronicity is delayed in 
Fbxo41 KO DG, which correlates with delayed neuronal migration, and that GABA 
affects network activity similarly in both genotypes 
 
(A-B) The percentage of active cells (A), and number of events per second in active cells (B), 
increases upon treatment with gabazine at P10 in WT and there is a trend for increase in the KO 
condition.  
(C-D) At P10, gabazine treatment increases the percentage of synchronized cells only in the KO 
condition (C), while the number of synchronous events increases both in WT and KO (D). Gabazine 
has no significant effect at P2 or at P6. 
Data from 3 (P2/3) and 4 (P6/7 and P10/11) independent experimental weeks. Each individual point 
represents one slice and the lines connect the measures at baseline (Bas, closed circles) and upon 
gabazine treatment (10µm Gbz, open circles) of the same slice. In red is depicted average ± SEM. 
Numbers in figures represent slices. For statistical details see Supplementary Table 4.1. 
Figure 4.7 – Network activity in the CA3 region is more frequent and synchronous with faster 
events compared to DG.  
Two-photon calcium imaging in acute CA3 slices of Fbxo41 KO and WT littermates at P10. 
Recordings of the two areas were obtained in the same slice. 
(A) The percentage of active cells is the same in DG and CA3 area for both WT and KO. 
(B) The number of events per second in active cells is higher in the CA3 than in DG in WT and KO 
slices. 
(C) The percentage of active cells showing synchronous activity is higher in WT CA3 compared to 
the DG. 





(D) The number of synchronous events is similar in both hippocampal regions. 
(E-F) Events are faster in the CA3 than in DG, for both WT and KO, as shown by the decrease in 
the median event duration (E), and in the increase in percentage of events that last less than 2 
seconds (F). 
Data from 2 independent experimental weeks at P10. Each individual point represents one slice and 
the lines connect the measures in DG (circles) and CA3 (diamonds) of the same slice. In red is 
depicted average ± SEM. Numbers in figures represent slices. For statistical details see 




Here, we report several deficits in postnatal DG development in Fbxo41 KO mice. 
First, from P6 onward, Fbxo41 KO mice had a smaller DG, with reduced hilar and GCL 
area, and fewer cells (Fig. 4.1). Second, RGL and DCX cell number were reduced in 
GCL and hilus (Figs. 4.2 and 4.3). Third, cell migration to the GCL was disturbed, with 
a concomitant increase in hilar cell density at P6 (Fig. 4.1G and 4.4). Fourth, the 
development of synchronized network activity was delayed (Fig. 4.5). Together, our 
findings point towards a role for FBXO41 in early postnatal DG development, before 
behavioral deficits are detected in Fbxo41 null mutants. 
 
4.4.1. Fbxo41 KO mice have a smaller DG 
The development of the DG starts embryonically with migration and proliferation of 
cells from the dentate neuroepithelium, and ends postnatally with the organization of 
the DG in 3 distinct layers: the molecular layer, the GCL and the hilus 2-4. In WT mice, 
the GCL area and cell numbers increased over time, whereas cell density in the hilus 
decreased (Fig. 4.1), reflecting a previously described model of cell migration from the 
hilus to the GCL 2,3. In animals lacking FBXO41, the GCL area and cell numbers were 
similar at P2 but gradually decreased at P6 and P9 compared with WT (Fig. 4.1). In 
contrast, hilar area and cell numbers were already lower at P2 and the typical increase 
in hilar area at P6 in WT was significantly smaller in KO (Fig. 4.1E). Hence, FBXO41 
depletion results in early defects in DG size, well before any observable behavioral 
phenotype, with reductions in cell numbers in the hilar region preceding those in the 
GCL.  
 
4.4.2. GFAP+ and DCX+ cell populations are most affected in Fbxo41 KO 
Characterization of neurogenic markers revealed that the number of RGL cells were 
reduced, in both the GCL and the hilus, already at P2 (Fig. 4.2C-E and 4.3A-B). The 
number of immature DCX+ neurons was also reduced in Fbxo41 KO (Fig. 4.2 H-I and 
Fig. 4.3E), whereas mature NEUN+ neuron numbers and density in the GCL were 
unaffected (Fig. 4.3 J-K). During DG development, RGL cells migrate and proliferate 
from the dentate neuroepithelium 2-4. The reduction in the RGL cells in the DG may 
result from: 1. reduced proliferation in the neuroepithelium, 2. decreased migration 
from the neuroepithelium to the DG, 3. increased cell death, or 4. decreased or altered 
cell proliferation of RGL cells in the DG. We consider defects in overall cell proliferation 
in the neuroepithelium, a key structure in brain development, unlikely as this would 
affect overall brain size and organization already at birth. Also, significantly disturbed 
cell migration from the neuroepithelium would have a similar general effect. 
Importantly, defects in these upstream processes would also affect the number of 
NEUN+ neurons in Fbxo41 KO DG, which we do not observe. Similarly, increased 
RGL cell death at this early postnatal period is an unlikely possibility. However, 
increased cell death has been observed in Fbxo41 KO mice in the cerebellum and 
hippocampus at P30 12. Hence, while increased RGL cell death during early postnatal 
development is an unlikely explanation for the reduction of this cell population, it is 
evident that during later stages cell viability is compromised in absence of FBXO41.  





We consider alterations in RGL cell division a plausible mechanism. During 
development these cells divide symmetrically or asymmetrically, and in this way self-
renew and originate neurons, respectively (reviewed in 21). As mitotic Ki67+ cells were 
only marginally reduced in Fbxo41 KO (Fig. 4.2 F-G and 4.3 C), we conclude that the 
overall cell division rate was not significantly affected. However, enhanced asymmetric 
division of RGL cells in Fbxo41 KO is in line with the observed phenotype, as this 
would gradually deplete the number of RGL cells. Initially, enhanced asymmetric 
division results in increased numbers of DCX+ and NEUN+ neurons. However, due to 
the depletion of proliferative RGL cells, DCX+ neuron numbers would reduce over time 
whereas end-stage mature NEUN+ neuron numbers would be less affected, which is 
in line with our observations. Similar defects of premature depletion of progenitor RGL 
cells have been previously described to lead to smaller brains (reviewed in 21).  
 
Defects in neural stem cells are a hallmark of microcephaly, a neurodevelopment 
disorder in which brains are smaller, but with normal brain architecture (reviewed in 
22). Most genes linked to microcephaly code for centrosomal proteins, leading to the 
proposal of a convergent pathway in which these genes affect symmetric and 
asymmetric division leading to depletion of neural stem cell population and a reduced 
brain size (reviewed in 22). Interestingly, primary cilium function is thought to be 
instructive, at least in part, for asymmetric/symmetric division decisions. Remarkably, 
FBXO41 shares molecular and phenotypical features with microcephaly genes: it 
accumulates at centrosomes (Chapter 2), and its absence results in decrease of radial 
glial cell numbers, without affecting the number of mature neurons. 
 
The process of neuronal maturation after initial division can take more than 2 weeks 
23,24. Our window of analysis ranges from P2 to P9, and the observed phenotypes are 
maintained at least until P9. Conceivably, not all the cells originating from the reduced 
RGL pool would have been completely matured within the timeline of our experiments. 
Hence, we anticipate that the effect sizes will be even bigger at later timepoints. This 
is in line with the reported smaller brain size at P16 in Fbxo41 KO mice 12. Importantly, 
the phenotype in the DG precedes other phenotypic differences in Fbxo41 KO 
animals. At P14-16, Fbxo41 KO animals showed increased mortality and decreased 
bodyweight 12, which might result from these earlier brain abnormalities. DG 
phenotypes might also contribute to the behavioral deficits observed later. 
 
4.4.3. Cell migration from the hilus to the GCL is delayed in Fbxo41 KO 
The hilus transitions from a highly proliferative relatively undefined area during early 
development, to a larger area encaged by the GCL and without cell division in 
adulthood 2,3,14. During this transition cells migrate from the hilus to the GCL 2,3. The 
timing of this transition is not well defined, but starts around P5 and is believed to end 
at P14 in mice 14,25. Accordingly, we observed that NEUN+ cells accumulate in the 
hilus at P2, and at P6 accumulate at the outer edge of the GCL (Supplementary Fig. 
S4.2). In Fbxo41 KO at P6, the hilus area was smaller with increased DAPI+ nuclei 
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density (Fig. 4.1 E and G) that coincided with the increased NEUN+ cell density at the 
hilus (Fig. 4.3H) and decreased NEUN area (Fig. 4.2L). We hypothesized that these 
resulted from defective migration of cells from the hilus to the GCL. Indeed, at P6 cells 
accumulated closer to the hilus (Fig. 4.4B-C) and at P9 the GCL width was reduced 
(4.4.D). These observations are in line with a delay in neuronal radial migration in the 
GCL between P6 and P9 and consistent with a previous study showing that FBXO41 
depletion results in defective cell migration and delayed layer organization in the 
cerebellum at P16 12. Importantly, the defects observed in the cerebellum occur at a 
later stage (P16), than those reported here in the DG (P6). This indicates that FBXO41 
has a general role in post-natal neuronal migration and layering of brain areas, which 
becomes most prominent at the different critical stages of development throughout the 
brain.  
 
4.4.4. Developmental network activity is affected in the absence of Fbxo41 
A final stage in the development of a functional DG is the establishment of active 
neuronal networks. Network activity during development follows a widely studied 
pattern, and is essential for formation of sensory maps (reviewed in 8). As previously 
described for CA1 19, we observed that early network activity gradually increases in 
frequency (Fig. 4.5 B-C), and then synchronizes (Fig. 4.5D-E), after which this type of 
network activity disappears (Fig. 4.5E) giving rise to more mature forms of activity 8,19. 
However, in Fbxo41 KO DG the increase in network frequency was delayed (maximum 
frequency at P10 in KO vs at P6 in WT – Fig. 4.5C), which also affected the 
appearance of synchronous events (Fig. 4.5E). The difference in event frequency 
between WT and KO was most obvious at P6 (Fig.4.5 C). Taken together, our data 
suggest that the absence of FBXO41 delays the fine-tuning of network activity, which 
is relevant given that correctly timed development of network activity is important for 
mature network activity and development of sensory maps 7,26, and that interfering 
with developmental processes during critical windows of development can lead to 
disease later in life 1. 
 
During early development, GABA acts as an excitatory neurotransmitter, and this 
property of GABA is thought to be important for immature network activity (reviewed 
in 27). In our experiments, the GABA-A receptor antagonist gabazine increased 
network activity frequency only at P10 (Fig. 4.6), indicating that the GABA switch from 
excitatory to inhibitory neurotransmitter occurred between P6 and P10, in line with 
previous findings (reviewed in 8). In addition, previous studies in the CA1 region 
reported that a combination of GABA and Glutamate blockers reduced network activity 
mostly from P6 to P10, in line with our findings 19. As such, network activity probably 
does not depend on synaptic activity during early postnatal stages, suggesting an 
involvement of activity transmission via gap junctions, which switches to synaptic 
transmission after the first postnatal week, concomitant with the excitation to inhibition 
switch of GABA. Importantly, effects of gabazine were similar in WT and KO animals 
(Fig. 4.6), indicating that FBXO41 does not control the GABA switch.  
 




In summary, our study shows that FBXO41 controls several processes of DG 
development: DG growth and composition, migration from hilus to GCL, and network 
activity maturation. FBXO41 may function in both mitotic and postmitotic cells. Our 
experiments on DG composition indicate that FBXO41 may regulate the type of RGL 
division, which fits with its centrosomal location. The observed migration deficits and 
network activity delays in Fbxo41 KO could be explained by defects in centrosomal or 
ciliary function and hence suggest a uniform role of FBXO41 affecting multiple 
pathways, possibly through targeting a small set of centrosomal proteins for 
ubiquitination. Hence, FBXO41 emerges as a candidate to modulate part the UPS 
mediated effects on brain development and synaptic activity 9,28. Given that FBXO41 
forms an E3 ubiquitin ligase complex, a better understanding of FBXO41 targets is 





4.5. Materials and Methods 
 
4.5.1. Animals 
All experimental animals were handled according to VU University Animal Ethics and 
Welfare Committee protocols, and housed and bred according to Dutch governmental 
guidelines. Fbxo41 KO mice were generated as previously described 12. 
 
4.5.2. Immunohistochemistry 
Animals were genotyped and pairs of WT and KO littermates were selected. Brains 
were removed at the indicated postnatal days (P2, P6-7 and P9), and left in 4% 
formaldehyde solution for at least one week at 4oC. Brains were then washed in PBS 
(phosphate-buffered saline, 137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM 
KH2PO4, pH=7,4) and immersed in a 30% sucrose solution (Serva, dissolved in PBS) 
at 4oC. After brains sunk, they were washed in PBS and kept at -80oC, until slicing. 
Brains were sliced in 30-35μm coronal sections using a cryostat and kept in PBS 
containing 0.02% NaN3 until stained. For immunostaining, a fixed number of slices per 
group was used, to avoid different antibody availability, and procedures were done 
under slight agitation. Slices were washed with PBS, and then incubated for 30min 
with 3% H2O2 (Merck, dissolved in PBS). Slices were then washed with PBS and 
blocked for 1h at room temperature with blocking solution. For immunostainings 
containing primary goat antibodies the blocking solution was 0.25% fish gelatin 
(Aurion) and 0.2% Triton X-100 (Fisher Scientific) in PBS, and for all others the 
blocking solution was 5% normal goat serum (NGS, Fisher Scientific), 2.5% bovine 
serum albumin (BSA, Fisher Scientific) and 0.2% Triton X-100 (Fisher Scientific) in 
PBS. Slices were then left overnight at 4oC with primary antibody, washed in PBS and 
incubated with secondary antibody for 2h at room temperature in the dark. Slices were 
then incubated with 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen) diluted in PBS 
(6.67 μg/ml) for 10 min at room temperature. Slices were mounted on microscope 
slides with Mowiol-Dabco (Invitrogen) and kept at 4oC. The following primary 
antibodies were used: guinea pig anti-glial fibrillary acidic protein (GFAP, 1:1000, 
Synaptic Systems, Cat. N. 173004), rabbit anti-NEUN (1:500, Millipore, Cat. N. 
ABN78), goat anti-Doublecortin (DCX, 1:1000, Santa Cruz), rabbit anti-ki67 (1:500, 
Santa Cruz). The following secondary antibodies were used at 1:500 dilution: Alexa 
Fluor 488-conjugated goat anti rabbit, Alexa Fluor 546-conjugated goat anti guinea 
pig, Alexa Fluor 488-conjugated donkey anti rabbit, Alexa Fluor 546-conjugated 
donkey anti goat. Image acquisition was performed with a confocal A1R microscope 
(Nikon) using a 40x oil immersion objective (NA = 1.3). Images were acquired as z 
stacks (20 steps of 0.5μm), and adjacent images were stitched using the NIS software, 
in order to obtain the image of the full dentate gyrus. 
 
4.5.3. Image Analysis 
The experimenter was blind during image analysis, and the order of images analyzed 
was randomized. For image-analysis z-stacks were selected for analysis using Fiji 
Software 29: for the NEUN, DCX and DAPI signal a single image was used, for GFAP 




a maximum projection of 4 slices was used (as GFAP processes are not straight). The 
dentate gyrus and hilus masks were made using the DAPI signal. At P6 and P9, 
NEUN+ cells accumulated at the edge of GCL layer, and were not included inside the 
GCL area defined using DAPI signal. So, for P6 and P9 a NEUN mask was created 
using the NEUN signal and in a similar way that the GCL mask was created. To 
enhance detection of the borders, images were blurred with a gaussian blur. After, 
area, mean and total intensities of DAPI, NEUN, GFAP, DCX were measured inside 
the selected masks. NEUN intensities were measured inside GCL mask at P2, and 
inside NEUN mask at P6 and P9, as at P2, NEUN layer is not yet organized in the 
outer edge of the GCL. To normalize the signal in each slice, the intensity of single 
NEUN+, GFAP+ and DCX+ cells were calculated, by averaging the intensity of 5 
regions of interest centered on a single neuron per cell-type. The region of interests 
used were constant in size. The total number of cells was estimated by dividing the 
total fluorescence of a marker, by the total intensity inside a single-cell (region of 
interest). Due to small differences in single cell detection accuracy, cell numbers 
between different markers are not comparable. The cell density was calculated by 
dividing the cell number by the area. Ki67+ cells were mostly non-overlapping and 
were counted using all z-stacks available. The number of GFAP processes per slice 
was determined by drawing 2-4 150μm wide lines per slice parallel to the DG. A line 
profile was obtained for each line, and the number of peaks assessed using Find 
Peaks, in BAR plugin in ImageJ 30. For the distribution of DAPI and NEUN profiles, 10 
lines of 150μm per slice were drawn perpendicular to dentate gyrus, starting at the 
hilus. For each of these the intensity profile along the line was obtained and an 
average intensity profile per slice calculated. Normalization of the data was obtained 
by averaging the maximum 3 and minimum 3 intensity values in each line. Then, the 
minimum was subtracted and the result divided by the maximum. Finally, both the 
peak distance from hilus and the width at half maximum were calculated using the 
average intensity profile per slice. For the peak distance from hilus, the 3 maximum 
intensity values were detected and the correspondent x values (distance from hilus) 
averaged. The width at half maximum was calculated as the distance between the 
curve points at the peak half maximum level. In some of the DAPI intensity profile 
curves all the points before the peak were higher than width at half maximum. In such 
cases the first point was defined as x=0.  
 
4.5.4. Calcium Imaging 
Mice were genotyped, selected and quickly decapitated, and processed as previously 
described 31,32. Animals were collected in three age groups: P2 and P3 (P2/3), P6 and 
P7 (P6/7), P10 and P11 (P10/11). In each of these groups, one animal was processed 
each day, and were randomly assigned to be on first or second day. Brain was isolated 
and sliced on ice bathed in iced-ACSF solution containing choline (110 mM Choline 
chloride, 26 mM NaHCO3, 10 mM Dglucose, 11.6 mM sodium ascorbate, 7 mM MgCl2, 
3.1 mM sodium pyruvate, 2.5 mM KCl, 1.25 mM NaH2PO4, and 0.5 mM CaCl2). Slices 
of 300 µm were obtained using a vibratome, and were left for at least 30 minutes at 
room temperature in resting solution (ACSF solution with higher magnesium 
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concentration: 125 mM NaCl, 26 mM NaHCO3, 10 mM D-glucose, 3 mM KCl, 2.5 mM 
MgCl2, 1.6 mM CaCl2, and 1.25 mM NaH2PO4). From this step on slices were bubbled 
with 95% Oxygen and 5% CO2. Slices are transferred to an interface chamber and 
temperature was slowly raised to 37oC, while in elevated magnesium ACSF. When 
that temperature is reached the slices are loaded with calcium dye (50µg of fura2-AM, 
Invitrogen) diluted in 9µL DMSO and 1µL Pluronic F-127 (20% solution in DMSO, 
Invitrogen), between 20 to 40 minutes depending on the age of the animal. After, the 
excess dye was washed off for one hour before transfer to a recording chamber. 
During image acquisition slices are perfused with oxygenated standard ACSF. Images 
were acquired using a two-photon microscope (Trimscope (LaVision Biotec) using a 
Ti-sapphire laser tuned to 820-nm wavelength): first a Z-stack of the selected area 
was acquired, for detecting cells, and then a 7.65Hz movie of 8 minutes was recorded 
32. Analysis was done using previously described MATLAB scripts 31. 
 
4.5.5. Statistics 
Statistical analysis was performed using GraphPad Prism 8.0 software, and all 
statistical details can be found in Supplementary Table 4.1. Normality was tested using 
D’Agostino & Pearson test. A p value of ≤ 0.05 was considered statistically significant. 
The following code was used to signify significance: * ≤ 0.05; ** ≤ 0.002; *** ≤ 0.0002; 
*** ≤ 0.0001. 
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Supplementary Figure S4.1 – From P2 to P9, the GCL becomes more compact and the hilar 
region contains fewer cells  
Example figures of DAPI staining in the dentate gyrus of P2, P6 and P9 WT (top) and KO animals 
(bottom) used in Fig. 4.1; scale bar 40µm. 
Supplementary Figure S4.2 – The DG is more organized at P9, compared to P2. 
Examples of immunostained WT slices at both postnatal days 2 and 9. The top left composite image 
of a P2 WT slice is stained for DAPI, NEUN and GFAP, and bottom left is a zoom in of the individual 
markers. A P9 WT slice is depicted on the right. At P9 the cell layers in the DG are more compact 
(DAPI staining). In addition, at P9 GFAP processes organize consistently parallel to the DG, 
extending from the hilus to the molecular layer, whereas NEUN+ neurons accumulate at the outer 
edge of the DG. Neither of these organizational features is present at P2, which was also observed 
previously 14.  










Supplementary Figure S4.3 – Event Duration is mostly unaffected in the absence of FBXO41. 
Two-photon calcium imaging in acute DG slices of Fbxo41 KO and WT littermates. These data 
correspond to events depicted in Fig. 4.5. 
(A-B) Events become faster with age: events tend to last less than 2 seconds at P6-P10 compared 
to P2 (A), and at P10 there are almost no events longer than 10 seconds (B). Change in event 
duration over time occurs differently in WT and KO. 
Data from 3 (P9) or 2 (P6) independent weeks. Data is represented as mean ± SEM. Numbers in 
figures are slices. For statistical details see Supplementary Table 4.1. 
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WT-P2 66 873 2878 19 3 Yes Two-Way ANOVA: 
• Time: F(2,142) = 84.51; ****p < 0.0001 
• Genotype: F(1,142) = 12.77; ***p = 0.0005 
• Interaction: F(2,142) = 1.66; p = 0.19 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.85; P6: p = 0.13; P10:****p < 0.0001 
KO-P2 62 038 2366 18 3 Yes 
WT-P6 99 916 5187 13 2 Yes 
KO-P6 83 974 4757 13 2 Yes 
WT-P9 125 182 3667 42 3 Yes 






WT-P2 526.44 21.1 19 3 Yes Two-Way ANOVA: 
• Time: F(2,142) = 69.98; ****p < 0.0001 
• Genotype: F(1,142) = 18.79; ****p < 0.0001 
• Interaction: F(2,142) = 2.49; p = 0.087 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.81; P6: *p = 0.03; P10:****p< 0.0001 
KO-P2 484.16 15.1 18 3 Yes 
WT-P6 790.30 45.4 13 2 Yes 
KO-P6 629.6 39.3 13 2 Yes 
WT-P9 964.21 28.73 42 3 Yes 
KO-P9 783.11 27.85 43 3 Yes 
4.1D 
DAPI Cells 
per µm2 in 
GCL 
WT-P2 0.008 0.0002 19 3 Yes Two-Way ANOVA: 
• Time: F(2,142) = 2.70; p = 0.071 
• Genotype: F(1,142) = 3.75; p = 0.055 
• Interaction: F(2,142) = 0.58; p = 0.56 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.99; P6: p = 0.44; P10: p = 0.099 
KO-P2 0.008 0.0002 18 3 Yes 
WT-P6 0.008 0.0002 13 2 Yes 
KO-P6 0.008 0.0002 13 2 Yes 
WT-P9 0.008 0.0002 42 3 Yes 




WT-P2 34 065 1927 19 3 Yes Two-Way ANOVA: 
• Time: F(2,142) = 73.15; ****p < 0.0001  
• Genotype: F(1,142) = 26.49; ****p < 0.0001  
• Interaction: F(2,142) = 5.91; **p = 0.0034 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p =0.12; P6:****p < 0.0001; P10: p = 0.37 
KO-P2 26 084 1916 18 3 Yes 
WT-P6 75 086 3245 13 3 Yes 
KO-P6 53 166 3199 13 3 Yes 
WT-P9 54 467 2068 42 2 Yes 





in the Hilus 
WT-P2 196.96 8.1 19 3 No Two-Way ANOVA: 
• Time: F(2,142) = 44.48; ****p < 0.0001  
• Genotype: F(1,142) = 9.07; **p = 0.0031 
• Interaction: F(2,142) = 0.21; p = 0.81 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.083; P6: p = 0.58; P10: p = 0.071 
KO-P2 164.58 10.4 18 3 Yes 
WT-P6 203.19 12.93 13 2 Yes 
KO-P6 183.02 18.3 13 2 Yes 
WT-P9 127.48 7.95 42 3 Yes 
KO-P9 105.45 4.63 43 3 Yes 
4.1G 
DAPI Cells 
per µm2 in 
Hilus 
WT-P2 0.006 0.0001 19 3 Yes Two-Way ANOVA: 
• Time: F(2,142) = 466.8; ****p < 0.0001  
• Genotype: F(1,142) = 8.81; **p = 0.0035  
• Interaction: F(2,142) = 6.11; **p = 0.0028 
Sidak’s post-hoc tests – WT vs KO: 
KO-P2 0.006 0.0002 18 3 Yes 
WT-P6 0.003 0.0001 13 3 Yes 
KO-P6 0.003 0.0002 13 3 Yes 
WT-P9 0.002 0.0001 42 2 Yes 











WT-P2 111.17 8.1 12 3 Yes Two-Way ANOVA: 
• Time: F(2, 68) = 2.34; p = 0.10 
• Genotype: F(1, 68) = 19.21; ****p < 0.0001  
• Interaction: F(2, 68) = 0.11; p = 0.90  
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.071; P6: p = 0.081; P10:**p = 0.039 
KO-P2 79.06 6.2 13 3 Yes 
WT-P6 100.70 11.1 8 2 Yes 
KO-P6 60.28 7.4 7 2 NA 
WT-P9 123.78 10.4 18 3 Yes 




per µm2 in 
GCL 
WT-P2 0.002 0.0001 12 3 Yes Two-Way ANOVA: 
• Time: F(2, 68) = 50.53; ****p < 0.0001 
• Genotype: F(1, 68) = 13.36; ***p = 0.0005 
• Interaction: F(2, 68) = 0.70; p = 0.50 
Sidak’s post-hoc tests – WT vs KO: 
• P2: **p = 0.0062; P6: p = 0.41; P10: p = 0.14 
KO-P2 0.001 0.0001 13 3 Yes 
WT-P6 0.001 0.0001 8 2 Yes 
KO-P6 0.002 0.0001 7 2 NA 
WT-P9 0.001 0.0001 18 3 Yes 





per 150 µm 
in GCL 
WT-P6 18.03 1.03 8 2 Yes Two-Way ANOVA: 
• Time: F(1, 45) = 0.19; p = 0.67 
• Genotype: F(1, 45) = 8.11; **p = 0.0066  
• Interaction: F(1, 45) = 0.064; p = 0.80 
Sidak’s post-hoc tests – WT vs KO: 
• P6: p = 0.14; P10: *p = 0.046 
KO-P6 15.46 1.04 7 2 NA 
WT-P9 18.18 0.54 18 3 Yes 






WT-P2 235.14 19.4 7 2 NA Two-Way ANOVA: 
• Time: F(2, 53) = 84.25; ****p < 0.0001 
• Genotype: F(1, 53) = 169; *p = 0.031  
• Interaction: F(2, 53) = 0.74; p = 0.48  
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.87; P6: p = 0.14; P10: p = 0.57 
KO-P2 220.60 32.6 5 2 NA 
WT-P6 240.40 17.6 5 1 NA 
KO-P6 197.00 18.6 6 1 NA 
WT-P9 105.53 4.71 17 3 Yes 




per µm2 in 
GCL 
WT-P2 0.0034 0.0002 7 2 NA Two-Way ANOVA: 
• Time: F(2, 53) = 213.2; ****p < 0.0001 
• Genotype: F(1, 53) = 5.04; *p = 0.029 
• Interaction: F(2, 53) = 1.25; p =  0.29 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.59; P6: p = 0.14; P10: p = 0.95 
KO-P2 0.0031 0.0002 5 2 NA 
WT-P6 0.0026 0.0001 5 1 NA 
KO-P6 0.0022 0.0001 6 1 NA 
WT-P9 0.0010 0.0001 17 3 Yes 






WT-P2 621.28 97.6 7 2 NA Two-Way ANOVA: 
• Time: F(2, 50) = 2.30; p = 0.11 
• Genotype: F(1, 50) = 7.63; **p = 0.008 
• Interaction: F(2, 50) = 0.091; p = 0.91 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.51; P6: p = 0.48; P10: *p = 0.019 
KO-P2 473.80 36.6 5 2 NA 
WT-P6 654.63 42.8 5 1 NA 
KO-P6 496.69 42.4 6 1 NA 
WT-P9 776.39 61.55 16 3 Yes 
KO-P9 577.63 46.18 17 3 No 




per µm2 in 
GCL 
KO-P2 0.007 0.0004 5 2 NA • Time: F(2, 50) = 5.95; **p = 0.0048 
• Genotype: F(1, 50) = 10.03; **p = 0.0026  
• Interaction: F(2, 50) = 0.87; p = 0.42  
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.096; P6: p = 0.20; P10: p = 0.42 
WT-P6 0.007 0.0005 5 1 NA 
KO-P6 0.006 0.0004 6 1 NA 
WT-P9 0.006 0.0004 16 3 Yes 






WT-P2 295.33 20.3 12 3 No Two-Way ANOVA: 
• Time: F(2, 84) = 88.01; ****p < 0.0001 
• Genotype: F(1, 84) = 2.81; p = 0.098 
• Interaction: F(2, 84) = 0.50; p = 0.61 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.99; P6: p = 0.39; P10: p = 0.51 
KO-P2 281.60 11.2 13 3 Yes 
WT-P6 520.12 45.2 8 2 Yes 
KO-P6 408.7 30.3 7 2 NA 
WT-P9 785.71 35.1 25 3 No 
KO-P9 732.52 38.9 25 3 Yes 
4.2K 
NeuN Cells 
per µm2 in 
GCL 
WT-P2 0.005 0.0002 12 3 No Two-Way ANOVA: 
• Time: F(2, 84) = 178.5; ****p < 0.0001 
• Genotype: F(1, 84) = 0.009; p = 0.99 
• Interaction: F(2, 84) = 0.66; p = 0.51 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.95; P6: p = 0.99; P10: p = 0.59 
KO-P2 0.005 0.0001 13 3 Yes 
WT-P6 0.008 0.0004 8 2 Yes 
KO-P6 0.008 0.0002 7 2 NAA 
WT-P9 0.010 0.0003 25 3 Yes 




WT-P6 64 022 3761 8 2 Yes Two-Way ANOVA: 
• Time: F(1, 61) = 22.29; ****p < 0.0001  
• Genotype: F(1, 61) = 4.75; *p = 0.033  
• Interaction: F(1, 61) = 2.29; p = 0.13 
Sidak’s post-hoc tests – WT vs KO: 
• P6: p = 0.077; P10: p = 0.74 
KO-P6 50 125 4407 7 2 NA 
WT-P9 76 071 2258 25 3 Yes 







WT-P2 40.73 1.9 12 3 Yes Two-Way ANOVA: 
• Time: F(2, 68) = 7.83; ***p = 0.0009 
• Genotype: F(1, 68) = 34.92; ****p < 0.0001  
• Interaction: F(2, 68) = 2.23; p = 0.12 
Sidak’s post-hoc tests – WT vs KO: 
• P2: **p =0.007; P6: ***p =0.0002; P9:*p= 0.04 
KO-P2 26.43 3.0 13 3 Yes 
WT-P6 57.40 6.5 8 2 Yes 
KO-P6 32.75 4.1 7 2 NA 
WT-P10 36.56 2.7 18 3 Yes 
KO-P10 26.60 2.4 16 3 Yes 
4.3B 
GFAP Cells 
per µm2 in 
Hilus 
WT-P2 0.014 0.0008 12 3 Yes Two-Way ANOVA: 
• Time: F(2, 68) = 64.6; ****p < 0.0001 
• Genotype: F(1, 68) = 7.12; **p = 0.0095 
• Interaction: F(2, 68) = 1.01; p = 0.37 
Sidak’s post-hoc tests – WT vs KO: 
• P2: *p = 0.017; P6: p = 0.89; P9 = 0.37 
KO-P2 0.011 0.0007 13 3 Yes 
WT-P6 0.008 0.0005 8 2 No 
KO-P6 0.007 0.0007 7 2 NA 
WT-P9 0.006 0.0005 18 3 Yes 




WT-P2 92.4 6.9 7 2 NA Two-Way ANOVA: 
• Time: F(2, 53) = 62.60; ****p < 0.0001 
• Genotype: F(1, 53) = 7.87; **p = 0.007 
KO-P2 69.2 11.7 5 2 NA 
WT-P6 161.6 15.7 5 1 NA 





in Hilus  
KO-P6 129.8 22.2 6 1 NA • Interaction: F(2, 53) = 1.24; p = 0.29 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.29; P6: p = 0.11; P9 = 0.75 
WT-P9 54.8 3.3 17 3 Yes 




per µm2 in 
Hilus 
WT-P2 0.002 0.0002 7 2 NA Two-Way ANOVA: 
• Time: F(2, 53) = 45.36; ****p < 0.0001 
• Genotype: F(1, 53) = 1.17; p = 0.28 
• Interaction: F(2, 53) = 4.37; p = 0.65 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.50; P6: p = 0.99; P9 = 0.85 
KO-P2 0.002 0.0003 5 2 NA 
WT-P6 0.002 0.0002 5 1 NA 
KO-P6 0.002 0.0003 6 1 NA 
WT-P9 0.001 0.0001 17 3 Yes 






WT-P2 457.38 64.4 7 2 NA Two-Way ANOVA: 
• Time: F(2, 50) = 41.45; ****p < 0.0001 
• Genotype: F(1, 50) = 11.63; **p = 0.0013 
• Interaction: F(2, 50) = 1.19; p = 0.31 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.06; P6: p = 0.14; P9 = 0.43 
KO-P2 311.11 39.2 5 2 NA 
WT-P6 572.08 52.5 5 1 NA 
KO-P6 443.81 42.6 6 1 NA 
WT-P9 221.93 24.8 16 3 Yes 
KO-P9 171.56 17.6 17 3 No 
4.3F 
DCX Cells 
per µm2 in 
Hilus 
WT-P2 0.01 0.001 7 2 NA Two-Way ANOVA: 
• Time: F(2, 50) = 58.86; ****p < 0.0001 
• Genotype: F(1, 50) = 2.56; p = 0.12 
• Interaction: F(2, 50) = 1.44; p = 0.25 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.11; P6: p = 0.99; P9 = 0.89 
KO-P2 0.009 0.0004 5 2 NA 
WT-P6 0.008 0.001 5 1 NA 
KO-P6 0.008 0.001 6 1 NA 
WT-P9 0.004 0.0003 16 3 Yes 







WT-P2 148.95 9.0 12 3 Yes Two-Way ANOVA: 
• Time: F(2, 4) = 18.5; ****p < 0.0001 
• Genotype: F(1, 84) = 5.59; *p = 0.02 
• Interaction: F(2, 84) = 0.037; p = 0.96 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.52; P6: p = 0.63; P9 = 0.08 
KO-P2 120.76 7.0 13 3 Yes 
WT-P6 224.30 24.7 8 2 Yes 
KO-P6 192.65 20.6 7 2 NA 
WT-P9 235.65 14.8 25 3 No 
KO-P9 200.03 10.6 25 3 Yes 
4.3H 
NeuN Cells 
per µm2 in 
Hilus 
WT-P2 0.005 0.0001 12 3 Yes Two-Way ANOVA: 
• Time: F(2, 84) = 26.07; ****p < 0.0001 
• Genotype: F(1, 84) = 2.94; p = 0.090 
• Interaction: F(2, 84) = 5.14; **p = 0.0078 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.59; P6: *p = 0.049; P9 = 0.23 
KO-P2 0.005 0.0001 13 3 Yes 
WT-P6 0.003 0.0002 8 2 Yes 
KO-P6 0.004 0.0004 7 2 NA 
WT-P9 0.004 0.0002 25 3 Yes 
KO-P9 0.004 0.0002 25 3 Yes 
4.4B 
P6 – DAPI; 
Distance to 
Peak (µm) 
WT 33.74 2.8 8 2 Yes 
Mann-Whitney 
(U = 6; **p = 0.0084) 
KO 20.06 3.0 7 2 NA 
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WT 57.68 2.6 8 2 No 
Mann-Whitney 
(U = 14; p = 0.11) 
KO 51.77 2.2 7 2 NA 
4.4C 
P6 –NeuN; 
 Distance to 
Peak (µm) 
WT 76.15 3.4 8 2 Yes 
Mann-Whitney 
(U = 7; *p = 0.013) 
KO 61.41 3.6 7 2 NA 




WT 44.99 4.3 8 2 Yes 
Mann-Whitney 
(U = 16.5; p = 0.20) 
KO 53.58 5.0 7 2 NA 
4.4D 
P9 – DAPI; 
Distance to 
Peak (µm) 
WT 31.57 2.0 25 3 Yes 
Unpaired t-test 
(t(48) = 0.47; p = 0.63) 
KO 29.99 2.7 25 3 Yes 




WT 63.11 1.4 25 3 Yes 
Unpaired t-test 
(t(48) = 2.82; **p = 0.007) 





WT 75.34 1.8 25 3 Yes 
Unpaired t-test 
(t(48) = 1.81; p = 0.0762) 
KO 70.09 2.3 25 3 Yes 




WT 45.45 1.7 25 3 Yes 
Unpaired t-test 
(t(48) = 1.857; p = 0.0695) 





WT-P2 17.52 4.88 7 3 NA Two-Way ANOVA: 
• Time: F(2, 68) = 3.30; *p = 0.043 
• Genotype: F(1, 68) = 0.22; p = 0.64 
• Interaction: F(2, 68) = 1.34; p = 0.27 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.87; P6: p = 0.25; P10: p = 0.99 
KO-P2 23.3 6.51 6 3 NA 
WT-P6 38.01 4.63 12 4 Yes 
KO-P6 28.08 4.34 15 4 Yes 
WT-P10 31.66 4.22 16 4 Yes 





WT-P2 0.005 0.0008 7 3 NA Two-Way ANOVA: 
• Time: F(2, 68) = 5.03; ***p = 0.009 
• Genotype: F(1, 68) = 0.10; p = 0.75 
• Interaction: F(2, 68) = 2.96; p = 0.058 
Sidak’s post-hoc tests – WT vs KO: 
KO-P2 0.0088 0.003 6 3 NA 
WT-P6 0.021 0.004 12 4 Yes 
KO-P6 0.0096 0.001 15 4 Yes 
WT-P10 0.018 0.002 16 4 Yes 




KO-P10 0.022 0.005 18 4 No 
• P2: p = 0.94; P6: p = 0.085; P10: p = 0.72 
Unpaired t-test P6 WT vs KO: 






WT-P2 0 0 7 3 NA Two-Way ANOVA: 
• Time: F(2, 68) = 2.74; p = 0.072  
• Genotype: F(1, 68) = 0.87; p = 0.35  
• Interaction: F(2, 68) = 0.29; p = 0.75  
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.99; P6: p = 0.50; P10: p = 0.89 
KO-P2 0 0 6 3 NA 
WT-P6 16.86 6.46 12 4 Yes 
KO-P6 7.29 3.44 15 4 No 
WT-P10 16.9 5.76 16 4 Yes 






WT-P6 0.061 0.016 5 4 NA Two-Way ANOVA: 
• Time: F(1,17) = 0.21; p = 0.65  
• Genotype: F(1, 17) = 0.098; p = 0.76 
• Interaction: F(1,17) = 9.44; **p = 0.007 
Sidak’s post-hoc tests – WT vs KO: 
• P6: p = 0.075; P10: p = 0.1 
KO-P6 0.013 0.008 4 4 NA 
WT-P10 0.011 0.003 7 4 NA 





WT P2 bas 17,52 4,88 7 3 NA Wilcoxon signed-rank test 
(T = 7; p = 0.297) WT P2 gbz  14,17 5,7 7 3 NA 
KO P2 bas 23,3 6,51 6 3 NA Wilcoxon signed-rank test 
(T = 3; p = 0.156) KO P2 gbz 14,55 2,93 6 3 NA 
WT P6 bas 38.01 4.63 12 4 Yes Paired t-test 
(t(11) = 0.0397; p = 0.97) WT P6 gbz  37.87 5.00 12 4 Yes 
KO P6 bas 28.08 4.34 15 4 Yes Paired t-test 
(t(14) = 0.0516; p = 0.61) KO P6 gbz 26.48 3.14 15 4 Yes 
WT P10 bas 31.17 4.16 14 4 Yes Paired t-test 
(t(13) = 2.17; *p = 0.0495) WT P10 gbz 37.37 3.84 14 4 Yes 
KO P10 bas  30.48 2.45 18 4 Yes Paired t-test 





WT P2 bas 0.005 0.0008 7 3 NA Wilcoxon signed-rank test 
(T = 13; p = 0.94) WT P2 gbz  0.0047 0.001 7 3 NA 
KO P2 bas 0.0088 0.003 6 3 NA Wilcoxon signed-rank test 
(T = 9; p = 0.84) KO P2 gbz 0.0094 0.003 6 3 NA 
WT P6 bas 0.021 0.004 12 4 Yes Wilcoxon signed-rank test 
(T = 18; p = 0.11) WT P6 gbz  0.028 0.006 12 4 Yes 
KO P6 bas 0.0096 0.001 15 4 Yes Wilcoxon signed-rank test 
(T = 35; p = 0.17) KO P6 gbz 0.016 0.004 15 4 No 
WT P10 bas 0.018 0.002 14 4 Yes Wilcoxon signed-rank test 
(T = 3; ****p = 0.0006) WT P10 gbz 0.030 0.005 14 4 Yes 
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KO P10 bas  0.022 0.005 18 4 No Wilcoxon signed-rank test 






WT P2 bas 0 0 7 3 NA Wilcoxon signed-rank test 
(T = 0; p = 0.99) WT P2 gbz  3.85 3.85 7 3 NA 
KO P2 bas 0 0 6 3 NA 
NA 
KO P2 gbz 0 0 6 3 NA 
WT P6 bas 16.86 6.46 12 4 Yes Wilcoxon signed-rank test 
(T = 9; p = 0.84) WT P6 gbz  18.96 6.24 12 4 Yes 
KO P6 bas 7.29 3.44 15 4 No Wilcoxon signed-rank test 
(T = 1; p = 0.25) KO P6 gbz 9.93 4.49 15 4 Yes 
WT P10 bas 13.68 5.41 14 4 Yes Wilcoxon signed-rank test 
(T = 13; p = 0.30) WT P10 gbz 21.56 5.14 14 4 Yes 
KO P10 bas  12.66 5.66 18 4 No Wilcoxon signed-rank test 






WT P2 bas 0 0 7 3 NA 
NA 
WT P2 gbz  0.0003 0.0003 7 3 NA 
KO P2 bas 0 0 6 3 NA 
NA 
KO P2 gbz 0 0 6 3 NA 
WT P6 bas 0.025 0.01 12 4 Yes Wilcoxon signed-rank test 
(T = 7; p = 0.56) WT P6 gbz  0.033 0.01 12 4 Yes 
KO P6 bas 0.0034 0.002 15 4 No Wilcoxon signed-rank test 
(T = 0; p = 0.13) KO P6 gbz 0.013 0.008 15 4 No 
WT P10 bas 0.0030 0.001 14 4 Yes Wilcoxon signed-rank test 
(T = 0; **p = 0.0039) WT P10 gbz 0.028 0.008 14 4 Yes 
KO P10 bas  0.014 0.008 18 4 No Wilcoxon signed-rank test 
(T = 12.5; *p = 0.034) KO P10 gbz 0.033 0.011 18 4 Yes 
4.7A 
% of Active 
Cells 
WT DG 39,24 4,94 6 2 NA Wilcoxon signed-rank test 
(T = 5; p = 0.313) WT CA3 31,84 2,78 6 2 NA 
KO DG 35,10 3,46 7 2 NA Wilcoxon signed-rank test 




WT DG 0,02 0,00 6 2 NA Wilcoxon signed-rank test 
(T = 0; *p = 0.031) WT CA3 0,06 0,02 6 2 NA 
KO DG 0,03 0,01 7 2 NA Wilcoxon signed-rank test 





WT DG 17,7 6,68 6 2 NA Wilcoxon signed-rank test 
(T = 0; *p = 0.031) WT CA3 53,1 7,19 6 2 NA 
KO DG 20,9 8,44 7 2 NA Wilcoxon signed-rank test 
(T = 2; p = 0.188) KO CA3 40,1 15,43 7 2 NA 








WT DG 0,01 0,00 6 2 NA Wilcoxon signed-rank test 
(T = 2; p = 0.0938) WT CA3 0,02 0,01 6 2 NA 
KO DG 0,02 0,01 7 2 NA Wilcoxon signed-rank test 





WT DG 4,11 0,19 6 2 NA Wilcoxon signed-rank test 
(T = 0; *p = 0.031) WT CA3 1,93 0,05 6 2 NA 
KO DG 4,86 0,56 7 2 NA Wilcoxon signed-rank test 
(T = 1; *p = 0.031) KO CA3 2,53 0,32 7 2 NA 
4.7F 
% of Events 
that last 
less than 2 
seconds 
WT DG 5,08 1,27 6 2 NA Wilcoxon signed-rank test 
(T = 0; *p = 0.031) WT CA3 54,20 2,81 6 2 NA 
KO DG 3,11 1,37 7 2 NA Wilcoxon signed-rank test 








less than 2 
Seconds 
WT-P2 0 0 7 3 NA Two-Way ANOVA: 
• Time: F(2, 68) = 2.82; p = 0.067 
• Genotype: F(1, 68) = 0.33; p = 0.57  
• Interaction: F(2, 68) = 0.19; p = 0.83 
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.99; P6: p = 0.78; P10: p = 0.99 
KO-P2 0.74 0.59 6 3 NA 
WT-P6 6.44 3.18 12 4 No 
KO-P6 9.63 4.19 15 4 No 
WT-P10 5.9 1.56 16 4 Yes 









WT-P2 49.72 8.44 7 3 NA Two-Way ANOVA: 
• Time: F(2, 68) = 6.093; ***p = 0.0037 
• Genotype: F(1, 68) = 0.69; p = 0.41  
• Interaction: F(2, 68) = 3.78; *p = 0.028  
Sidak’s post-hoc tests – WT vs KO: 
• P2: p = 0.11; P6: p = 0.25; P10: p = 0.98 
KO-P2 70.88 6.7 6 3 NA 
WT-P6 74.81 7.03 12 4 No 
KO-P6 62.87 5.5 15 4 No 
WT-P10 78.42 3.55 16 4 Yes 
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The ubiquitin proteasome system (UPS) has been extensively linked to 
neurodevelopment and synaptic transmission. FBXO41 is an E3 ligase subunit that 
selects targets for ubiquitination. Fbxo41 knockout mice show early lethality, reduced 
dentate gyrus size, and defects in network activity. To test the role of FBXO41 at 
different time points of development and to minimize compensatory mechanisms, we 
developed a conditional Fbxo41 knockout mouse. Cre-dependent deletion of Fbxo41 
exon 4 induced an early stop codon through a frame shift preventing translation of full 
length Fbxo41. Western blot analysis showed a truncated product expressed at lower 
levels compared to full length FBXO41. Interfering with FBXO41 expression acutely in 
hippocampal neurons in culture resulted in longer axons, less efficient synaptic 
communication, and an increased paired pulse ratio. Hence, acute truncation of 









Brain development is a complex process, fundamental for proper brain function. 
During development neurons proliferate, migrate, and wire forming cohesive networks 
(reviewed in1). Defects in all of these steps can lead to neurodevelopmental disorders 
(reviewed in 1). In the adult brain, neuronal wiring is key for proper brain function and 
several disorders have been linked to defects in synaptic composition and 
neurotransmission (reviewed in 2,3).  
 
Ubiquitination has been consistently linked to both brain development and synaptic 
transmission (reviewed in 4-6). Ubiquitination occurs through a cascade of reactions, 
catalyzed by E1 activating enzyme, E2 ubiquitin conjugating enzyme and E3 ubiquitin 
ligases, that lead to binding of ubiquitin to a target protein 7,8. Depending on the site of 
ubiquitination, the size and type of the ubiquitin chain, ubiquitinated proteins are 
targeted for degradation by the proteasome or have other nonproteolytic fates 
(reviewed in 4,9). The ubiquitin proteasome system has been shown to regulate 
synaptic composition and efficacy, mediate memory formation, as well as to change 
its location and proteolytic activity in response to neuronal stimulation (reviewed in 5,6). 
In addition, ubiquitination has been shown to be relevant in several stages of nerve 
cell development, including neuron proliferation, synaptic formation and neuronal 
arborization (reviewed in 4). Even though there is an extensive link between UPS and 
brain development and synaptic plasticity, relatively few UPS components have been 
identified and insight in their molecular mechanisms is scarce.  
 
F-box proteins are components of the S phase kinase-associated protein 1 (SKP1)–
cullin 1 (CUL1)–F-box protein (SCF), a multiprotein E3 ubiquitin ligase, that target 
proteins for ubiquitination (reviewed in 8). FBXO41 is a brain enriched F-box protein, 
whose null mutant (knockout, KO) results in early lethality in mice 10. We have 
previously shown that FBXO41 accumulation at the centrosome results in disassembly 
of neuronal primary cilia, a structure linked to brain development (Chapter 2). In 
addition, FBXO41 impacts neurotransmission, network activity during development 
and dentate gyrus structure. Even though there is extensive data demonstrating the 
importance of FBXO41 in brain function, a conditional knockout model would help 
elucidate the effect of removing FBXO41 at different stages of development, and could 
unveil novel insights by preventing compensatory mechanisms often present in 
classical knockout models.  
 
In this study, a conditional null mutant (cKO) model of Fbxo41 was developed and the 
effect of acute FBXO41 deficiency on hippocampal morphology and function was 
investigated. The cKO strategy consisted in deleting Fbxo41 exon 4, by introducing 
loxP sites around this exon, that could then be cleaved using Cre recombinase 
(Fbxo41lox/lox), producing a frame shift that would induce an early stop codon thus 
preventing Fbxo41 translation. This strategy proved efficient in preventing translation 
of full-length FBXO41 upon Cre-expression, but resulted in a truncated version of 
FBXO41. This truncated FBXO41 was recognized by antibodies targeting both the C 
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and N terminus of the protein and was expressed at lower levels compared to wild 
type FBXO41. Acute depletion of full length FBXO41 resulted in increased axonal 
length in cultured hippocampal neurons, and increased paired pulse ratio. Hence, 
acute depletion and chronic KO of full length Fbxo41 from neurons both decrease the 
efficacy of synaptic transmission, strengthening the role of FBXO41 in such a function.  
 
  





5.3.1. Removal of exon 4 from Fbxo41 prevents translation of full length FBXO41 while 
generating a truncated version of FBXO41 
To study the developmental effects of FBXO41, a conditional knockout (cKO) model 
of Fbxo41 was generated (Fig. 5.1). The cKO strategy consisted in removing Fbxo41 
exon 4, which results in an early stop codon induced by a frame shift, impeding Fbxo41 
translation (Fig. 5.1A). Using antibodies against the C and N terminus of the protein 
(Fig. 5.1B) we demonstrated that this strategy succeeded in preventing translation of 
full length FBXO41: both in lysates of Fbxo41 cKO after Cre-mediated KO via crossing  
Figure 5.1 – Removal of Fbxo41 exon 4 deletes full length FBXO41 and results in a truncated 
version of FBXO41. 
(A) Strategy for generation of conditional Fbxo41 KO mice. Top shows scheme of Fbxo41 gene, with 




with Cre-deleter mice, and in Fbxo41 cKO neurons infected with Cre virus at day in 
vitro (DIV) 0 and lysed at DIV14 or DIV21 (Fig. 5.1C-D). In both preparations, a smaller 
band was observed that cross-reacted with both C and N terminal antibodies. FBXO41 
full length was observed at around 120KDa and the smaller band at 100KDa (Fig. 
5.1C-D). This protein, likely a truncated version of FBXO41 due to skipping of exons 
4 and 5 and partly deleting the coiled coil domain of FBXO41, was expressed at lower 
levels compared to full length FBXO41 in wild type (WT) neurons (Fig. 5.1C-D). Hence, 
the cKO strategy successfully prevented translation of full length FBXO41, while 
generating a truncated version of FBXO41 expressed at lower levels than WT 
FBXO41. 
 
5.3.2. Hippocampal Fbxo41 cKO neurons have longer axons  
To study the effect of FBXO41 truncation in hippocampal neurons, we infected 
cultured Fbxo41lox/lox neurons with lentivirus expressing GFP-Cre or a scrambled 
version of Cre (ΔCre) at DIV 0. Neurons were fixed at DIV 14 and stained for dendritic 
(MAP2), synaptic (Synaptophysin) and axonal (SMI-312) markers (Fig. 5.2). FBXO41 
full length deficiency had no effect on dendritic length or branching (Fig. 5.2C and E), 
but significantly increased axonal length (Fig. 5.2D). In addition, the number of 
synaptophysin puncta (synapses) was somewhat decreased in Fbxo41 cKO neurons, 
compared to controls (Fig. 5.2F). However, the number of synapses per dendrite 
length was not affected (Fig. 5.2G), and synaptophysin puncta intensity, as a proxy for 
the number of synaptic vesicles per synapse, was similar in control and Fbxo41 cKO 
neurons (Fig. 5.2H). In conclusion, preventing translation of full length FBXO41 in 
hippocampal neurons increases axonal length, without affecting synapse density, 
dendritic length or branching. 
  
strategy, which consists in removing exon 4 from Fbxo41. Targeting vector included a neomycin 
resistance cassette (NEO) for selection, surrounded by frt recombination sites (oval), and Lox P sites 
(triangles) surrounding Fbxo41 exon 4. The Neo cassette can be removed using Flip recombinase, 
generating Fbxo41lox/lox. Cre recombinase driven recombination of LoxP sites removes Fbxo41 exon 
4, resulting in a frame shift and preventing Fbxo41 translation. Addition of Cre can be controlled in 
time and space, thus generating a conditional knockout (cKO). 
(B) Scheme of FBXO41 protein, depicting exons 1-14, and the predicted protein domains: ZnF (zinc 
finger), Coiled-coil and F-box domain. Two antibodies were used in this study, one targeting the N-
terminus (antibody A), and the other the C-terminus (antibody B) of FBXO41. 
(C) Western blot showing FBXO41 staining of lysates obtained from P1 WT and Fbxo41 cKO 
littermate brains. Both antibodies show depletion of full length FBXO41 (indicated green arrow – 
around 120 KDa) in cKO lysates, and the appearance of a smaller, truncated version (red arrow – 
around 100 KDa). Both antibodies detect an unspecific band indicated by an asterisk.  
(D) Fbxo41lox/lox neurons in culture, infected at day in vitro (DIV) 0 with GFP-Cre or a scrambled 
version of Cre (GFP-ΔCre), and lysed at DIV 14 or 21 do not express full length FBXO41 (green 
arrow – around 120 KDa). A smaller, truncated version of FBXO41 (red arrow - around 100 KDa) is 
recognized by antibodies binding to C or N terminus of the protein (Antibody A or B, respectively). 
Cre and Delta Cre coupled to GFP were visualized using GFP antibody and distinguished by their 
difference in molecular weight (middle lanes). Actin was used as a loading control (bottom lane).   








5.3.3. Hippocampal neurons lacking full length Fbxo41 have increased paired pulse 
ratio 
Truncation of FBXO41 increases axonal length of hippocampal neurons. To test if 
synaptic transmission is also impacted, we used whole-cell patch clamp 
electrophysiology on DIV 14 hippocampal Fbxo41lox/lox neurons infected with Cre or 
DeltaCre (ΔCre) at DIV 0 as control. Spontaneous neurotransmission, assessed by 
mini excitatory postsynaptic current (mEPSC) frequency and amplitude was not 
affected in neurons lacking full length FBXO41 (Fig. 5.3 A-C). Evoked EPSC charge 
and amplitude were slightly reduced in Fbxo41 cKO neurons without reaching 
statistical significance (Fig. 5.3D-E). High frequency release upon 100 action 
potentials at 40 Hz, a stimulus known to deplete the readily releasable pool (Fig. 5.3 
F-G and 11), was similar in cKO compared to control and response kinetics were not 
affected (Fig. 5.3 F-G). The readily releasable pool (RRP), estimated by back 
extrapolation of the cumulative charge during the train, was smaller in cKO neurons 
but again not statistically different (Fig. 5.3I). RRP recovery tested by applying 14 
pulses at 0.2 Hz after pool depletion was similar between the two conditions (Fig. 5.3F-
H). The vesicular release probability, determined by dividing the EPSC charge (Fig. 
5.3D) by the total charge of the RRP (Fig. 5.3I), was not affected Fbxo41 cKO neurons. 
Finally, paired pulse ratio, calculated by dividing the amplitude of two consecutive 
pulses given at different time intervals, was increased in neurons infected with Cre 
(Fig. 5.3K), at 50 and 100 msec time intervals. Interestingly, Fbxo41 cKO neurons 
showed a tendency towards decreased synaptic efficacy in several of the parameters 
tested: mEPSC frequency (Fig. 5.3C), EPSC charge and amplitude (Fig. 5.3 D-E), 
total charge transmitted during a 40Hz train (Fig. 5.3F), and RRP charge (Fig. 5.3I) in 




Figure 5.2 – Acute knockout of full length Fbxo41 increases axonal length of hippocampal 
neurons. 
(A-B) Representative images of DIV 14 Fbxo41lox/lox hippocampal neurons infected with Cre (cKO), 
or DeltaCre (ΔCre-Control), and stained for dendritic (MAP2), axon (SMI-312), and synapse 
(Synaptophysin) markers. Scale bars = 20μm.  
(C) Dendritic length is not affected in Cre infected hippocampal neurons. 
(D) Hippocampal cKO neurons have increased axonal length.  
(E) Sholl analysis of dendritic branching revealed no differences between control (ΔCre) and cKO 
(Cre) conditions. 
(F-G) Total synapse number and synaptic density – detected using Synaptophysin – are similar 
between the two groups.  
(H) The intensity of Synaptophysin puncta was not affected in hippocampal cKO neurons.  
Data from 7 (dendrites and axons) and 3 (synapses) independent experimental weeks. Data is 
represented as mean ± SEM. Numbers in figure are neurons. For statistical details see 
Supplementary Table 5.1. 





Figure 5.3 – Acute loss of full length FBXO41 does not majorly impact synaptic transmission. 
Voltage-clamp recordings from isolated hippocampal excitatory Fbxo41lox/lox neurons, infected with 
ΔCre (control) or Cre (cKO). 
(A) Representative spontaneous mEPSC traces for Fbxo41 cKO and control neurons. 
(B-C) Spontaneous mEPSC amplitude (B) and frequency (C) are not significantly different in 
Fbxo41lox/lox neurons infected with ΔCre or Cre.  
(D-E) Average EPSC charge and amplitude is not affected in neurons lacking full-length FBXO41.  
(F-G) Kinetics of high frequency release are similar between cKO and control neurons, as depicted 
by the total charge (F) and normalized train amplitude (G). Inset shows example traces of responses 
induced by single action potentials. High frequency release was studied using a stimulus of 100 
pulses at 40 Hz (red bar), followed by 14 recovery pulses at a frequency of 0.2Hz (blue bar). 
(H) The amplitude of the first recovery pulse, after readily releasable pool (RRP) depletion (first pulse 
in blue bar on figure F), is not affected by acute loss of full length FBXO41. 
(I) Back extrapolation of the cumulative EPSC charge in a 40Hz train to the Y axis, to estimate RRP 
size, is similar between the two groups. 
(J) The vesicular release probability – calculated by dividing the total charge of the first single action 
potential detected and the total charge of the readily releasable pool – is not affected by depleting 
full-length FBXO41. 
(K) Paired pulse ratio assessed by stimulating neurons with two consecutive pulses with varying 
intervals is increased in Fbxo41 KO neurons for pulses with intervals of 50 and 100 msec. 
Data from 5 independent experimental weeks, and represent average ± SEM. Numbers in bars are 




In the present study we developed a conditional Fbxo41 null model and tested the 
effect of acute depletion of Fbxo41 on hippocampal morphology and synaptic 
transmission. Cre expression in Fbxo41lox/lox neurons prevented generation of full 
length FBXO41, but resulted in translation of a truncated FBXO41 variant at lower 
levels compared to full length FBXO41 (Fig. 5.1). In hippocampal neurons, acute 
deficiency of full-length FBXO41, resulted in increased axonal length, but no effect on 
synaptic density or dendritic morphology (Fig. 5.2). Synaptic transmission was mostly 
unaffected, although several parameters were lower in Fbxo41 cKO neurons without 
reaching statistical significance (Fig. 5.3). Importantly, in all models tested, Fbxo41 
KO hippocampal and striatal neurons, and Fbxo41 cKO hippocampal neurons, a trend 
for less efficient synaptic communication was consistently observed. Collectively, 
these data point to a subtle role of FBXO41 in synaptic transmission, which may 
contribute to the disturbance of network activity observed in Fbxo41 null mutant brain 
slices (Chapter 4).  
 
Conditional KO models are important tools of research, as they allow to study the 
acute loss of a protein, while minimizing compensatory mechanisms. In addition, in 
cKO models it is possible to temporally and spatially control the depletion of a gene. 
In order to generate a cKO model we employed a commonly used strategy consisting 
in deleting a small part of the genomic sequence of Fbxo41, which should prevent 
expression of the protein. In the model described here insertion of loxP sites 
surrounding exon 4 of Fbxo41, allowed its deletion with Cre recombinase, originating 
in a mRNA fragment with a frame shift leading to an early stop codon. Eukaryotic cells 
have mechanisms that target and degrade defective mRNA. Nonsense mediated 
mRNA decay is one such mechanism, degrading mRNA with a premature stop codon 
(reviewed in 12). As such, the Fbxo41 mRNA fragment originating from exon 4 deletion 
should be degraded preventing Fbxo41 translation. However, we observed a smaller 
FBXO41 fragment arising from this cKO strategy (Fig. 5.1). Several mechanisms can 
explain this. First, it is possible that the mRNA originating from frame shift in Fbxo41 
mRNA translation is not fully degraded by the cell. If this would be the case, antibodies 
against the N-terminus of FBXO41 protein (the first part of the protein to be produced), 
should still recognize FBXO41, but antibodies against the C-terminal end of the protein 
should not (Fig. 5.1). However, C-terminal antibodies did recognize the smaller 
fragment, indicating that the amino acid composition of both N and C terminus of 
FBXO41 is not defective. In addition, this truncated FBXO41 fragment should have a 
size of 299 amino acids, which would be around 33 KDa, much smaller than the 
fragment we observed. A second possible explanation is that the truncated FBXO41 
arises from alternative splicing, in which depletion of an additional exon or exons 
corrects the frame shift. Indeed, deletion of both exon 4 and exon 5 does not result in 
a frame shift resulting in a truncated FBXO41 protein of approximately 100kD with 
intact N- and C termini, consistent with what we observe. Hence, we consider this the 
most likely possibility for two reasons: 1) antibodies against both N and C terminus 
recognized the FBXO41 fragment; 2) deletion of these two exons would explain the 




difference in size from WT FBXO41. Finally, it is noteworthy that the levels of this 
truncated protein seem to be much lower than the levels of full length FBXO41. It is 
possible that deletion of Fbxo41 exon 4 pushes the cell to correct the induced frame 
shift, by deleting an extra exon. Arguably, the emergence of this splice variant would 
be less efficient than production of the original one, as it requires additional regulation. 
Alternatively, the cell might recognize this truncated FBXO41 as aberrant and degrade 
it partially, resulting in decreased levels of the truncated FBXO41. In conclusion, our 
cKO model presents a smaller, truncated version of FBXO41, which could be 
explained by the emergence of a splice variant in which exon 5 is deleted in addition 
to the removal of exon 4 induced by the model. 
 
Deletion of exon 4 (coding for amino acids 300-420) disrupts a large part of the coiled 
coil domain (amino acids 207-349). As such, it is very likely that the structure of the 
coiled coil domain is disrupted. The coiled coil domain has been previously shown to 
be important for FBXO41 centrosome targeting (Chapter 2 and 10), which in turn affects 
cilia length (Chapter 2). Additional removal of exon 5 would not interfere with any of 
the predicted FBXO41 domains, as F-box and Zinc-Finger domains, are coded by 
amino acids in exons 7 and 3, respectively. Importantly, if the F-box domain of 
FBXO41 is still intact, FBXO41 can form a SCF complex and participate in the UPS 
pathway. This means that the truncated version of FBXO41 could conserve some of 
FBXO41 functions, while disrupting others, rendering further study of this truncated 
version of FBXO41, a very difficult endeavor. Without knowledge of FBXO41 
substrates, and how they interact with the different FBXO41 domains, it is hard to test 
how/if this truncation affects FBXO41 function. For these reasons, further study of this 
model was abandoned.  
  
Hippocampal neurons lacking full length FBXO41 had a tendency for decreased 
synaptic transmission, and longer axons. The observed tendency for decrease in 
synaptic transmission mimics our observations in Fbxo41 KO neurons, both from 
striatum and hippocampus. Consistently, we observed a small increase (facilitation) in 
paired pulse ratio in some of the intervals tested. Notably, this phenotype was also 
observed in Fbxo41 full KO hippocampal neurons (Chapter 3).  Paired pulse facilitation 
is often correlated to a decrease in vesicular release probability, which we do not 
observe. The reason for this inconsistency might be the small effect size, and some 
variability in the data. However, synaptic transmission is a fundamental process for 
neuronal function, and even small effects on synaptic communication can greatly 
impact network activity. As far as morphology is concerned, Fbxo41 cKO had no effect 
on dendritic length or branching, consistent to what was observed before. However, 
we did observe an increase in axonal length as a result of acute depletion of full length 
FBXO41, and a tendency for decreased synaptic numbers. The trend on synapses 
does not reach statistical significance and was not observed before, but it would be in 
line with the trend for decreased synaptic transmission. The effect on axonal length 
was also not observed in the classical KO model, neither in striatal nor in hippocampus 
neurons. The reason for this disparity might be compensatory mechanisms in the full 
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KO that counterbalance the effect of chronic FBXO41 depletion in axonal arborization. 
It is also possible that the truncated version of FBXO41 interacts differently with its 
targets which might impair both FBXO41 function and localization. In conclusion, the 
KO and the cKO models show a consistent trend for FBXO41 depletion impacting the 








5.5. Materials and Methods 
5.5.1. Animals and generation of Fbxo41lox/lox mice 
All experimental animals were handled according to VU University Animal Ethics and 
Welfare Committee protocols, and housed and bred according to Dutch governmental 
guidelines.  
 
To generate a Fbxo41lox/lox mouse line a target vector was used to introduce LoxP 
sites around exon 4 of Fbxo41 gene. Upon Cre recombination exon 4 is removed 
inducing a stop-codon through frameshift after amino acid Q299. In addition, a 
neomycin cassette (NEO), flanked by two Frt sites, was introduced upstream of exon 
4. This NEO cassette is removable upon expression of Flp recombinase. Finally, the 
vector contained two homologous arms, 5’ and 3’ respectively, of 5.7 Kb and 6.3 kb in 
length, and a diphtheria toxin A (DTA) expression cassette. The DTA cassette allowed 
counterselection against random genomic integrations of the NEO cassette. The 
vector was introduced in embryonic stem cells, and G418 resistant clones were 
derived and validated. Correctly target embryonic stem cells were used for blastocyst 
injections to obtain chimeric mice. After germ line transmission, heterozygote colonies 
were maintained by backcrossing with C57BL/6 inbred mice to maintain a pure inbred 
genetic background. The NEO cassette was removed by crossing these mice with a 
C57BL/6 Flp-deleter strain (obtained from Prof. Jeroen Pasterkamp, Utrecht). The 
resultant Fbxo41lox/lox strain was used to obtain hippocampal neurons used in the 
experiments, which were then infected with either Cre in order to remove exon 4 from 
Fbxo41, or Delta Cre (ΔCre) as a control. Crossing of Fbxo41lox/lox mice with Ella-cre 
mice (obtained from The Jackson Laboratory, E2a-Cre 003724) resulted in 
Fbxo41null/null mice used for western blot (in figure 5.1C).  
 
5.5.2. Neuronal micro-dot culture 
Glial micro-islands were obtained as previously described 13,14. Briefly, glass 
coverslips were etched in 1M HCl for at least 2h, followed by washes with water, and 
1h incubation in 1M NaOH. Coverslips were sterilized in 70% EtOH, put in 12-well 
plates and treated with 1.5 mg/ml Agarose for 30 min. Afterwards, coverslips were 
stamped with poly-D-lysine (Sigma, P6407)-collagen (0.5 mg/ml, 3.66 mg/ml collagen 
in 17 mM acetic acid), and sterilized with UV light for 20 minutes. Glia cells were 
obtained from P0-1 rat pups. Rat cerebral cortex was incubated 45 min at 37 oC with 
Enzyme Solution (DMEM + Glutamax (Gibco, 31966-021)), 0.2 mg/ml of L-cysteine 
(Sigma, C7352), 100 mM CaCl2 (Sigma, C7902), 50 mM EDTA (AppliChem, 
A2937.0500) and 20-25 units/ml of papain; solution was bubbled with carbogen and 
filtered before use), and then incubated for 15 minutes at 37 oC with inhibitor solution 
(DMEM + Glutamax, 10% heat-inactivated fetal bovine serum (Gibco, 10270), 2.5 
mg/ml Albumine (Bovine Fraction V; Applichem, A1391.0100) and 2.5 mg/ml Trypsin 
Inhibitor (Type II-O, Chicken Egg; Sigma, T9253)). Solution was replaced with DMEM 
culture medium (DMEM + Glutamax, 10% heat-inactivated fetal bovine serum, 1x non-
essential aminoacids (Sigma M7145), and 1x and 0.1% Penicillin-Streptomycin 
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(Gibco, 15140-122)). Cells were triturated with a fired polished pasteur pipette, 
counted and plated at a density of 8000/well.  
 
Hippocampal and cortical neurons were obtained from Fbxo41lox/lox P1 pups. Brains 
were isolated in Hanks’ balanced salt solution (Sigma, H9394) supplemented with 10 
mM HEPES (Gibco, 15630-056) and hippocampi and striatum removed. They were 
then incubated 0.25% Trypsin (Gibco, 15090-046) in Hanks-HEPES for 20 min at 
37°C. Trypsin was removed with 3x washes of Hanks-HEPES solution and triturated 
in DMEM culture medium with a fired polish pasteur pipette. Triturated cells were spun 
down for 5 minutes at 800 rpm, the pellet resuspended in Neurobasal medium (Gibco, 
21103-049) supplemented with 2% B-27 (Gibco, 17504-044), 1.8% HEPES, 0.25% 
glutamax (Gibco, 35050-038) and 0.1% Penicillin-Streptomycin, and cells counted. 
Hippocampal neurons were plated in 12-well plates at density of 1400 cells/well on 
18mm coverslips with rat gila micro-dot cultures prepared 3 days before. High density 
cortical cultures used for western blot were plated on 6-well plates previously coated 
overnight with 0.01% poly-L-ornithine (Sigma, P4957) and 2.5 μg/mL laminin (Sigma, 
L2020) diluted in sterile water.  
 
5.5.3. Western Blot 
To test FBXO41 presence in cKO mice, brain samples were isolated, weighted and 
triturated in ice-cold PBS (phosphate-buffered saline, 137 mM NaCl, 2.7 mM KCl, 6.5 
mM Na2HPO4, 1.5 mM KH2PO4) with protease inhibitor (SIGMAFAST™ Protease 
Inhibitor; Sigma-Aldrich). Samples were centrifuged for 5 min at 4oC, the supernatant 
discarded and 100μl of Laemmli sample buffer added per 0.01g of brain (2% w/v 
sodium dodecyl sulfate (SDS), 10% v/v Glycerol, 0.26 M β-mercaptoethanol, 60 mM 
Tris-HCl pH 6.8, and 0.01% w/v Bromophenolblue). Samples were vortexed and 
boiled for 5 min at 90oC, then homogenized using insulin needles, and kept at -20oC 
until further use. To test FBXO41 presence in Fbxo41lox/lox neurons infected with Cre, 
high density cortical neuronal cultures were washed with ice cold PBS, lysed with 
Laemmli sample buffer and kept at -20oC until further use. Samples were boiled for 5 
min at 90oC, homogenized and loaded on an 8% SDS-polyacrylamide gels with 2,2,2-
Trichloroethanol and transferred Polyvinylideenfluoride (PVDF) membranes (Bio-rad) 
(1 hour, 0.3 mA, 4oC). Blots were blocked in a solution of PBS containing 0.1% Tween-
20, 2% milk and 0.5% normal goat serum, and incubated with the primary antibodies 
over-night at 4oC under medium agitation. The following primary antibodies were used, 
all dissolved in blocking solution: monoclonal mouse anti Actin (1:10,000; Chemicon, 
MAB1501), polyclonal rabbit anti FBXO41 (1:500; ProteinTech, 24519-1-AP, and 
1:500 Synaptic Systems), monoclonal mouse anti-GFP (1:1500; eBioscience, 14-
6674). Blots were washed with PBS containing 0.1% Tween-20 and incubated with 
alkaline phosphatase conjugated secondary antibodies (dissolved in blocking solution) 
for 1h at room-temperature, in the dark and under medium agitation. After blots were 
washed in of PBS containing 0.1% Tween-20, incubated for 5 minutes with AttoPhos 
(Promega) and scanned using a FLA-5000 fluorescent image analyzer (Fujifilm). 
 




5.5.4. Viral infections 
For deletion of exon 4 in Fbxo41lox/lox neurons, neurons were infected at DIV0 with 
EGFP-Cre or EFGP-delta Cre (inactivate Cre used as a control) constructs created as 
previously described 15,16. These constructs contained a nuclear localization sequence 
and were GFP tagged, allowing detection of infected neurons. The constructs were 
cloned to synapsin-promoter driven constructs, and subcloned into pLenti vectors. 
 
5.5.5. Immunocytochemistry 
Animals were genotyped and Fbxo41lox/lox mice selected. Neurons were fixed at DIV 
14 using 3.7% formaldehyde (Electron Microscopies Sciences, 15680) for 15 minutes 
at room temperature.  Neurons were washed with PBS, and then permeabilized for 8 
minutes at room temperature using PBS containing 0.2% Triton X-100 (Fisher 
Chemical, T/3751/08). Afterwards neurons were incubated for 40 minutes in blocking 
solution (PBS containing 2% normal goat serum (GIBCO, 16210-072) and 0.1% Triton 
X-100) and then for 2 hours in primary antibodies, both at room temperature. The 
following primary antibodies were used, all diluted in blocking solution: polyclonal 
chicken anti MAP2 (1:20000, Abcam, ab5392), monoclonal mouse anti SMI-312 
(1:1000, Biolegend, Smi-312R), polyclonal guinea pig anti Synaptophysin-1 (1:1000, 
Synaptic Systems, 1011004). Coverslips were washed in PBS and incubated in 
secondary antibody. Secondary antibodies were conjugated with AlexaFluor dyes 
(1:1000, Invitrogen) and diluted in blocking solution. Finally, coverslips were washed, 
mounted in Mowiol-Dabco (Invitrogen) and kept at 4oC. Image acquisition was 
performed with a confocal A1R microscope (Nikon) using a 40x oil immersion objective 
(NA = 1.3). Images were acquired as single z stack and neuronal morphology was 
analyzed blindly using automated image analysis software 17. 
 
5.5.6. Electrophysiology 
Electrophysiological recordings were obtained at room temperature from DIV13-18 
isolated neurons, using whole-cell voltage clamp (holding potential -70mV), as 
previously described 14. Neurons were kept in a bath of extracellular solution 
containing 140mM NaCl, 2,4 mM KCl, 4mMCaCl2, 4mM MgCl2, 10mM HEPES and 
10mM Glucose (pH = 7.3 and Osmolarity 300 mOsmol). The intracellular solution used 
in the patching pipettes contained 125mM K+-Gluconic acid, 10mM NaCl, 4,6mM 
MgCl, 4mM K2-ATP, 15 mM Creatine Phosphate, 20U/ml Phosphocreatine Kinase 
and 1mM EGTA. (pH = 7.3 and Osmolarity 300 mOsmol). Action potentials were 
induced by a 30mV depolarization of 0.5ms (spontaneous recordings were followed 
by paired pulse measurements, 10Hz train and finally a 40Hz train with recovery 
pulses). 1st EPSC charge and amplitude were determined in the first pulse of the 10Hz 
train. Release probability is determined by dividing the charge in the first pulse of the 
40Hz train, by the estimated RRP from that same train. Recordings were made blind, 
and only analyzed when the estimated series resistance was lower than 12 mΩ and 
leak current lower than 500pA. The readily releasable pool was estimated by back-
extrapolation of the cumulative charge from the last 30 pulses of 100 pulses at 40Hz 
train. Inhibitory neurons were identified and excluded based on the decay of 
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postsynaptic currents. MultiClamp 700B amplifier, Digidata 1440 A, and pCLAMP 10.3 
software (Molecular Devices). Data was analysed blind using a custom-written Matlab 
program R2017a (Mathworks). 
 
5.5.7. Statistics 
Statistical analysis was performed using GraphPad Prism 8.0 software, and all 
statistical details can be found in Supplementary Table S5.1. Normality was tested 
using D’Agostino & Pearson test. A p value of ≤ 0.05 was considered statistically 
significant. The following code was used to signify significance: * ≤ 0.05; ** ≤ 0.0021; 
*** ≤ 0.0002; *** ≤ 0.0001. 
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5.2C Dendritic Length (mm) 
ΔCre 1.59 0.065 133 6 No Mann-Whitney 
(U= 10854; p= 0.80) Cre 1.57 0.058 166 6 No 
5.2D Axon Length (mm) 
ΔCre 1.89 0.15 75 6 No Mann-Whitney 
(U= 2275; **p= 0.0092) Cre 2.36 0.15 80 6 No 
5.2F Number of Synapses 
ΔCre 716 54.2 32 3 Yes Mann-Whitney 
(U=538.5; p=0.0607) Cre 605.7 55.1 45 3 No 
5.2G Number of Synapse per µm 
ΔCre 0.37 0.01 32 3 Yes Unpaired t-test 




ΔCre 63.0 4.8 32 3 No Mann-Whitney 
(U=693; p=0.79) Cre 65.7 6.0 45 3 No 
5.4B mEPSC Amplitude (pA) 
ΔCre 26.8 2.4 14 5 Yes Mann-Whitney 
(U=85; p=0.57) Cre 25.9 2.6 14 5 No 
5.4C mEPSC Frequency (Hz) 
ΔCre 22.8 5.2 14 5 No Mann-Whitney 
(U=66; p=0.15) Cre 13.3 2.6 14 5 Yes 
5.4D EPSC Charge (pC) 
ΔCre 240 59.6 22 5 No Mann-Whitney 
(U=260; p=0.36) Cre 150.7 24.6 28 5 No 
5.4E EPSC Amplitude (nA) 
ΔCre 18.2 3.8 22 5 No Mann-Whitney 
(U=252; p=0.28) Cre 13.1 2.5 28 5 No 
5.4H 
1st Recovery Pulse Amplitude 
(nA) 
ΔCre 10.66 2 19 5 No Mann-Whitney 
(U=173; p=0.49) Cre 9.28 2.1 21 5 No 
5.4I 
Readily Releasable Pool 
Charge (nC) 
ΔCre 0.86 0.24 19 5 No Mann-Whitney 
(U=147; p=0.24) Cre 0.46 0.68 20 5 Yes 
5.4J Release Probability (%) 
ΔCre 28.3 3.6 17 5 No Mann-Whitney 
(U=155; p=0.66) Cre 31.8 4.5 20 5 No 
5.4K 
Paired Pulse Ratio (20msec) 
ΔCre 0.74 0.05 19 5 Yes Mann-Whitney 
(U=196; p=0.25) Cre 0.80 0.04 26 5 Yes 
Paired Pulse Ratio (50msec) 
ΔCre 0.72 0.04 19 5 Yes Mann-Whitney 
(U= 159; *p=0.0435) Cre 0.85 0.04 26 5 Yes 
Paired Pulse Ratio 
(100msec) 
ΔCre 0.75 0.05 19 5 Yes Mann-Whitney 
(U=150; *p=0.0255) Cre 0.87 0.03 26 5 Yes 
ΔCre 0.76 0.04 19 5 Yes Mann-Whitney 
Chapter 5 
 136 
Paired Pulse Ratio 
(200msec) 
Cre 
0.85 0.02 26 5 No 
(U=171; p=0.0827) 
Paired Pulse Ratio 
(500msec) 
ΔCre 0.79 0.04 19 5 No Mann-Whitney 
(U=177; p=0.11) Cre 0.86 0.02 26 5 Yes 
Paired Pulse Ratio 
(1000msec) 
ΔCre 0.81 0.04 19 5 No Mann-Whitney 
(U=205; p=0.34) Cre 0.86 0.02 26 5 Yes 
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CHAPTER 6  
 
 
Summary and General Discussion 
 
6.1. Summary of main results 
In this thesis we characterized the function of Fbxo41 in neuronal signaling and brain 
development. We show that FBXO41 interacts with SKP1 and cullin 1 in an E3 
ubiquitin ligase SKP1-cullin-F-Box protein (SCF) complex and localizes at 
centrosomes, from which primary cilia emanate (Chapter 2). Accumulation of FBXO41 
at centrosomes disassembles primary cilia and affects Sonic Hedgehog (SHH) 
signaling. FBXO41 mediates cilia disassembly through aurora a kinase in proliferative 
cells, but not in neurons, while actin polymerization impacts FBXO41 dependent 
disassembly in both cell types. In addition, we identify the phorbol ester PDBU as a 
trigger of neuronal cilia disassembly, also in the absence of FBXO41. Hence, FBXO41 
is sufficient but not required for cilia disassembly in neurons.  
 
Cilia are important for brain function and maturation (reviewed in 1), we therefore 
tested the effects of FBXO41 depletion on neurotransmission (Chapter 3) and dentate 
gyrus development (Chapter 4). In FBXO41 knockout (KO) neurons, neurite length, 
dendritic branching and synaptic density is normal compared to WT controls. 
However, synaptic transmission is less efficient. Hippocampal glutamatergic neurons 
lacking FBXO41 show decreased release probability which, with the relatively small 
sample size in our study, does not accumulate in significant effects on evoked 
postsynaptic current (EPSC) amplitudes. However, the effect on striatal GABAergic 
neurons appears more robust with a reduced readily releasable vesicle pool and 
decreased charge transfer during repetitive stimulation. These neurons also have less 
Synaptophysin at synapses, which may point to reduced vesicle numbers at 
GABAergic terminals. Dentate gyrus (DG) development is affected in Fbxo41 KO with 
a smaller overall size and less radial glial-like (RGL) cells and immature neurons, and 
delayed migration of neurons from the hilus to the granule cell layer (GCL). During 
brain development, neurons not only have to organize but also establish efficient 
connections to produce functional networks. In Fbox41 KO, network activity in the DG 
is perturbed with delayed increase in activity and synchronicity during early postnatal 
development.  
 
In order to better characterize the role of FBXO41 during development, we generated 
a conditional Fbxo41 KO (cKO) mouse model (Chapter 5). By deleting exon 4 of the 
Fbxo41 gene we were able to delete full length Fbxo41, but a truncated variant arose 
probably due to exon skipping, which was expressed at lower levels compared to full 
length FBXO41. Neurons lacking full length FBXO41 have increased axonal length 




Overall, our studies uncovered several traits of FBXO41 (Fig. 6.1): it 1. is an E3 ligase; 
2. accumulates at centrosomes, and regulates cilia length; 3. contributes to efficient 
neurotransmission; 4. regulates development of the dentate gyrus.   
 
  
Figure 6.1 – FBXO41 affects centrosomal and synaptic functions, impacting neuronal 
communication and hippocampal development. 
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6.2. FBXO41 as an E3 ubiquitin ligase component 
F-box proteins are characterized by their F-box domain, through which they interact 
with SKP1 and cullin 1 forming an E3 ubiquitin ligase complex and participating in the 
ubiquitin proteasome system (UPS) pathway (reviewed in 2,3). SCF complexes are 
formed by a cullin 1 scaffold, a SKP1 adaptor, and an F-box protein, which interacts 
with the target protein for ubiquitination 2-4. Even though cullin 1 is the classical cullin 
in SCF complexes, there are 7 human cullins. FBXW8, for example, can interact with 
Cullin7 and SKP1, forming a non-classical SCF complex, arguing that the composition 
of these complexes is flexible 5. Also, F-box proteins can have SCF-independent 
functions (reviewed in 6,7). F-Box FBH1 has DNA helicase activity, when on its own or 
when in a SCFhFbh1 complex 8,9. MokA (FBXO38) coactivates KLF7, even though 
ubiquitination of KLF7 by Moka is not detected 10. FBXO22 interacts with and activates 
serine racemase, implicated in brain function, without affecting its turnover or targeting 
to the proteasome 11. Taken together, F-box proteins are characterized by the 
presence of an F-box domain, essential for interacting with SKP1 and a cullin to form 
a SCF complex and ubiquitinate proteins, in addition to other SCF-independent 
functions.  
 
FBXO41 assembles in an E3 ligase complex (Fig. 6.1A). We and the Stegmüller lab 
show that FBXO41 interacts with SKP1, and this interaction is dependent on the 
integrity of the F-box domain (Fig. 2.1A and personal communication). In addition, we 
show that FBXO41-SKP1 forms a complex with cullin 1, albeit less efficiently than 
FBXO21 (Fig. 2.1A). In contrast, the Stegmüller lab observed that FBXO41 interacts 
with cullin 7 and not with cullin 1 (personal communication). Different experimental 
conditions may explain these discrepancies, but regardless both conclude that 
FBXO41 forms a SCF complex, either with cullin1 or 7, or both. Finally, experiments 
from the Stegmüller lab confirmed that FBXO41 ubiquitinates neurofilament medium 
polypeptide (personal communication). Given that FBXO41 interacts less strongly with 
cullin1 than FBXO21 (Fig. 2.1A), and that so far only one ubiquitination target of 
(A) FBXO41 can form an E3 ligase complex therefore targeting proteins for ubiquitination. A cascade 
of reactions catalyzed by E1 activating, E2 conjugating enzymes and E3 ubiquitin ligases leads to 
the binding of ubiquitin to a target protein, Protein X. Protein X location, function and levels might be 
regulated, depending on the ubiquitination signal. In the absence of FBXO41, there is no 
ubiquitination and the normal function of the protein might be disturbed.  
(B) Removal of Fbxo41 results in less efficient synaptic transmission. This probably results from 
perturbances of functioning of the FBXO41 target protein in the synapse.  
(C) Removal of Fbxo41, which accumulates at centrosomes, might affect radial glial like (RGL) cell 
division. RGL can divide asymmetrically, originating new RGL and neurons, or symmetrically, 
generating more RGL. In this way, the pool of neural stem cells is maintained ensuring new neurons 
can be formed. We propose that in Fbxo41 KO mice there is an increase in asymmetrically dividing 
RGLs. At first, this would increase the number of neurons formed, while the RGL pool would be 
decreased compared to WT. As the RGL pool would deplete, the numbers of newly formed neurons 
would also be reduced. As the mature neurons accumulate, their numbers would be first higher in 
the Fbxo41 KO compared to WT, than would normalize, and eventually would also be fewer.    
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FBXO41 was detected, additional E3 ligase-independent functions cannot be 
excluded. 
 
6.3. FBXO41 as a regulator of cilia length 
GFP-tagged FBXO41 targets to centrosomes. Also, subcellular fractionation 
experiments in cultured granule neurons revealed endogenous FBXO41 in the 
centrosome fraction 12. So, what is the function of FBXO41 at centrosomes? We show 
that FBXO41 accumulation in the centrosome reduces the percentage of ciliated 
neurons and cilia length (Chapter 2). An FBXO41 mutant that targets to centrosomes 
but lacks the F-box domain, does not affect cilia length, showing that F-box domain 
interactions, likely with SKP1, are required (Fig. 2.4). The ciliary axoneme is in 
dynamic equilibrium between assembly and disassembly, thereby establishing its size 
(reviewed in 13,14). Overexpression of FBXO41 after cilia formation induces deciliation 
(Fig. 2.3), showing that FBXO41 can induce cilia disassembly. Collectively these data 
show that FBXO41 accumulation at the centrosome induces ciliary disassembly, 
requiring a functional F-box domain.  
 
6.3.1. FBXO41-induced cilia disassembly mechanisms differ between neurons and 
mitotic cells 
FBXO41 regulates ciliary length through different mechanisms in neurons and mitotic 
RPE cells. Inhibition of aurora a kinase or actin polymerization prevents FBXO41 
induced deciliation in RPE cells (Fig. 2.6). In neurons however, aurora a kinase 
inhibitors do not rescue, and actin polymerization inhibitors only partially rescue the 
FBXO41 induced cilia disassembly (Fig. 2.6). Aurora a kinase’s role in ciliary 
disassembly was first described in RPE cells, in response to serum induced cell 
division 15. In addition, aurora a kinase is extensively linked to the cell cycle (reviewed 
in 16). Aurora a kinase is present at centrosomes in neurons 17,18, where its inhibition 
affects neuronal migration 18. However, whether aurora a kinase controls cilia size in 
neurons is unknown. Neurons are post-mitotic cells that lack proliferative capacity and 
rely on robust ciliary signaling capacity throughout their life. As such, neurons might 
have developed alternative and redundant mechanisms to ensure cilia function. 
Redundant mechanisms for controlling cilia have been previously described. In 
Zebrafish, the MST1/2-SAV1complex – a core component of the Hippo pathway 
involved in organ size control and development – regulates ciliogenesis through two 
mechanisms: one dependent and one independent of aurora a kinase 19. Besides 
aurora a kinase, actin is also a hub for cilia size regulation (reviewed in 14). Inhibition 
of actin polymerization partially recues the reduction in cilia length induced by FBXO41 
overexpression (Fig. 2.6). This indicates that actin’s role in controlling cilia size might 
be more central in neurons than aurora a kinase. A more important role for actin in 
cilia size regulation is in line with it being a central component of cell’s cytoskeleton, 
which extensively interacts with microtubules to influence cell function (reviewed in 20). 
Collectively, our data identify FBXO41 as a novel regulator of cilia size in neurons, and 
reveal differences in cilia size regulation in mitotic and postmitotic cells.  
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6.3.2. FBXO41 is not required for cilia disassembly 
Cilia length is not affected when Fbxo41 is depleted with shRNA (Fig. 2.3) or in Fbxo41 
KO (data not shown). In addition, ciliary disassembly can be induced in neurons in the 
absence of FBXO41 (Fig. 2.5). Hence, FBXO41 is not required for cilia disassembly. 
Cilia assembly and disassembly are related, but independent, processes. Other 
proteins have been shown to affect cilia size when overexpressed, but not when 
removed, such as aurora a kinase 15, TCTEX-1 21, HDAC6 22 and NEK2 23. Importantly, 
these proteins are required for cilia disassembly induced by cell division in mitotic cells. 
Neurons are postmitotic, hence mitosis is a non-relevant trigger for cilia disassembly 
in neurons. In a search for neuron-specific triggers we observed that cilia disassembly 
can be induced by the phorbol ester phorbol 12,13-dibutyrate (PDBU), a diacylglycerol 
analog and activator of protein kinase C (PKC). This effect persisted in the absence 
of FBXO41. In contrast, in mitotic epithelial cells, phorbol myristate acetate (PMA) – a 
similar PKC activator – elongates cilia, which coincides with actin cytoskeleton 
rearrangement 24. In addition, cytokine induced ciliary elongation in chondrocytes and 
epithelial cells is prevented by PKC inhibitors 25,26. Hence, unlike in neurons, in these 
cells PKC activation induces cilia elongation, highlighting yet another difference in 
ciliary size control in mitotic and post-mitotic cells. In conclusion, we identify PDBU as 
a novel regulator of cilia length in neurons, in a mechanism independent of FBXO41.  
 
A question that emerges from our studies is whether Fbxo41 KO neurons have deficits 
in ciliary signaling, even though their structure is unaffected. The experiments on 
dentate gyrus development provide some insight (Chapter 4). Cilia and SHH signaling 
have been extensively linked to brain development and patterning (reviewed in 27). 
Even though Fbxo41 KO brains are smaller 12, no abnormalities were detected in 
overall brain patterning (Chapter 4). In addition, cilia function has been extensively 
linked to the cell cycle 14. In our experiments cell division was only mildly affected (Fig. 
4.2 and 4.3). This indicates that ciliary disassembly induced by cell division can occur 
in the absence of FBXO41. Hence, two important aspects of cilia signaling, patterning 
and cell division are not significantly affected in absence of FBXO41. Cilia have also 
been linked to neuronal migration 28-31. Both our and a previous study indicated 
migration defects in Fbxo41 KO mice hippocampus and cerebellum 12. These defects 
might be due to ciliary deficits induced by Fbxo41 KO, but further experiments are 
required to prove this hypothesis. 
 
In conclusion, overexpressed FBXO41 targets to the centrosome and disassembles 
primary cilia, affecting ciliary signaling; however, FBXO41 is not required for normal 
cilia structure or PDBU-induced cilia disassembly in neurons. This indicates that 
neurons have redundant mechanisms to modulate ciliary size in absence of FBXO41, 
while migration defects suggest a putative role for FBXO41 controlling cilia signaling.   
 
6.4. FBXO41 as a synaptic transmission modulator 
The UPS has been extensively linked to synaptic function and plasticity. 
Pharmacological inhibition of the proteasome with MG132 or lactacystin affects 
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synaptic transmission in models ranging from Aplysia to mammals (reviewed in 32-34). 
The reverse is also true, as proteasomal function and location is regulated by neuronal 
activity (reviewed in 32-34). As target recognition modules, E3 ligases are vital for UPS 
specificity. Predicting the effects of protein ubiquitination impairment upon deletion of 
a E3 ligase is difficult, but some examples exist. SCRAPPER is a brain-enriched F-
box protein that ubiquitinates Rab-3-Interacting Molecule 1 (RIM1), targeting it for 
proteasomal degradation 35. Scrapper KO mice have increased RIM1 levels and 
increased mini EPSC (mEPSC) frequency, which is rescued when RIM1 levels are 
reduced 35. In mice, stress reduces excitatory neurotransmission via ubiquitination of 
glutamate receptor subunits by NEDD4 and FBX2 36. Proteasome inhibition or 
knockdown of these E3 ligase subunits prevents the effect of stress on glutamatergic 
currents 36. In Drosophila, Highwire ubiquitinates and regulates the levels of 
nicotinamide mononucleotide adenyltransferase (dNmnat) 37. Highwire mutants have 
increased levels of dNmnat and neurotransmission defects that are rescued when 
dNmnat levels are restored 37. Hence, modulation of protein levels by the UPS can 
influence synaptic transmission. 
 
In addition, other proteasome-independent roles of the UPS in neuronal function have 
been described. For instance, neuronal activity triggers ubiquitination and endocytosis 
of AMPA receptor subunits. Mutations in AMPA receptors preventing ubiquitination 
prevented their sorting to late endosomes and degradation by lysosomes 38. Also, the 
E3 ligase Neuralized 1 catalyzes ubiquitination of the cytoplasmic polyadenylation 
element-binding protein 3 (CPEB3), which increases levels of glutamate receptor 
subunits, due to increased mRNA translation 39. Finally, the neuronal E3 ligase 
RNF220 ubiquitinates GLI proteins, key components of the SHH signaling pathway, 
which does not affect their levels, but their nuclear/cytoplasmatic localization 40. 
Collectively, these data show that ubiquitination regulates neuronal function 
independently and dependently of the proteasome, both of these are possible 
mechanisms of action for FBXO41. 
 
6.4.1. FBXO41 is a novel neuronal UPS component involved in synaptic transmission  
FBXO41 regulates synaptic transmission in isolated neurons. Our experiments 
consistently showed that FBXO41 depletion resulted in less efficient synaptic 
transmission in several models: cKO hippocampal neurons (Chapter 5), KO 
hippocampal neurons and striatal neurons (Chapter 3). The release parameters most 
strongly affected by Fbxo41 KO are different in glutamatergic and GABAergic neurons. 
These differences might result from lack of power, since similar trends are observed. 
However, they might also result from different mechanisms in both neuronal 
populations. KO hippocampal neurons show a decreased release probability and 
increase in paired pulse ratio, compared to WT controls (Fig. 3.4). In cKO hippocampal 
neurons paired pulse ratios are higher in some of the intervals tested (Fig. 5.3). These 
findings indicate that FBXO41 controls proteins that promote the release probability of 
synaptic vesicles. Several factors at the pre-synapse can influence release probability: 
calcium dynamics, expression of different calcium sensors such as synaptotagmin 1 
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or 7, the stoichiometry of Soluble NSF attachment proteins receptors (SNAREs), or 
the local accumulation and activity of priming/docking factors such as MUNC13 and 
RIM1 (reviewed in 41), all of which may be targeted by FBXO41 in order to influence 
vesicle release. Striatal GABAergic neurons show decreased charge transfer upon 
single and repetitive stimulation and a smaller RRP. Hence, FBXO41 may affect 
GABAergic transmission by controlling vesicle numbers and/or their priming at the pre-
synapse. Many of the previously mentioned factors in vesicle release also affect the 
size of the readily releasable pool, including synaptotagmin 1, SNAREs, MUNC13, 
and RIM1 42-44. As such, a single target for both neuron types may be parsimonious. 
In addition, Synaptophysin intensity at synapses, a proxy for synaptic vesicle numbers, 
was lower in Fbxo41 KO Striatal GABAergic neurons, suggesting that in addition to a 
smaller readily releasable pool, total synaptic vesicle numbers or synapse size are 
affected in these cells. Identifying the ubiquitination targets of FBXO41 will give 
important mechanistic insights in FBXO41 regulation of synaptic function (Fig. 6.1B). 
Initial studies showed that FBXO41 binds to MUNC18, however MUNC18 was not 
ubiquitinated by FBXO41. Preliminary mass spectrometry analysis comparing protein 
expression levels in WT and Fbxo41 KO hippocampus, did not show upregulation of 
obvious candidates that could explain the synaptic effects (data not shown). More in-
depth characterization of potential FBXO41 substrates will be essential for a deeper 
understanding of FBXO41 function in synapses.  
 
6.4.2. Network activity during development is affected in Fbxo41 KO mice 
During development networks display characteristic activity patterns that are believed 
to be important for their maturation (reviewed in 45). This activity is particularly 
important during early stages of development, which is when Fbxo41 KO mice start 
developing phenotypes. In addition, our results in isolated neurons show that FBXO41 
modulates neurotransmission efficacy. So, we hypothesized that FBXO41 regulates 
developmental network activity. Indeed, the normal increase in network activity and 
synchronicity during development is delayed in the absence of FBXO41 (Fig. 4.5). The 
effects on network activity are most prominent at P6. Even though the Fbxo41 KO has 
a restricted role in network activity, the effect of FBXO41 in evoked synaptic 
transmission in isolated neurons, is also reflected in less spontaneous network activity 
and synchronicity at P6. This confirms that FBXO41 also has a role in 
neurotransmission in vivo. At P6, mice seem to be particularly vulnerable to the lack 
of FBXO41, specifically in the dentate gyrus, as in addition to the network activity 
defects we also observe defects in composition and organization in these mice 
(Chapter 4), which might influence network activity. In conclusion, FBXO41 affects 
synaptic transmission both in cultures and in vivo. 
 
6.5. FBXO41 in dentate gyrus development  
Brain development is an orchestrated process with key implications for long-term brain 
function, and is influenced by FBXO41. Fbxo41 KO mice are born with normal 
mendelian ratios (Fig. 3.1), and no visible defects (data not shown). During early 
postnatal stages phenotypical differences between WT and KO littermates appear, 
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and at P14 KOs are easily distinguishable and have an 80% mortality 12. So, FBXO41 
absence is particularly detrimental in the early postnatal days, which are relevant 
stages for the formation and organization of the granule cell layer 46,47, and for the 
network activity maturation 48,49. As such, we set out to investigate these processes in 
Fbxo41 KO mice. We show that Fbxo41 KOs have a smaller dentate gyrus, with lower 
cell numbers in hilus and granule cell layer (Fig. 4.1). These defects are significant 
already at P6 (Fig. 4.1), and even earlier, at P2, the radial-glial like cell population is 
reduced (RGL; Fig. 4.3). Interestingly, this is accompanied by reduced levels of 
doublecortin (DCX+) immature neurons, but normal levels of mature NEUN+ neurons 
in the GCL (Fig. 4.2). At P6 also neuronal migration and network activity are affected 
(Fig. 4.4). As most phenotypes in Fbxo41 KO seem more prevalent at P6 it is possible 
that FBXO41 or its targets are particularly important at this timepoint. More studies 
need to be conducted to test if FBXO41 expression increases at this timepoint or if 
there is a process during development that particularly relies on FBXO41 at P6. 
Collectively, these results reveal hippocampal defects precede, and so might 
contribute to, the observable phenotypes in mice.  
 
The smaller brain of Fbxo41 KO animals may result from a decreased pool of RGL 
cells, the neural stem cells of the dentate gyrus. The reduction of GFAP+ RGL cell 
population might have diverse causes: decreased number of neuroepithelial cells, 
which originate RGL cells, reduced migration of cells from the neuroepithelium to the 
developing dentate gyrus, increased cell death, reduced cell proliferation, or defects 
in type of RGL cell division. As RGL numbers are lower already at P2, the earliest 
timepoint checked, effects on migration or on the number of neuroepithelial cells 
cannot be excluded. However, defects in these pathways would probably have bigger 
effects in brain size already at birth, and cannot explain why the number of NEUN+ 
neurons is mostly unaffected. We do not observe major defects in the number of Ki67+ 
cells – a marker of dividing but not quiescent cells 50 – so mitosis is probably not 
significantly affected in Fbxo41 KO. Neurodegeneration is also unlikely as we observe 
an effect specifically in the RGL cells, not in NEUN neurons. Previous studies showed 
increased apoptotic markers in Fbxo41 KO brains at P30, but not at P16, the earliest 
timepoint examined 12. As such, the most likely explanation is a defect in the type of 
RGL division. RGL cells can divide through symmetric self-renewing, or asymmetric 
division, originating one self-renewing progenitor and one cell that initiates 
differentiation (reviewed in 51). Differentiating cells first go through an intermediate 
proliferating stage, and then sequentially become an immature and finally a mature 
neuron (reviewed in 52). An increase in asymmetric division would form more neurons, 
while the RGL cell population would deplete. Consequently, the transiently expressed 
DCX+ marker would temporarily increase, but as the RGL cell numbers decrease 
would also be reduced. Similarly, the end-stage NEUN+ neurons would accumulate 
and at first their numbers be augmented and then normalized (Fig. 6.1C). Of note, the 
process of cell maturation after initial division can take more than 2 weeks 52,53, which 
is the window of time analyzed in our study, so we hypothesize that the effects on the 
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RGL cells would have an even bigger impact on the dentate gyrus composition at later 
timepoints.  
 
Interestingly, similar phenotypes have been reported in models of microcephaly, a 
developmental disorder characterized by a smaller brain with normal structures 
(reviewed in 54). Microcephaly is often linked to defects in the neural stem and 
progenitor cell population, and most proteins linked to microcephaly in humans are 
centrosomal (reviewed in 54). It has been suggested that microcephaly proteins 
interfere with centrosomal maturation and spindle alignment – both of which have been 
shown to influence RGL mitotic fate – thus altering the pattern asymmetric vs 
symmetric division of RGL cells, resulting in less RGL cells and a consequently smaller 
brain (reviewed in 51,54). Given that FBXO41 accumulates at the centrosome it is 
possible that a similar mechanism, in which FBXO41 interferes with centrosome 
function, affects the RGL cell population.  
 
6.6. Different models to study FBXO41 
In order to study the role of FBXO41 in the brain we used a range of model systems. 
In cellular models we analyzed FBXO41 enrichment in centrosomes where it is 
sufficient, but not required, to reduce cilia length (Chapter 2). KO models uncovered 
functions that require the presence of FBXO41, both in isolated neurons in culture 
(Chapters 3 and 5) and in slices (Chapter 4). The autaptic culture system is a widely 
used and powerful method 55-59 that allowed us to investigate the cell-autonomous 
functions of FBXO41, determine single neuron morphology and study 
neurotransmission at great detail. Using slices, we studied the role of FBXO41 in 
development and network composition and function.  
 
Classical and conditional KO models are complementary tools to study the function of 
a gene. The strategy for generating a cKO model for Fbxo41, involved inserting LoxP 
sites surrounding exon 4 of Fbxo41. Upon treatment with Cre, exon 4 would be 
deleted, induce a frame shift resulting in an early stop codon, preventing Fbxo41 
translation. However, this generated a truncated FBXO41 (Fig. 5.1), probably resulting 
from a splice variant, which corrected the induced frame shift. We concluded that this 
confounding variant rendered this model sub-optimal for our studies on FBXO41 
function. Therefore, we moved to a previously described classical full Fbxo41 KO, 
kindly provided by Dr. Judith Stegmüller. To generate this mouse model, embryonic 
stem cells (C57BL/6-Fbxo41tm1(KOMP)Vlcg) were obtained from the KOMP Repository at 
the University of California, Davis. The entire Fbxo41 gene was replaced by a ZenUB1 
reporter/selection (LacZ/neomycin) cassette, flanked by loxP sites, via homologous 
recombination (VelociGene 15414; bacterial artificial chromosome 318E13). A 
deletion of 11,374 base pairs was obtained (from 85,484,721 to 85,472,988 of 
Chromosome 6) deleting Fbxo41 exons 2 to 14. The disadvantage of such model is 
that removal of the entire Fbxo41 gene potentially disturbs genome structure more 
than removing just one exon. The Fbxo41 gene does not overlap with any other 
annotated gene. In addition, we sequenced genomic DNA around the sites modified 
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for KO generation, and no additional rearrangements were detected (data not shown). 
Both in human and mouse genome, the closest gene to Fbxo41 is Chaperonin 
Containing TCP1, Subunit 7 (Cct7), with around 1000 base pairs separating the two. 
The CCT complex of eight subunits is important for protein folding and proteostasis. 
GeneHancer – a database that predicts genes which sequence contains enhancer 
elements promoting expression of other genes 60 – predicts Cct7 expression to be 
regulated by Fbxo41. Quantitative polymerase chain reaction (qPCR) experiments, 
revealed a significant reduction of Cct7 mRNA in the Fbxo41 KO (~ 50 % reduction; 
data not shown). Preliminary mass spectrometry data revealed a ~15% downward 
trend in CCT7 protein levels in Fbxo41 KO compared to WT, although this effect did 
not reach statistical significance. Similar decreases in protein levels of the other seven 
CCT subunits were detected, which is not surprising given that they are all necessary 
to form the CCT complex. Hence, deletion of Fbxo41 may affect expression of the 
CCT complex to some extent. It is possible that regulation of Cct7 expression by 
Fbxo41 serves biological purposes as suggested by the conserved genomic location 
in mouse and human. Given the small effect size we consider it unlikely that CCT7 
levels contribute to the observed Fbxo41 KO phenotype but rescue experiments could 
test for potential confounding effects. 
  
6.7. FBXO41 mechanism of action  
As stated above, the present work uncovered FBXO41 as a centrosomal protein 
sufficient to induce cilia disassembly, required for efficient neurotransmission, 
regulating dentate gyrus size and composition, and mediating development of network 
activity. Can all these functions be combined in a single model? FBXO41 is an E3 
ligase, therefore its actions are likely mediated by ubiquitination of a target substrate. 
In addition, FBXO41 is a centrosomal protein, so its target might interfere with the cell 
cycle, and in this way modulate RGL cell fate (reviewed in 51). This is in line with our 
results showing a depletion of the RGL cells but normal numbers of differentiated 
neurons in Fbxo41 KO DG. Importantly, the different maturation states might not only 
influence the cell composition of the DG, but also the type of neurons in culture. 
Newborn and mature neurons have different electrophysiological properties  61,62. As 
such, the difference in synaptic efficacy in cultured neurons from WT and KO animals 
may result from differences in cell composition in the P1 hippocampus. In such a 
model, FBXO41’s effect on the centrosome would explain both the effects on DG 
composition and neuronal activity. Alternatively, FBXO41 might have independent 
roles in centrosomes and synapses. In fact, when overexpressed in neurons, FBXO41 
puncta can be visualized in places besides the centrosomes, for example along 
neurites and in the soma (data not shown). In addition, F-box proteins can target more 
than one protein for ubiquitination (reviewed in 3). Finally, Fbxo41 KO cultures do not 
have morphological defects, which would be expected if maturity of neurons was 
greatly altered. As such, it is more likely that FBXO41 regulates ubiquitination of 
targets that interfere with both neurotransmission and RGL cell fate. FBXO41 could, 
for example, ubiquitinate targets that mediate traffic of vesicles to synapses, readily 
releasable pool size, or calcium channels at the pre-synapse. These would influence 
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synaptic efficacy in addition to centrosomal defects. In conclusion, FBXO41 is likely to 
ubiquitinate multiple substrates affecting both centrosomal and synaptic functions. 
 
6.8. Future outlook and outstanding questions 
FBXO41 is a brain enriched UPS component, which removal has severe phenotypical 
consequences. Our studies revealed that FBXO41 is important for neuronal cilia, 
neurotransmission and hippocampal development, but also raised novel questions 
that remain to be answered.  
 
6.8.1. What are the substrates of FBXO41? 
In order to fully understand the role of FBXO41 in neurons we need to characterize 
FBXO41 ubiquitination targets. This means not only identifying which proteins can be 
ubiquitinated by FBXO41 but also determining in which conditions such ubiquitination 
takes place. Moreover, it is key to study the consequences of ubiquitination by 
FBXO41: are the proteins degraded or is their function regulated, and if so how? 
Mapping FBXO41 interactome is key to understanding Fbxo41 mechanisms of 
actions. This is, however, a complex task, as FBXO41 interactions with its targets 
might be transient, and temporally and spatial regulated.  
 
6.8.2. Is FBXO41 required for centrosomal functions? 
FBXO41 can target to centrosomes and induce ciliary disassembly. However, no 
centrosomal dysfunction was unequivocally linked to FBXO41 absence. We propose 
that during development absence of FBXO41 influences the type of RGL cell division. 
Further studies testing the effect of FBXO41 depletion on RGL cell division – length, 
type, and success rate – are necessary to validate this hypothesis. Another possible 
centrosomal function of FBXO41 is its effects on neuronal migration Fig. 4.4 and 12, 
which has been linked to cilia 28,30. To confirm such relation, we must test directly the 
effect of FBXO41 depletion on migratory capacity of neurons in vivo. Finally, Fbxo41 
KO neurons might have disturbed ciliary signaling, which can be tested directly by 
assessing their response to SHH pathway activation, and their enrichment for ciliary 
G protein-coupled receptors. Given the importance of cilia for brain development and 
function (reviewed in 1,27), further understanding the role of FBXO41 in neuronal 
centrosomes and cilia is of key importance. 
 
6.8.3. Is mature network activity influenced by Fbxo41 removal? 
Our studies revealed that spontaneous network activity during development is 
disrupted in the absence of FBXO41 (Chapter 4). Given the importance of this activity 
for network maturation and long term brain function (reviewed in 45,63), it is likely that 
network activity at later stages is affected by absence of FBXO41. In addition, our data 
in cultures (Chapters 3 and 5) revealed defects in evoked neurotransmission in the 
Fbxo41 KO, affecting excitation and inhibition. Neuronal networks have complex forms 
of organization. Inhibition of inhibition, for example, increases network activity, so it is 
hard to translate directly the results in isolated neurons to brain networks. As such, 
further studies on the effect of Fbxo41 removal on evoked network activity could give 
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us important insights into the role of FBXO41. Given the severe phenotypes suffered 
from Fbxo41 KO at early stages of development, such studies would require novel 
cKO models allowing removal of Fbxo41 in adulthood. 
 
6.8.4. Is FBXO41 a developmental protein? 
The classical Fbxo41 KO mice are born with normal mendelian ratios and with no 
apparent defects, but in early postnatal stages fail to develop properly and mortality 
beyond P14 is very high 12. The reasons why Fbxo41 KO mice die are not completely 
understood. Given that not all animals die, and that the survivors can grow and live at 
least until P60, it is possible that Fbxo41 KO mice die because they show 
developmental disturbances and lose competition to their WT littermates. De novo 
FBXO41 mutations in humans have been linked to epileptic encephalopathies 64,65, a 
group of epileptic disorders that appear early in life and in which epileptic activity 
results in neurologic disturbances 66. We did not investigate the role of FBXO41 in 
epileptic activity, but given the effects of FBXO41 in neurotransmission and its effects 
in early development, it is possible that indeed FBXO41 mutations in humans can 
result in neurodevelopmental disorders, such as epileptic encephalopathy. Given that 
neurodevelopmental disorders are highly impairing for individuals and families, and 
their mechanisms still largely unknown, FBXO41 could be an important novel player 
in development. Further studies to test the effects of FBXO41 removal on other brain 
structures during early stages of development, and the mechanisms of such 
phenotypes are relevant. In addition, it would be interesting to test the effect of Fbxo41 
removal after P14, to see if FBXO41 plays a role mostly during development or if it is 
also important in adulthood. Given the high expression of FBXO41 in the 
hippocampus, which is one of the few brain areas where adult neurogenesis takes 
place, and that FBXO41 affects the population of RGL cells in the dentate gyrus, it is 
conceivable that Fbxo41 removal affects adult neurogenesis. However, whether 
FBXO41 is expressed in RGL cells is not known.   
 
In conclusion, FBXO41 is an UPS component enriched in the brain. Our study unveiled 
novel functions for FBXO41 in neuronal cilia, neurotransmission efficacy and 
hippocampal development. This knowledge opened new avenues for future studies to 
explore. FBXO41 is an E3 ligase, and so it can flexibly regulate neuronal function. 
Given that the brain relies heavily on plasticity for function, further understanding 
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